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Adaptive immune responses are highly co-ordinated and rely upon efficient intracellular 
communication to orchestrate cell function. Phosphoinositide 3-kinase (PI3K) signalling 
is a well-studied and important positive mediator in T lymphocyte function; however the 
role for SH2-domain containing inositol phosphatase 1 (SHIP-1), a negative regulator 
of PI3K signalling, has not been so thoroughly investigated. The use of knockout 
mouse models has given an insight into the role of SHIP-1 in murine T cells, but these 
are compromised by loss of function during development which impinges upon mature 
T cell function and by the loss of non-catalytic functions of SHIP-1.  
Recent work has indicated a clear role for reactive oxygen species (ROS), specifically 
hydrogen peroxide (H2O2), in immune cell signalling and functional responses including 
migration. However like SHIP-1, the functional roles of ROS are poorly understood in 
human T lymphocytes, particularly the mechanisms by which ROS signals to alter T 
lymphocyte biology. ROS has been previously shown to activate PI3K, Mitogen 
activate protein kinase (MAPK) and Src family tyrosine kinase (SFK) signalling in a 
number of different cell types. In addition, ROS have been shown to inactivate 
phosphatase and tensin homology (PTEN), another negative regulator of PI3K, and are 
postulated to inactive SHIP-1 signalling.  
A pharmacological approach was utilised to manipulate the catalytic activity of SHIP-1 
and the cellular accumulation of ROS in primary human T lymphocytes. Remarkably, it 
was determined that both SHIP-1 activation and inhibition reduced the ligand-mediated 
functions of human T lymphocytes, including signalling, proliferation, adhesion and 
migration. Furthermore, H2O2 selectively inhibited directional migration to chemokine 
CXCL11, enhanced F-actin polymerisation and decreased actin polarisation to 
CXCL11. H2O2 required SFK signalling to induce the phosphorylation/catalytic 
activation of SHIP-1 and to decrease the surface expression of CXCR3, both of which 
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1.1 Overview of the immune system  
We depend upon our immune system’s ability to produce a co-ordinated and rapid 
response to protect us from foreign pathogens and tissue damage resultant of infection 
or trauma. To function correctly, the immune system has evolved to be complex, multi-
cellular and destructive in nature. As such, it is critical that our immune system is highly 
regulated and targeted. Dysregulation of the immune system results in a wide array of 
pathologies; under-activity increases our susceptibility to infection, whilst over-activity 
can lead to chronic inflammation and autoimmune disease. 
The immune system is commonly divided into two complementary branches; the 
immediate response is termed the innate immune system and the later more specific 
response is termed the adaptive immune system. The cells of the immune system are 
shown in Figure 1.1. 
Figure 1.1 Cells of the immune system. The majority of the cells of the immune 
systems differentiate from a common hematopoietic stem cell progenitor. Two main 
branches are generated; the left branch is the myeloid cells and right branch 
represents the lymphoid cells Although monocytes have long been described as the 
sole precursors of macrophages, recent evidence suggests that a significant number of 
tissue resident macrophages arise prenatally during embryonic development from 
progenitors derived from the yolk sac or fetal liver (Hettinger et al., 2013) (Original 
graphic). 
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1.1.1 The innate immune system  
The innate immune system is the first method of defence against a pathogen. 
Sequentially it limits pathogen entry, rapidly recruits immune cells to site of infection, 
inactivates or destroys invaders and then repairs the damaged tissue. The skin and 
epithelial cell linings of the lungs and gut are important anatomic barriers which 
normally act to prevent pathogen entry to the body. However, when these tissues 
become infected or injured an acute inflammatory response is initiated to protect the 
host. Briefly, tissue resident inflammatory cells become activated when they detect 
damage associated molecular patterns (DAMPS) or pathogen associated molecular 
patterns (PAMPS) produced by the damaged cells or pathogens, respectively. Tissue 
resident immune cells include mast cells which de-granulate and release inflammatory 
mediators including histamine, prostaglandins and leukotrienes which enhance 
inflammation, vasodilation and vascular permeability. This allows increased leukocyte 
recruitment from the blood to amplify the immune response. Phagocytic cells 
(macrophages and neutrophils) engulf debris and foreign bodies to neutralise or 
destroy the pathogen. Finally, tissue resident dendritic cells capture antigen and enter 
the lymph to co-ordinate activation of the adaptive immune system (Delves et al., 
2000b; Medzhitov et al., 2008) (Figure 1.2).  
1.1.2 The adaptive immune system  
The adaptive immune system provides a highly specific response to a specific 
pathogen. Adaptive immunity can also provide long-lasting protection: and an 
immunological memory to a specific pathogen, co-ordinating a more effective immune 
response upon subsequent exposure. To do this each adaptive immune cell specifically 
recognises only one antigen, which results in its initial response taking days to develop. 
Antigens are transported to the lymphoid organs by antigen presenting cells (APCs) 
where they are recognised by the adaptive immune cells, the naïve B-lymphocytes and 
T-lymphocytes. A humoral response is driven by B lymphocytes. Activation of B 
lymphocytes induces proliferation, maturation and the secretion of antibodies. 
Antibodies bind/block the toxicity of the pathogen and target it for phagocytosis. 
Whereas T lymphocytes drive cell mediated immunity, so called due to the T 
lymphocytes ability to detect intracellular pathogens such as viruses by recognising 
antigens presented upon the surfaces of other cells (Figure 1.2). Activated T 
lymphocytes are divided into cytotoxic (CD8+) and helper (CD4+) subsets. Both 
subsets subsequently proliferate, with CD8+ able to destroy the pathogen through the 
release of cytotoxins and CD4+ able to differentiate into effector cells which orchestrate 
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an inflammatory response against the pathogen (Delves et al., 2000a; Pepper et al., 
2011). The T lymphocytes will be discussed further in following sections. 
 
Figure 1.2 The immune response. 1) The epithelium provides an anatomical barrier 
preventing pathogen entry; but following epithelial wounding, damage or infection 
tissue resident inflammatory cells are activated. 2) Upon activation, macrophages and 
mast cells release of inflammatory mediators, such as chemokines and cytokines to 
evoke vasodilation, increase vascular permeability and promote expression of 
adhesion receptors on the endothelium of blood vessels. 3) Leukocytes are recruited 
from the blood vessels, involving tethering, rolling, adhesion, and extravasation into the 
tissue. 4) Leukocytes migrate towards the source of inflammation following gradients of 
chemoattractant. 5) Phagocytic cells (macrophages and neutrophil) engulf debris and 
foreign bodies to neutralise or destroy the pathogen. 6) Tissue resident dendritic cells 
capture antigen and enter the lymph to co-ordinate activation of the naïve T and B 
lymphocytes of the adaptive immune system. 7) Activation of lymphocytes causes their 
differentiation, clonal expansion and migration to the site of infection. Lymphocytes are 
part of the adaptive arm of the immune response, and induce cell-mediated (cytotoxic) 
and humoral (B cell antibody mediated) killing of pathogen. Finally, infection is resolved 
and wound is repaired (Original graphic). 
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1.1.3 Pathologies of immune cell regulation 
Pathologies of inflammatory regulation include 1) an overly abundant acute 
inflammatory response to pathogen (i.e. cytokine storm), 2) primary deficiencies in 
immune cells (i.e. Kostmann syndrome or chronic granulomatous disease) or 3) the 
inability of the inflammatory response to eradicate the primary initiator of the immune 
response, resulting in sustained inflammation and tissue damage (Tabas et al., 2013).  
Autoimmunity belongs to the third category, whereby most commonly the primary 
stimulator of the immune response is the body’s own cells which the immune system 
has lost the ability to recognise. As such, the immune system continually attempts to 
destroy the body’s own tissues. Autoimmune diseases arise through aberrant activation 
of the T and B lymphocytes driving a continuous inflammation state (Arkwright et al., 
2002). 
Autoimmune diseases are often associated with life changing, painful symptoms.  
There are more than eighty illnesses known to be caused by autoimmunity which most 
commonly affect women and are among the top ten leading causes of death in women 
under the age of 65. Current treatment aims to reduce the inflammation by using broad 
spectrum immunosuppression (i.e Non-steroidal anti-inflammatory drugs (NSAID) and 
steroids), which can sometimes dangerously relieve sufferers of a physiologically 
functioning immune system. As such there is a huge drive for a more targeted 
treatment which functions to suppress the ability of lymphocytes to drive inflammation 
in the first place (Walsh et al., 2000).  
Ideally, an autoimmune and inflammatory disease treatment would alter the threshold 
of immune activation to restore homeostasis, modulate antigen-specific responses to 
spare target organs and reduce immune cell migration to inhibit the enhanced 
recruitment. Therefore in order to create new treatments to target the immune system, 
a detailed understanding of the signalling pathways involved in lymphocyte functions is 
required.  
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1.2 T lymphocytes 
 
1.2.1 T lymphocyte development and maturation 
T lymphocytes originate from hematopoietic stem cells (HSCs) in the bone marrow 
which home to the thymus to mature (Miller, 2002). Development in the thymus 
requires a stringent selection process, where thymocytes mature from double negative 
(CD4-/CD8-) to either a singular positive CD4+ or CD8+ cell which expresses a self-
restricted αβTCR receptor (Figure 1.3) (Anderson et al., 2001). CD4+ and CD8+ T 
lymphocytes bind to antigen upon either Class II or Class I MHC molecules 
respectively (Germain, 1994). During development, gene rearrangement of the variable 
(V), diversity (D), joining (J) and constant (C) regions of the TCR receptor produces a 
plethora of structurally distinct TCR receptors, which allow T lymphocytes to recognise 
specific antigens.  
Singular positive CD4+ and CD8+ cells are long lived and can remain in the 
extrathymic environment for weeks or months. These naïve (prior to stimulation with 
antigen) T lymphocytes typically express low levels of glycoprotein CD44 and high 
levels of lymph node homing receptors CD62L and CCR7. Naïve lymphocytes survey 
the lymphatic system for antigen and rely on contact with self-peptides and IL-7 to 
survive and proliferate. Following activation, IL-7 can also drive the transition of naïve 
and effector T lymphocytes to form antigen specific memory T lymphocytes, cells either 
become central memory T lymphocytes (CD44hi, CD62Lhi, CCR7hi) or effector memory 
cells (CD44hi, CD62Llow, CCR7low) (von Andrian et al., 2003).  




Figure 1.3 T lymphocyte maturation in the thymus. T lymphocyte precursors (TCPs) 
migrate to the thymus from the bone marrow. These cells are termed double negative 
(DN) as they do not express either of the T cell cluster of differentiation (CD) markers 
CD4 or CD8. T lymphocyte maturation involves distinct phases that are marked 
rearrangement of the TCR receptor, as well as changes in the expression of cellular 
surface proteins. c-kit+ and CD44+ DN1 thymocytes progress to the DN2 stage by 
gaining CD25+ expression and down-regulating CD44 expression. DN2 thymocytes 
also begin to rearrange the TCRβ subunit of the TCR receptor and the cells lose their 
pluripotent ability to transform into B lymphocytes or natural killer cells. At the DN2 
stage, the TCR components begin to be rearranged forming either DN3 or T 
lymphocytes which eventually express a γδ TCR receptor. c-kit-, CD44-, CD25+ DN3 
thymocytes, express TCRβ and a pre- TCRα in a complex with CD3. CD25 expression 
is lost at the DN4 stage and cells rearrange the TCRα receptor and express CD4+ and 
CD8+ to become double positive (DP). The DP cells that bind to MHC expressed on 
epithelial cells gain signals to progress to singular positive CD8+ or CD4+ cells, this is 
termed positive selection. A stringent selection process occurs whereby T lymphocytes 
are screened for TCR reactivity to self-peptides bound to MHC molecules. Cells with 
high avidity for the peptides undergo apoptosis as they will be self-reactive, this is 
termed negative selection. However, about 98% of DP cells have very low affinity for 
the MHC presented peptide and die from “neglect” or lack of a TCR signal, termed 
positive selection. The surviving singular positive CD4+ or CD8+ cells leave the thymus 
and enter the circulation (Godfrey et al., 1993) (Original graphic).  
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1.2.2 T cell activation  
The activation of T lymphocytes is described by a two signal model. Firstly, “signal 1” 
involves the TCR engaging with a specific foreign peptide (antigen) presented upon the 
major histocompatibility complex (MHC) of an APC. The MHC protein is also bound by 
either CD4 or CD8 on the cell. Secondly, “signal 2” is initiated by the binding of 
costimulatory molecules on the surface of the T cell, typically activation of CD28 by an 
appropriate ligand such as CD80/CD86 (B7.1 or B7.2). B7.1 and B7.2 are up-regulated 
upon the surface of APCs following inflammatory cytokine exposure. The lack of co-
stimulation through CD28 commonly results in T lymphocyte anergy (McAdam et al., 
1998; Sharpe et al., 2006), a protective mechanism which prevents aberrant response 
to self-antigen (Figure 1.4).  
In addition to CD28 ligation, other molecules can also provide the co-stimulatory signal 
to activate T lymphocytes. These include the inducible co-stimulatory receptor (ICOS), 
which is expressed on activated T lymphocytes, lymphocyte function associated 
antigen 1 (LFA-1) and some β1 integrins including very late antigen-4 (VLA-4) (Van 
Seventer et al., 1990) [Figure 1.4]. The ICOS receptor shares a high level of homology 
with CD28, but exhibits a distinct expression pattern and signalling profile which 
indicates non-redundant functions. ICOS activation in often associated with the 
activation of follicular T helper cells and Treg cells (Ma et al., 2012).  
Negative regulation of TCR signalling also occurs. B7.1 or B7.2 can also inhibit T cell 
activation by binding to inhibitory co-receptors such as cytotoxic T lymphocyte antigen 
4 (CTLA-4) and programmed death 1 (PD1) (Figure 1.4). Other B7 family members, 
B7.3 and B7.4 have also been observed, however at present their binding partners and 
roles in T lymphocyte activation are not well understood (Okamoto et al., 2003). CTLA-
4 is upregulated upon activated T lymphocytes and is important in the resolution of the 
adaptive immune response (Oosterwegel et al., 1999; Smith-Garvin et al., 2009). 
Termination of TCR signalling also occurs through negative regulators such as 
phosphatase and tensin homolog (PTEN) or the Dok adaptor proteins of SH2-domain 
containing tyrosine phosphatase 1 (SHP1) (Smith-Garvin et al., 2009). Super-antigens, 
such as staphylococcal enterotoxin B (SEB) act independently of MHC to activate a 
large number of T lymphocytes irrespective of the antigen specificity of these cells 
(Alber et al., 1990).  
The TCR receptor complex does not have intrinsic enzymatic activity and relies on 
recruitment of cytoplasmic signalling molecules for propagation of the receptors signal. 
The CD3 complex contains immunoreceptor tyrosine-based activation motifs (ITAMs) 
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which provide docking sites for the recruitment of signalling molecules containing SH2 
domains. Signal transduction downstream of the TCR receptor involves multiple 
kinases and Ca2+ elevation followed by changes in gene transcription which are 
discussed further Section 1.4. The signalling has a number of crucial roles in T 
lymphocyte activation, perhaps the most important of which is the production of IL-2. 
IL-2 is a key factor in the activation and proliferation of T lymphocytes (Smith-Garvin et 
al., 2009). 
 
Figure 1.4 T cell activation and co-stimulation. “Signal 1” consists of the recognition 
of peptide antigen presented upon MHC complexes by the TCR receptor. CD4 T 
lymphocytes recognise Class II MHC which are expressed upon professional APCs, 
whereas CD8 T lymphocytes recognise Class I MHC which is expressed upon all cells. 
1) “Signal 1” alone induces anergy, or even death of the T lymphocyte. 2) However, a 
combination of “signal 1” and “signal 2”, provided by B7.1 or B7.2 on the APC binding 
CD28, directs the cell towards activation and proliferation (e.g. IL-2 production). 3) 
Upon T cell activation, inducible co-stimulatory receptor (ICOS) is upregulated and 
interacts with ICOSL to modulate the functions of the active cells. ICOS is highly 
homologous with CD28, yet exhibits key differences in signalling and expression. ICOS 
has a minimal role during naïve T lymphocyte priming or initial proliferation. However, 
in activated cells ICOS has been shown to induce greater PI3K signalling and is crucial 
in production of IL-21 and IL-4, key cytokine in the development of T follicular helper 
cells (Okamoto et al., 2003). ICOS also has a role in the function and homeostasis of 
Tregs (Tuettenberg et al., 2009). 4) Negative regulation of TCR signalling occurs 
through the interaction of B7.1 or B7.2 within CTLA4 or 5) via Programmed Death 
Ligand (PD-L) co-stimulation.  
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1.2.3 T lymphocyte differentiation and subsets  
The differentiation of naïve T lymphocytes into effector and memory cells is 
fundamental in T lymphocyte mediated cellular immunity. Activated cytotoxic CD8+ 
cells are very effective at direct lysis of infected or malignant cells which express 
antigen upon their cell surface, whereas helper CD4+ cells produce cytokines to 
stimulate other immune cells and mobilise a powerful inflammatory response. Most 
effector cells will disappear after the antigenic agent is destroyed, although some 
remain and form memory cells, which are able to perform immediate effector functions 
if re-exposed to the same antigen. 
CD4+ T helper cells acquire highly specialised functions by differentiating into distinct 
subsets. Differentiation is co-ordinated by the external cytokine environment and 
activation of specific transcription factors. CD4+ T helper cell lineages are categorised 
by their distinct surface receptor expression and cytokine production (Figure 1.5). 
Briefly, Th1 cells produce cytokines involved in activating innate immune cells and B 
lymphocyte class switching to greatly enhance their ability to kill intracellular 
pathogens. Th1 cells are implicated in the pathology of multiple sclerosis (Jager et al., 
2009). Whereas, Th2 cells are required for immunity against an extracellular pathogen 
(i.e. helminths), and are able to regulate B lymphocyte activation and antibody class-
switching to aid eosinophil recruitment and promote mucosal defence. Aberrant Th2 
responses are implicated in allergic diseases such as asthma (Zhu et al., 2010).  
Th17 cells arrive early at sites of inflammation and regulate neutrophil recruitment and 
activation. They are commonly found at epithelial barrier sites and therefore are 
thought to be involved in fighting extracellular bacteria and fungi (Korn et al., 2009). 
Th17 cells produce IL-17A, IL-17F, IL-21 and IL-22. IL-17A and IL-17F have both been 
implicated in airway inflammation (Liang et al., 2007; Fouser et al., 2008), as well as 
several autoimmune diseases including multiple sclerosis, psoriasis, inflammatory 
bowels disease, rheumatoid arthritis and systemic lupus erythromatosis (Fouser et al., 
2008; Shin et al., 2011; Pan et al., 2013). In addition, they are also thought to have 
both pro- and anti- tumour functions, with IL-17F exacerbating tumour growth by 
facilitating angiogenesis (Murugaiyan et al., 2009; Coffelt et al., 2015; Saito et al., 
2015).  
Tregs can be broadly divided into natural Treg (nTregs), which are generated in the 
thymus, and inducible Tregs (iTregs), which can be generated from naïve T 
lymphocytes in the periphery (Zheng et al., 2004; DiPaolo et al., 2007). Tregs aid 
immunological self-tolerance by suppressing self-reactive T lymphocytes (Wing et al., 
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2010). Further T lymphocyte subsets Th9 and Th22 have more recently been identified, 
which produce IL-9 and IL-22 respectively. The niche functions of these cells are 
currently being investigated, IL-9 is known to exhibit pleiotropic functions and has 
putative roles in pathogen immunity and immune-mediated disease (Kaplan et al., 
2015). IL-22 regulates auto-antibody production and restricts commensal bacteria to 
their tissue niches preventing inflammation (Raphael et al., 2014). 
 
Figure 1.5 Differentiation of CD4+ T lymphocytes into distinct subsets. The 
cytokine environment, indicated in the blue text, surrounding naïve T lymphocytes is 
able to “skew” them to specific subsets. Typical chemokine receptors associated with 
specific subsets are stated in red and the cytokines produced by specific subsets are 
shown in the black text (Original graphic).  
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1.3 T lymphocyte migration and trafficking 
 
1.3.1 Cell migration and chemotaxis 
Migration is vital to T lymphocyte function in all stages of development and activation. 
Initially, stem cells precursors have to home from the bone marrow to mature in the 
thymus. Next, naïve T lymphocytes migrate to survey the circulatory and lymphatic 
systems to maximise their likelihood of antigen detection. When activated, T 
lymphocytes enter the periphery and are distributed to aid the clearance of pathogens 
(Figure 1.9). Finally, memory T cells remain distributed throughout the organism and 
provide localised immuno-surveillance to detect and induce a rapid response to a 
previously detected antigen. T lymphocytes function locally and their migration is 
required to be highly co-ordinated. Therefore, understanding the mechanisms which 
manipulate T lymphocyte migration may lead to the development of treatments of 
diseases mediated by T lymphocytes. However, cell migration is complex and involves 
multiple signalling mechanisms which can be distinct depending upon the 
developmental stage of the T lymphocyte (Marelli-Berg et al., 2008). 
The key features which are reported to influence the migration of immune cells include 
1) anatomical borders, 2) adhesion to other cells or extracellular matrix, 3) physical and 
chemical signals which trigger migration and 4) directional cues that guide the cells 
(Sixt, 2011). Immune cells are able to migrate in the absence of direction cues this is 
termed chemokinesis (Massberg et al., 2007), however immune cells often undergo co-
ordinated and directional migration in response to specific external chemical signals, 
termed chemotaxis. 
Chemotaxis was first described in bacteria by Pfeffer (Pfeffer, 1884) and later in 
phagocytic leukocytes by Metchnikoff (Metchnikoff, 1893). Since then cell migration 
has been intensely researched. Co-ordinated migration depends upon the formation of 
chemoattractant gradients which cells detect and prioritise. Exposure to a 
chemoattractant gradient leads to small spatial or temporal differences in cell receptor 
activation that are amplified intracellularly to induce actin polymerisation and protrusion 
formation at the side of the cell facing the highest concentration of chemoattractant. A 
polarised morphology is then stabilised by positive-feedback loops at the front of the 
cell and inhibitory signals in the rest of the cell (Swaney et al., 2010; Insall, 2013; Reig 
et al., 2014). Thus, receptor activation is described to generate a local asymmetric 
accumulation of intracellular signalling molecules or “chemotactic compass” toward the 
highest concentration of chemoattractant. 
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1.3.2 Chemoattractant gradients 
The most frequently investigated chemoattractants are formyl peptides (i.e formyl-
methionine-leucine-phenylalanine [fMLP]) and chemokines (Section 1.3.4). Size, 
polarity, diffusion rate and reactivity, as well as the nature of its surrounding 
environment all affect the ability of a given chemoattractant to form and maintain a 
stable gradient. Chemoattractants are produced, often in precise spatial locations, and 
then diffuse to form a gradient which can spread over short or long distances 
(Majumdar et al., 2014). Gradients can also be maintained by immobilisation of the 
chemoattractant on tissues by binding to heparin sulphates (Shute, 2012).   
Gradients of small highly diffusible molecules are less likely as they are rapidly 
diffusible and thus would be unable to maintain a gradient long enough to convey 
signals to migrating cells. However, interestingly hydrogen peroxide (H2O2), a highly 
diffusible molecule, has been shown to form a gradient 100-200μm into injured 
zebrafish tail fin epithelium. The H2O2 gradient is maintained by a graded expression of 
a its synthesising enzyme. The injured zebrafish epithelia express higher levels of H2O2 
producing NADPH oxidase dual oxidase (DUOX) in cells with higher degrees of injury 
allowing a gradient of H2O2 to be produced (Niethammer et al., 2009). The importance 
of reactive oxygen species and H2O2 in immune cell migration is discussed in more 
detail in Section 1.6.  
Most models of cell migration assume that a chemotactic gradient encountered by the 
cell is at a steady state, static and spatially stable. Moreover, it is often assumed that 
the gradient is simply created by diffusion of the chemoattractant from the source site 
towards a target cell (Schneider et al., 2006). However, in a physiological setting there 
are several other important parameters which could alter the formation and stability of a 
chemokine gradient. These include the decay of the chemoattractant, which can 
depend upon the distance of the chemoattractant from a secreting source, 
sequestration by the extracellular matrix, self-generation resulting in an amplified signal 
and modification by extracellular enzymes. Therefore in a given environment, cells 
could be exposed to dynamic and discontinuous gradients (Majumdar et al., 2014). 
Additionally, cells might detect more than one chemoattractant therefore must be able 
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1.3.3 Polarisation and gradient sensing 
The ability of a cell to detect the external chemoattractant gradient governs directed 
cell migration. Remarkably, many cells can detect less than a 5% difference in 
chemoattractant concentration between the front and back of the cell (Zigmond, 1977; 
Parent et al., 1999; Brzostowski et al., 2004). Cells will constantly monitor the chemical 
concentration of chemoattractant over-time through spatial sampling.  
Several theories exist to explain how detection of chemoattractant at cell surface 
receptors, typically GPCRs, leads to the formation of polarised protrusions and 
directional migration. As described earlier, the “chemotactic compass” model suggests 
localised accumulation of signalling molecules towards the highest concentrations of 
chemoattractant. The asymmetric distribution of the product of PI3K signalling 
PI(3,4,5)P3 at the front of the cell is a hallmark of cell polarisation (Wang et al., 2002a; 
Wang, 2009). PI3K accumulates at the front of the cell, whereas negative regulator 
PTEN is found at the rear of the cell. This localised signalling drives the accumulation 
of downstream small GTPases Rac and Cdc42 to the leading edge of the cell and 
forms a signalling compass directing the cell towards the chemoattractant gradient. An 
alternative model describes chemotactic bias, whereby the chemoattractant bias the 
organisation of protrusions without the need of a signalling compass (Insall, 2010; 
Insall, 2013).  
The main feature of a cell migrating on a 2D surface is the loss of its rounded 
morphology; instead the cell spreads and develops multiple peripheral protrusions, 
named lamellae and finger-like filopodia (Ridley et al., 2003). The cell becomes more 
adherent and one lamellae becomes broader and dominant to become the front of 
polarised cell (Lamellipodia). The cell moves in the preferred direction by repeating 
cycles of protrusion of the front region driven by Cdc42 and Rac activation, adhesion to 
the substrate, detachment of the cell body and rear, and finally the cytoskeleton 
contraction to pull the cell forward (Sixt, 2011; Sixt et al., 2011; Majumdar et al., 2014) 
Rho, myosin II and Ca2+ -activated proteases work together to alter actomyosin 
contractility and de-attachment of the cell (Majumdar et al., 2014). In vivo imaging in 
Zebrafish neutrophils indicates that lamellipoda contain highly branched actin filaments 
containing dynamic F-actin, whereas stable F-actin localises to the back of the cell 
(Yoo et al., 2010).  
 




Figure 1.6 Signalling pathways in immune cell polarisation. Upon detection of a 
chemoattractant gradient, PI3K signalling and PIP3 generation is increased at the 
leading edge of the cell. This leads to the activation of small GTPases Rac and Cdc42 
and subsequent actin polymerisation at the leading edge. At the rear of the cell, 
phosphatase and tensin homologue (PTEN) prevents PI3K-mediated PIP3 
accumulation and myosin contraction is driven by small GTPase RhoA. Adapted from 
(Deng et al., 2012) and (Yoo et al., 2010). 
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1.3.4 Chemokines and their receptors 
Chemokines are a large family of small 8-10kDa chemoattractant proteins which act to 
regulate immune cell recruitment (Kim et al., 1999). There are at least 50 known 
chemokines, however only 20 functional receptors have been described and subgroups 
of chemokines commonly bind to the same receptor on a target cell. Although 
chemokines have low sequence identity (Wells et al., 1999), their three dimensional 
structure exhibits homology (Clark-Lewis et al., 1995) and they are subdivided into four 
subfamilies based on the position of highly conserved cysteine residues, namely C, 
CC, CXC and CX3C (Nomenclature 2001; Bacon et al., 2002) which are shown in table 
1.1. 
The CXC chemokines are further subdivided according to the presence of tri-peptide 
motif glutamic acid-leucine-arginine (ELR) motif in their NH2 terminal region. Broadly, 
ELR+ chemokines are angiogenic and attract neutrophils to the sites of inflammation. 
Whereas ELR- chemokines, CXCL4, CXCL19, CXCL10, CXCL11-14, and CXCL16 are 
angiostatic and attract lymphocytes and monocytes (Laing et al., 2004). Chemokines 
can also be divided by their functional properties; the “homeostatic” are constitutively 
expressed, whereas the “inflammatory” chemokines are upregulated following 
inflammatory signals.  













CCR1 CCL3, CCL5, CCL7, CCL8, CCL14, CCL15, 
CCL16,CCL23 
T, Mo, Eo, Ba 
CCR2 CCL2, CCL8, CCL7, CCL13, CCL16 Mo, D, T
mem
 
CCR3 CCL5,CCL7, CCL8, CCL11, CCL13, CCL15, CCL24, 
CCL26, CCL28 
Eo, Ba, MC, 
Th2, P 
CCR4 CCL17, CCL22 Th2, D, Ba 
CCR5 CCL3, CCL4,CCL5, CCL8, CCL13, CCL16 T, Mo 
CCR6 CCL20, CCL21 Treg, Tmem, B, 
D 
CCR7 CCL19, CCL21 T, DC 
CCR8 CCL1, CCL18  Th2, Treg  
CCR9 CCL25  










CXCR1 CXCL6, CXCL8, N. Mo 
CXCR2 CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, 
CXCL8 
N, Mo, En 
CXCR3 CXCL9, CXCL10, CXCL11 Th1, CD8, NK 
CXCR4 CXCL12  Ubiquitous 
CXCR5 CXCL13 B, Tfh 
CXCR6 CXCL16 NKT, ILC 
CXCR8 CXCL17 Mucosal 
tissue, Mo 
CX3C  CX3CR1 CX3CL1, CCL26 Mac, En, SMC 













 ACKR1  CCL2, CCL7, CCL8, CCL13,CCL14, CCL17, CCL22, 
CXCL1, CXCL5, CXCL6, CXCL7, CXCL8, CXCL9, 
CXCL11, CXCL13  
Erythrocytes, 
neurons, VEC 
ACKR2 CCL2, CCL3, XXL3L1, CCL4, CCL5, CCL7, CCL8, 
CCL11, CCL13, CCL14, CCL17, CCL22  
B 
ACKR3  CXCL11, CXCL12  
ACKR4  CCL19, CCL21, CCL25, CXCL13 En 
Table 1.1 The chemokine superfamily. Adapted from (Zlotnik et al., 2012) and (Graham et al., 
2012). Chemokine ligands and their receptors are classed into families based on the location of 
cysteine residues. Atypical chemokine receptors can influence the activity of other chemokines 
but do not signal through classical pathways. T=T lymphocyte; B = B lymphocyte; Mo = 
monocyte; Eo = Eosinophil; Ba = Basophil; D= dendritic cell; Tmem = memory T cell; Th = T 
helper cell; NK = natural killer cell; MC = Mast cell; N= neutrophil, P= platelet, Treg = regulatory 
T cell, En= endothelial cell, Mac = Macrophage; SMC = smooth muscle cell; HSc = 
hematopoietic stem cell, VEC = vascular endothelial cells. 
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Typical chemokine receptors are members of the G-protein coupled receptor family 
(GPCR), are 340-370 amino acids in length with 25-80% homology (Murphy et al., 
2000). GPCRs couple with intracellular heterotrimeric G-proteins, which undertake their 
down-stream signalling, this is discussed further later in Section 1.4. Chemokines bind 
to their receptors with nanomolar affinity and binding often is class restricted, for 
example CXC chemokines only bind to CXC receptors, with the exception of ACKR2 
which binds CC and CXC chemokines (Murphy, 1996).  
Atypical chemokine receptors are cell surface receptors with seven transmembrane 
domains that are structurally homologous to GPCRs. However, upon ligation of by their 
cognate chemokines, atypical chemokine receptors fail to induce classical down-
stream signalling. Atypical chemokine receptors can impact on the activity of other 
chemokine ligands by altering chemokine availability and function (Ulvmar et al., 2011; 
Graham et al., 2012).   
 
1.3.5 Chemokine receptor internalisation  
GPCR signalling can be regulated at the level of receptor expression on the cell 
surface. Internalisation of the receptor reduces the amount of available GPCR on the 
cell surface, thus attenuating receptor mediated signalling (Lefkowitz, 1998; Morris et 
al., 1999). Following ligand activation, most GPCRs are internalised into endosomes 
and then either targeted for lysosomal degradation or recycled back to the plasma 
membrane. 
There are two main pathways of GPCR internalisation which are (1) arrestin/clathrin pit 
or the (2) lipid/raft caveolae dependent mechanisms. (1) Briefly, intracellular domains 
of the receptors are phosphorylated by kinases such as GPCR kinases (GRKs) which 
decrease the interaction of the GPCR with G proteins and increase their interaction 
with β-arrestin. β-arrestin binding further inhibits G protein interaction and can activate 
distinct arrestin-mediated signalling. Furthermore, β-arrestins can directly link with 
clathrin coated pits to enhance receptor endocytosis (Ferguson, 2001; Luttrell et al., 
2002; Kohout et al., 2003; Kohout et al., 2004). (2) It is thought that GPCR signalling 
components concentrate in membrane micro-domains such as caveolae and lipid rafts 
in order to undertake rapid signalling, however although it is less well understood that 
internalisation of receptors in caveolae has been observed and requires dynamin (Chini 
et al., 2004; Calizo et al., 2012) (Figure 1.7). 
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A considerable amount of our knowledge about chemokine receptors was initially 
determined for other GPCRs, including information about receptor trafficking. A few 
chemokine receptors, including CXCR1, CXCR2, CXCR4 and CCR2 and CCR5, have 
been more thoroughly investigated and it has been determined that like other GPCRs, 
chemokine receptor desensitization involves removing them from the plasma 
membrane by endocytosis. Although trafficking appears to be a conserved trend 
between chemokine receptors, the mechanisms appear to vary between individual sub-
types (Borroni et al., 2010; Bennett et al., 2011). 
Surface expression of chemokine receptors can also be altered by gene expression, 
mRNA stability and protein degradation as well as trafficking. This can lead to both up-
regulation and down-regulation of the chemokine receptor (Schioppa et al., 2003; 
Mehta et al., 2007). Expression of chemokine receptors has to be tightly regulated and 
their expression profile is altered dependent on an individual cells differentiation, 
activation and polarisation.  
Chemokines receptors can be internalised via clathrin or caveolin-dependent 
endocytosis, although interestingly other independent pathways have also been 
reported (Borroni et al., 2010). CCR2 and CCR5 have been shown to follow both 
clathrin-dependent and caveolae-mediated internalisation pathways and their route of 
endocytosis could be cell-type dependent (Andjelkovic et al., 2002; Signoret et al., 
2005; Garcia Lopez et al., 2009). Sorting of internalised receptor requires complex 
interactions with intracellular components including PDZ ligand motif and ubiquitination, 
which support recycling or degradation, respectively. At least 12 chemokine receptors 
contain the PDZ domain suggesting they are recycled (Borroni et al., 2010). For 
CXCR4, CXCL12 stimulation appears to lead to ubiquitination and degradation 
(Marchese et al., 2001; Mines et al., 2009). 
 
Here, the specific interest is CXCR12/CXCR4 homeostatic migration and 
CXCL11/CXCL10/CXCR3 inflammatory migration of naïve and activated T 
lymphocytes, respectively. Chemokines and chemokine receptors have been more 
extensively reviewed here (Olson et al., 2002; Allen et al., 2007; Bennett et al., 2011; 





Figure 1.7 Internalisation of GPCRs. G protein-mediated signalling by agonist-activated GPCRs can be terminated through GPCR 
phosphorylation by GPCR kinases (GRKs) and association with arrestins, which interact with clathrin and the clathrin adaptor AP2 to drive 
GPCR internalization into endosomes. GPCR internalisation can also occur through dynamin association with caveolae into early 
endosomes. GPCR internalization regulates the functional processes of receptor desensitization. Recruitment of arrestin to activated 
GPCRs can also lead to the initiation of distinct arrestin-mediated signalling pathways. Following internalization, GPCRs can be trafficked 
to lysosomes, where they are ultimately degraded, or to recycling endosomes for recycling back to the cell surface in the functional 
process of resensitization. Figure adapted from (Ritter et al., 2009).  
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1.3.6 CXCL12 and the CXCR4 receptor 
CXCR4 is one of the best studied chemokine receptors, primarily due to its roles as a 
co-receptor in HIV entry (Feng et al., 1996) and in cancer metastasis (Zlotnik, 2006). 
CXCR4 is widely expressed and is present on T lymphocytes, B lymphocytes, 
monocytes, neutrophils, blood-derived dendritic cells and endothelial cells. CXCR4 can 
form homo- and heterodimers, with CCR2 and CD4 and possibly CCR5. Mutations 
which reduce CCR5 surface expression also decrease expression of CXCR4. The 
functional consequences of CXCR4 heterodimerization are not well understood 
although it is likely to be an additional means of regulating chemokine signalling 
(Busillo et al., 2007). 
Many of the chemokine receptors are promiscuous and bind several chemokines; 
however 6 bind a single ligand (Balkwill, 2004). CXCR4 is 352 amino acids and 
selectively binds the CXC chemokine, CXCL12, also known as stromal development 
factor 1 (SDF1). CXCR4 binding to CXCL12 initiates survival, growth and chemotaxis 
pathways. There are currently 6 known splice isoforms of CXCL12 (α, β, γ, δ, ε, φ) that 
are comprised of an identical N-terminal core but exhibit varied additions of 1-41 largely 
basic amino acids at their C-terminal (Yu et al., 2006). These isoforms exhibit different 
tissue distribution; both α and β isoforms are detected in the primary tumour 
environment (Orimo et al., 2005) and γ has recently been identified in late stage cancer 
(Cavnar et al., 2014) however their functional importance is not well understood (Yu et 
al., 2006).  
CXCL12 also binds to atypical chemokine receptor ACKR3, also known as CXCR7, 
which like other atypical receptors fails to induce classical down-stream signalling. 
Interestingly, ACKR3 has been shown to interact with β-arrestins and induce G protein-
independent signals through ERK-1/2 phosphorylation (Canals et al., 2012).  Another 
hypothesis suggests CXCR7 is a “decoy receptor” or a chemokine scavenger 
(Rajagopal et al., 2010). However, interestingly dimerization of CXCR4/CXCR7 induces 
a positive binding co-operatively which enhances CXCR4 signalling mediated by 
CXCL12 (Sierro et al., 2007).  
The CXCR4 has been indicated to be important in the correct formation of the vascular, 
nervous, hematopoietic and cardiac systems and mice that lack either CXCR4 or 
CXCL12 exhibit late gestational lethality (Nagasawa et al., 1996; Zou et al., 1998). In 
the adult, CXCR4 is vital in directional migration of haematopoietic cells. CXCL12 is 
able to interact with glycosaminoglycans, such as heparin sulphate, and is likely to be 
immobilised in vivo allowing for gradient formation (Hoogewerf et al., 1997). Like 
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CXCR3, CXCR4 is coupled to Gαi, and is able to inhibit adenylyl cyclase, activate Src 
family tyrosine kinases (SFKs), with the liberated βγ subunit activating phospholipase 
C-β and PI3K ultimately leading to gene transcription, cell migration and cell adhesion.  
Incorporation of CXCR4 into lipid rafts has been observed, and this could underlie its 
desensitisation. CXCL12 also stimulates the incorporation of SFKs, focal adhesion 
kinase, PI3K and the small G protein Rac into lipid rafts, which suggests clustering in 
lipid rafts is involved in allowing signalling to occur (Wysoczynski et al., 2005). CXCR4 
signalling is regulated by de-sensitisation, internalisation and degradation. CXCL12 
signalling induces activation the G-protein coupled receptor kinase (GRK) 
phosphorylates of the serine/threonine residues of the third intracellular loop and the 
cytoplasmic tail of CXCR4. Phosphorylation allows for the binding of arrestin-2 and or 
arrestin-3, which successfully uncouple the G-protein and target the receptor for 
internalisation (Krupnick et al., 1998). 
 
1.3.7 CXCR3 receptor  
CXCR3 and its ligands co-ordinate cell mediated immunity in the periphery. CXCR3 is 
highly expressed on effector T lymphocytes and plays an important role in CD8+ and 
Th1 cell trafficking and function. CXCR3 is also expressed by a number of other cells 
including natural killer cells, malignant B lymphocytes, endothelial cells and thymocytes 
(Thomas et al., 2003).  
CXCR3 chemokines, CXCL9 (also known as monokine induced by interferon γ) 
CXCL10 (interferon-inducible protein-10) and CXCL11 (interferon-inducible T cell α or 
ITAC) are not detectable within the non-lymphoid tissues under physiological 
conditions, but are strongly induced by cytokines, particularly interferon γ, during 
inflammation. High surface expression of CXCR3 is found on activated and memory T 
lymphocyte and on NK cells and is driven by interferon γ (Cole et al., 1998). CXCL9, 
CXCL10 and CXCL11 exhibit differences in their kinetics, affinity, tissue expression 
pattern and their binding/activation requires two distinct intracellular domains of 
CXCR3. Both CXCL10 and CXCL11 have been implicated as allosteric ligands of 
CXCR3 (Nedjai et al., 2012) In humans, there is further complexity as there are two 
splice variants of the CXCR3 receptor, CXCR3-A and CXCR3-B, which exhibit different 
binding profiles for the ligands. Splice variants of CXCR3 are not observed in rodents 
which could indicate differences in function of the CXCR3 receptor between humans 
and rodents (Kelsen et al., 2004).  
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Like other GPCRs, CXCR3 signalling is regulated by the level of receptor expression at 
the surface membrane. CXCR3 does not appear to require clathrin-coated pits to 
internalise the CXCR3 receptor and it has been suggested that CXCR3 is degraded in 
the endosome following internalisation. It has to be replenished on the membrane by 
de novo synthesis; even 3 hours after treatment with CXCL11 only 70-80% expression 
of CXCR3 is re-established (Meiser et al., 2008). The regulation of CXCR3 surface 
expression is very important as CXCR3 has been indicated in playing an important role 
in the induction and perpetuation of several human inflammatory disorders including 
atherosclerosis (Mach et al., 1999), autoimmune diseases (Sorensen et al., 1999), 
transplant rejection (Hancock et al., 2000) and viral infection (Liu et al., 2000). 
Development of agents to reduce CXCR3-ligand interactions may provide novel 
treatments of these diseases. 
 
1.3.8 Signals that co-ordinate T lymphocyte migration 
(a) Naïve T lymphocyte extravasation 
Naive T lymphocytes must overcome shear forces to be able to leave the blood. To do 
this they form “tethering” contacts with specialised receptors expressed in high 
endothelial venules (HEVs). HEV are specialized post-capillary venous swellings that 
have a distinctive cuboidal appearance and enable circulating lymphocytes to directly 
enter a lymph node from the blood. Lymphocytes in the blood express L-selectin and 
α4 integrins (e.g VLA-4) on the tips of their microvilli. These form initial tethers to their 
ligands (e.g. vascular cell adhesion molecule (VCAM-1) on the endothelial cell 
membranes. After initial tethering, lymphocytes roll on the HEVs using a short-term 
interaction between CD62L (L-selectin) expressed on the T lymphocytes and 
addressins present upon the HEVs (Gallatin et al., 1983; Rosen, 2004). Tethering 
allows T lymphocyte proximity with chemokines (i.e. CCL21) associated with the 
endothelium. Positively charged, CCL21 is anchored onto the endothelium by binding 
to negatively charged heparin glycosaminoglycans, this prevents it being washed away 
by the shear blood flow (Bao et al., 2010). Chemokine-induced signalling activates 
lymphocyte function associated antigen 1 (LFA1) to bind intercellular adhesion 
molecule (ICAM-1) present on the T lymphocyte. This association causes T lymphocyte 
arrest upon the surface of the HEVs followed by the extravasation of T lymphocyte into 
the T cell zone of lymph nodes (von Andrian et al., 2000; von Andrian et al., 2003) 
[Figure 1.8]. 




(b) Retention in the lymph node 
Lymph nodes provide an environment which maximises cell to cell collaboration 
between a T lymphocyte and APCs. It is estimated that a single dendritic cell in the 
lymph node encounters between 500-5000 T lymphocytes per hour (Bousso et al., 
2003; Miller et al., 2004).  
After T lymphocytes enter the lymph node their migration within the T cell zone is 
CCR7-dependent. CCR7-dependent chemokines CCL21 and CCL19 increase T 
lymphocyte motility and antigen scanning (Kaiser et al., 2005). Competing signals are 
likely to dictate the longevity of T lymphocytes within the lymph node. Over time, 
CCL19 induces desensitisation of the CCR7 receptor, which limits the signalling 
retaining the cells in the lymph node (Bardi et al., 2001; Kohout et al., 2004).    
Conversely, sphingosine-1-phosphate (S1P) is involved in the egress of T lymphocytes 
out of the lymph node. S1P is abundantly expressed in the blood and lymph, but is not 
present in the T cell zone of the lymph node. Lymphocytes which have recently left the 
blood have been exposed to high levels of S1P, which induces a transient de-
sensitization of the S1P receptor and therefore these cells remain in the T cell zone to 
scavenge for antigen (Lo et al., 2005; Arnon et al., 2011). However, overtime the 
sensitivity of the S1P receptor is restored, and cells egress via the lymphatics (Figure 
1.8). 
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(c) Inflammatory recruitment 
Under inflammatory conditions, cytokines are produced within the inflamed tissues and 
then drained into lymph nodes. This leads to structural changes within the lymph node 
to further enhance antigen screening by naïve T lymphocytes. Up-regulation of ICAM-1 
and CCL21 expression and increased HEV diameter enhance the rate of T lymphocyte 
entry into the lymph node (Janatpour et al., 2001; Palframan et al., 2001). Once 
activated, expression of specific chemokine receptors facilitates cell migration to 
specific sites in the periphery. For example CCR9 initiates homing to the small intestine 
and E-selectin, CCR4, CCR10 direct migration towards the skin (Picker et al., 1993; 
Salmi et al., 2005) (Figure 1.8). Moreover, the distinct T helper subsets express 
characteristic chemokine receptors, shown in Figure 1.5. The signature cytokines 
released by the T lymphocytes encourage tissue resident cells to release the 
appropriate chemokines which aids the recruitment of more cells of the same T helper 
subtype and contributes to a positive feedback loop (Mikhak et al., 2006). 
Cytotoxic CD8+ T lymphocytes have critical role in destroying resistant pathogens and 
malignant cells, the inflammatory environment increases their expression of CCR5. 
CCR5 detects CCL3, CCL4 and CCL5 gradients, which often emanate from sites 
where helper CD4+ are in contact with APC allowing cytotoxic cells to aid clearance 
(Castellino et al., 2006). Once effector immune cells have combated the stimulus that 
originally activated and recruited them the cells are neglected, die by apoptosis and are 
then are cleared by macrophages resulting in the resolution of the inflammatory 
response. However, a few of these cells are retained as memory cells and upon 
recognition of the same antigen the memory T lymphocytes are rapidly re-activated. 




Figure 1.8 T lymphocyte migration. Haematopoietic stem cells from the bone marrow 
are disseminated into the bloodstream as T cell precursor cells. These cells home to 
the thymus, where they differentiate into T cells. The T cells are then exported to the 
periphery, where they recirculate from the blood, through T cell areas of the lymph 
nodes and back to the blood via the thoracic duct. To be able to leave the blood, under 
conditions of shear blood flow, T lymphocytes undergo extravasation. 1) Selectins and 
VLA-4 expressed on T lymphocytes bind CD62L and VCAM-1 on the endothelial cells, 
respectively. This forms an initial tethering link between the T cell and the endothelial 
cell. 2) Next, T cells begin to roll across the surface of the endothelial cells. 3) This 
exposes the T cell to further selectins, addressins and chemokines which evokes the 
up-regulation of integrins, LFA-1 and VLA-4. These interact with endothelial ligands 
ICAM-1 and VCAM-1, respectively, to arrest the cell on the endothelium. 4) Intracellular 
signalling mechanisms facilitate the spreading, crawling and finally the transmigration 
of the cells, which can either occur at trans- or para- cellular routes. The transfer of T 
cell between the blood and lymph nodes often occurs at high endothelial venules 
(HEV). Under inflammatory conditions, T cells can encounter their specific antigen in 
the lymph nodes they become activated and expression of specific chemokine 
receptors facilitates cell migration to specific sites in the periphery, i.e. they gain a 
specific “address code” to migrate to the area of inflammation (Original graphic). 
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1.4 Signalling pathways involved in T lymphocyte function 
T lymphocytes rely upon complex intracellular signal transduction pathways to 
undertake their functions of migration, activation and cytokine production. In addition, 
intracellular signalling provides the cell with continuous information about its 
environment and conveys a large amount of complex information to the cell. Multiple 
signalling pathways are involved in these processes; however tyrosine kinases, 
phospholipase C (PLC) and protein kinase C (PKC), calcium mobilisation and 
phosphoinositide 3-kinase (PI3K) are heavily involved in T lymphocyte responses. 
 
1.4.1 Non receptor, cytoplasmic, tyrosine kinases  
There are two major families of cytoplasmic tyrosine kinase families in T lymphocytes 
namely, the src family kinases (SFK) family and the spleen tyrosine kinases (SYK) 
family. The kinases are involved in cellular processes such as proliferation, survival, 
growth, adhesion and migration. 
In T lymphocytes, CD3 and CD28 co-receptors contain the immunoreceptor tyrosine-
based activation motifs (ITAMs) sequence, YxxLx(7-12)YxxL, in their intracellular tails. 
Upon ligation of the TCR receptor, this sequence becomes phosphorylated by Src 
family kinases (SFKs), Lck and Fyn. Phosphorylated ITAMs recruit Syk kinase family 
member, ZAP-70 which is tyrosine phosphorylated and activates downstream signallng 
SLP76 and LAT; which act as linkers to recruit a complex of signalling molecules 
including VAV1, ITK, GRB2, SOS and PLCγ. In addition, GPCR receptor signalling is 
able to activate downstream SFK and Syk signalling (Figure 1.9).  





SFKs are critical in cellular responses to external stimuli and they are activated by a 
diverse number of factors including cytokines, antigens, integrins and chemokines. 
SFKs phosphorylate tyrosine residues on target proteins including Tec family member, 
ITK, SYKs and tyrosine kinase FAK, which activate down-stream signalling including 
PI3K, Rho/WASP activation of actin polymerisation and PLC/PKC (Thomas et al., 
1997).  
Conventional Src (c-Src) kinase was the first proto-onocogene discovered encoding a 
tyrosine kinase and subsequent studies of its function have increased our 
understanding of the processes involved in malignant transformation (Blume-Jensen et 
al., 2001). SFKs are a family of 8 non-receptor tyrosine kinases that are divided into 
two subfamilies, those that are c-Src related c-Src, Yes, Fyn and Fgr and those that are 
Lyn related Lyn, Hck, Lck and Blk, there are also three related kinases Brk, Frk and 
Srm (Thomas et al., 1997).  
All SFK family members share a similar domain arrangement, including four Src 
homology domains (SH). Starting at the NH2-terminal domain, there is a SH4 domain 
and a “unique” domain, which is highly divergent between members but contains a 
myristoylation site which allows the SFK to be targeted to the membrane and 
determines cellular localisation. The SH3 domain detects proline rich motifs which are 
present in signalling and structural molecules and allows the SFK to be in close 
proximity to signalling targets. The SH2 domain interacts with phosphotyrosine 
residues, when SFK are in an inactive conformation the SH2 domain interacts with a 
phosphorylated tyrosine in its own C-terminal at site 527. This results in a closed, 
inactive conformation. Finally the SH1 domain is responsible for the enzymatic activity 
of Src, and auto-phosphorylation at Tyr416 in the SH1 domain results in an open active 
conformation.  
Thus the activity of SFKs is regulated by the phosphorylation and dephosphorylation of 
tyrosine residues within its own structure. C-terminal Src kinase (Csk) and Csk 
homology kinase (Chk) are tyrosine kinases which can also inactive SFK signalling by 
phosphorylating Tyr527, in particular Chk forms a non-covalent bond with Tyr527 to 
block kinase activity (Chong et al., 2006; Okada, 2012). Phosphatases including 
phosphatase 1B and phosphatase-α are capable of removing the phosphate group 
exposing the catalytic SH1 site (Xu et al., 1999).  
Chapter 1. Introduction 
29 
 
SFK expression differs amongst cell types and T lymphocytes predominately express 
Lck and Fyn which are 56 and 59kDa proteins respectively. Lck is expressed 
throughout the developmental lifetime of a T cell, whereas Fyn protein is transiently 
decreased at the double positive stage of thymocyte development but is upregulated 
thereafter in more mature cells (Cooke et al., 1989; Olszowy et al., 1995). Lck and Fyn 
have distinct localization within T cells. Lck has been shown to associate with the 
cytoplasmic tails of T-cell co-receptors CD4 and CD8 (Rudd et al., 1988; Shaw et al., 
1989) and commonly directs signalling through ZAP-70 to co-ordinate cell activation 
and survival. Fyn has been observed to be largely co-localised with the centrosomal 
and mitotic structures (Ley et al., 1994). Fyn can also interact with the focal adhesion 
kinase (FAK) family (Qian et al., 1997) and also activates WASP in T lymphocyte 
(Badour et al., 2004) indicating a role for Fyn in migration, adhesion and synapse 
formation.  
SFK signalling can also be activated downstream of GPCRs, G-proteins been shown to 
directly stimulate c-Src and Hck, by evoking a conformational change in their structure 
to reveal their active sites (Ma et al., 2000). Lyn kinase activation has also been 
observed downstream of CXCR4 and CCR5 signalling in macrophages. 
 
(b) SYK  
There are two members of the splenic tyrosine kinase family (SYK) kinases, namely 
Syk and Zeta-chain associated kinase 70kDa (ZAP-70). SYK are non-receptor, 
cytoplasmic, tyrosine kinases that have been implicated in the activation of PI3K, 
PLCγ, MAPK, nuclear factor-κB and the mobilization of calcium from intracellular stores 
(Rao et al., 1997; Lewis, 2001). SYKs share a characteristic dual SH2 domain 
separated by a linker domain (Au-Yeung et al., 2009).  
Typically, SFKs phosphorylate the ITAM adaptors which create docking sites for SYK 
kinases, thus SYK signalling is dependent upon SFK signalling. Interestingly, genetic 
silencing and pharmacological blockade studies have indicated that inhibition of SFKs 
and SYK does not always produce the same phenotypic consequences or effect down-
stream signalling in the same way. Instead, there is a high level of redundancy 
between the different SFK isoforms and they are involved in signalling pathways which 
do not involved SYK activation. As such, SFKs have been described to tune signalling 
responses in a graded fashion and although SYK signalling is also involved in broad 
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functional effects they are more defined due to a lack of redundancy and are critical in 
certain pathways (Lowell, 2011).  
Syk is abundant in B lymphocytes and expressed at lower levels in immature T cells, 
mast cells, endothelial cells and platelets. Syk has key roles in B lymphocyte 
proliferation and migration and in developmental angiogenesis (Turner et al., 2000). In 
particular, it has recently been indicated that Syk has a key role in co-ordinating B 
lymphocyte actin cytoskeleton re-organisation, Fcγ receptor clustering (Jaumouille et 
al., 2014) and Syk signalling is up-regulated in acute B lymphoblastic leukaemia 
(Uckun et al., 2014)  
In contrast, ZAP-70 is predominately expressed in T lymphocytes and has an 
imperative role in their activation and development. ZAP-70 deficiency mutations in 
human T lymphocytes causes patient’s to exhibit severe combined immune deficiency 
syndrome (Elder et al., 1994; Matsuda et al., 1999). ZAP-70 is known to associate with 
phosphorylated ITAMs in the CD3 and ζ chain dimers of the TCR receptor and mediate 
signalling. In addition, ZAP-70 has also been shown to be required for CXCR4 
mediated migration of T lymphocytes (Ticchioni et al., 2002) in the absence of a 
functional TCR receptor. This implies that ZAP-70 is activated downstream of CXCR4 
ligation; however the requirement of SYK induced signalling in migration is less well 
understood than in TCR activation. 





Figure 1.9 SFK and SYK signalling in T lymphocytes. SFK and SYK signalling is 
activated downstream of TCR and GPCR activation. Following cell activation, SFKs 
typically phosphorylate ITAM containing adaptors, CD3, CD28 to create docking sites 
for SYK kinases. SFKs also phosphorylate ZAP-70, Tec kinase Itk and Fak/Pyk2 
(Shown in purple) to activate signalling involved in T cell activation and migration.. 
ZAP-70 is activated by the SFK tyrosine phosphorylation and is recruited to the 
phosphorylated ITAM domains. Next ZAP-70 phosphorylates SLP76 and LAT (Shown 
in green) and co-ordinates the formation of the LAT signalosome. PLCγ1 is recruited 
and hydrolyses its substrate PI(4,5)P2 into IP3 and diacylglycerol (DAG). IP3 acts upon 
IP3 receptors in the endoplasmic reticulum and stimulates the release of calcium 
(Ca2+). Intracellular Ca2+ evokes Ca2+-dependent Ca2+ influx, through STIM and ORAI 
channels in the plasma membrane to enhance the Ca2+ signal. Ca2+ activates 
transcription factor Nuclear Factor of Activated T lymphocytes (NFAT) leading to 
synthesis of IL-2. DAG activates PKC signalling and the Ras/MAPK pathway to 
regulate gene expression and T lymphocyte activation. ZAP-70 also activates Fak/ 
Pyk2 which initiates signalling to regulate focal adhesions and cell movement (Own 
graphic).  




1.4.2 Pharmacological targeting of SFKs and SYK 
Given the importance of SYK signalling downstream of ITAM domains, its inhibition has 
therapeutic potential to treat a number of immune related diseases. Abnormal 
signalling through SYK has been implicated in several hematopoietic malignancies 
(Calpe et al., 2013; Tan et al., 2013; Puissant et al., 2014; Krisenko et al., 2015). 
Several transforming viruses contain ITAM domains including Epstein Barr virus, which 
lead to the pathological activation of SYK. Thus, Syk inhibition has been proposed as a 
therapy for lymphoma and chronic lymphocytic and inhibitors are in clinical trials 
(Friedberg et al., 2010). Syk inhibition is also putative treatment of auto-immune 
diseases. Fostamatinib (R788) an orally active pan inhibitor has recently produced 
promising results in a phase II clinical trial for human rheumatoid arthritis which is 
resistant to methotrexate (Kaur et al., 2014). 
 
Novel pan inhibitors of SFKs have also been designed and are being investigated in 
the treatment of cancer. Dasatinib (BMS-354825), a selective pan SFK inhibitor is 
currently approved for the second line treatment of chronic myeloid leukaemia and 
several other inhibitors are in clinical trials for the treatment of solid tumours. Dasatinib 
also has a potential therapeutic use in prostate cancer (Nam et al., 2005) and inhibits T 
lymphocyte activation and proliferation so could be useful in autoimmune disease and 
transplant allograft rejection (Schade et al., 2008), although long term inhibition of SFK 
could result in several side effects due to its wide spread functions.  
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1.4.3 PLC, PKC and calcium mobilisation   
PLC and PKC have been demonstrated to be activated downstream of chemokine 
receptors and TCR ligation. TCR activation evokes PLCγ recruitment (Irvin et al., 2000) 
and chemokine receptor activation leads to the activation of PLCβ either directly or via 
signalling of several protein kinases (Wu et al., 1993). The PLC family contains 6 
isoforms, namely β, γ, δ, and the more recently identified ε, ζ, η (Katan, 1996; Hwang et 
al., 2005). 
PLC recruitment and activation brings it into close proximity with its membrane 
anchored substrate PI[4,5]P2 and results in its hydrolysis into two second messengers 
diacyloglycerol (DAG) and inositol triphosphate (IP3). IP3 binds to the IP3 receptor 
(IP3R), which is itself a calcium permeable ion channel, and evokes the release of Ca2+ 
from intracellular endoplasmic reticulum (ER) Ca2+ stores. Ca2+ release from the ER 
activates STIM or ORAI channels in the plasma member. Intracellular Ca2+ 
concentrations are crucial for the activation of gene transcription and cytokine gene 
expression, as well as cytoskeleton rearrangements (Lewis, 2001; Feske, 2007). PLCβ 
are the most abundantly expressed in the immune system and are involved in 
neutrophil function (Tang et al., 2011).  
DAG is highly hydrophilic, and anchors to both conventional PKC (cPKC - α, β and γ) 
and novel PKC (nPKC - δ, ε, η and θ) isoforms at the inner leaflet. There are three 
groups of PKC isoforms, cPKC are sensitive to Ca2+ and DAG binding, whereas nPKC 
are DAG sensitive but Ca2+ insensitive and atypical PKCs ζ and λ contain altered C1 
domains and are both DAG and calcium insensitive. nPKCs (apart from δ) have been 
shown to be required for microtubule organising centre (MTOC) to the immunological 
synapse (Quann et al., 2009; Quann et al., 2011). PKCθ alongside GRB2 and SOS 
activate of GTPase Ras which has multiple roles in cell growth (Roose et al., 2005). In 
addition, other PKC substrates include PKD1 which forms a complex with adhesion 
and degranulation promoting adaptor protein (ADAP) and SLP76 and RAPL which are 
involved in integrin activation (Trucy et al., 2006). Consistently, PKC has also been 
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1.4.4 PI3K family signalling 
PI3K activation co-ordinates cell activation, growth, survival, proliferation, differentiation 
and the homing of inflammatory cells to the site of infection (Courtneidge et al., 1987; 
Vanhaesebroeck et al., 2012). Four distinct PI3K subclasses exist, which are 
designated Class I, II, III and IV due to their subunit composition, substrate specificity 
and regulation. Functionally, Class I PI3Ks phosphorylate the 3’ hydroxyl group of 
inositol ring of phosphoinositol (4,5) bis-phosphate (PI(4,5)P2) to convert it to 
phosphoinositol (3,4,5) tris-phosphate (PI(3,4,5)P3), whereas Class II PI3Ks convert 
PI-4-P into PI-3,4-P2 and the conversion of PI to PI-3-P can be mediated by both Class 
II and III PI3Ks. Class I PI3Ks are the most extensively studied, and their product 
PI(3,4,5)P3 is able to recruit and co-ordinate the activation of pleckstrin homology (PH) 
domain containing proteins, of which the most notable is the serine threonine protein 
kinase B (Akt). Akt activation initiates a plethora of signalling cascades which are 
described in detail in Figure 1.10. 
Class I PI3Ks are heterodimers comprised of a 110kDa catalytic subunit and a smaller 
Src Homology 2 (SH2) domain containing regulatory subunit. PI3K regulatory subunits 
have two vital functions in quiescent cells which are to inhibit PI3Ks functional activity 
and prevent the catalytic subunit protosomal degradation (Yu et al., 1998). Class I 
PI3Ks are further subdivided into two classes; the Class IA isoforms are composed of 
the catalytic subunits p110α, p110β and p110δ, which are associated with the 
regulatory subunits p85α, p55α, p50α, p85β or p55γ, whereas the Class IB catalytic 
subunit is p110γ which associates with either p84/p87. Class IA PI3K are principally 
activated by receptor tyrosine kinases (i.e. cytokine and antigen receptors), as their 
regulatory subunits contain SH2 domains which allow their recruitment to tyrosine 
phosphorylated proteins at the plasma membrane. In contrast, Class IB PI3Ks are 
generally activated upon G-protein coupled receptor (GPCR) ligation (i.e. chemokine 
receptors) (Foster et al., 2012; Vanhaesebroeck et al., 2012) However, PI3Kβ can also 
















Figure 1.10 Class I PI3K signalling pathways involved in regulating cell function. Adapted from (Workman et al., 2012), this diagram 
indicates the core components of PI3K signalling. Abbreviations include glycogen synthase kinase-3 (GSK-3β), Bcl-2-associated death 
promoter (BAD), 3-phosphoinositide-dependent kinase-1 (PDK-1), phospholipase C (PLC), protein kinase A (PKA), mammalian target of 
rapamycin complex (mTOR), Phosphatase and tensin homolog (PTEN), Serine/threonine-protein kinase (SGK), Tuberous sclerosis protein 1 & 
2 (TSC1; TSC2) Ribosomal protein S6 kinase beta-1 (p70S6K) extracellular-signal-regulated kinases (ERK1/2), mitogen-activated protein 
kinase kinase (MEK), Fas ligand (FASL), B-cell lymphoma 2 (BCL2), Eukaryotic translation initiation factor 4E-binding protein 1 (4EBP), 




1.4.5 Pharmacological targeting of PI3K  
Activation of PI3K initiates signalling cascades involved in the regulation of numerous 
cellular functions, such as growth, proliferation, migration and cytokine production 
(Fruman et al., 2009; Sasaki et al., 2009; So et al., 2012a) and is crucial for normal 
functioning of the immune system. Over-active and dysregulated PI3K signalling is 
however associated with chronic inflammation, immune-mediated disorders as well as 
cancer (Yuan et al., 2008; Ghigo et al., 2010; Marwick et al., 2010; Suarez-Fueyo et al., 
2011). Specifically, the hematopoietic cell restricted PI3K isoforms (γ and δ) are 
indicated as eliciting co-ordinated but non-redundant roles in the immune system. As 
such, null p110γ and p110δ mice exhibit severely defective immune responses to 
infection (Ji et al., 2007). Based on these findings selective inhibition of PI3Kδ or PI3Kγ 
isoforms was proposed as a putative treatment of haematological malignancies and 
autoimmune/inflammatory disease. Targeting these isoforms with their restricted 
expression profile should prevent widespread inhibition of other more widely expressed 
isoforms (e.g. p110α, p110β). Although there has been success at designing PI3Kδ 
inhibitors which have promising results against hematopoietic cancer, with PI3Kδ 
inhibitor Idelalisib now approved for treatment of CLL in the US (Wong et al., 2010; 
Foster et al., 2012; Meadows et al., 2012; So et al., 2012a), as yet the use of PI3K 
inhibitors to treat inflammatory disorders has been disappointing.  
A phase II study of PI3Kγδ inhibitor duvelisib (IPI-145) failed to meet its primary 
endpoint, which led to Infinity Pharmaceuticals announcing that it will not proceed with 
any further development of PI3K inhibitors in rheumatoid arthritis; however it will 
continue to elevate duvelisib for the treatment of hematopoietic cancers. [Infinity press 
release (Infinity, 2015)]. In addition, Gilead sciences have terminated development of 
CAL-263 after a Phase I trial for allergic rhinitis, and idelasib (CAL-101) no longer 
appears upon their development pipeline for the treatment of inflammatory diseases 
following completion of its Phase I trial for allergic rhinitis (Gilead website). There is the 
possibility that PI3Kγ inhibitors could be useful in inflammatory diseases, however it 
has been very difficult to design highly selective PI3Kγ inhibitors with an acceptable 
window of selectivity for p110γ versus other class IA isoforms and this has only 
recently been achieved (Bergamini et al., 2012). PI3K inhibitors that are currently in 
clinical trials are summarised in table 1.2 and IC50 values of commonly used pan PI3K 
inhibitors and selective p110γ and p110δ inhibitors shown in Table 1.3 
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Table 1.2 PI3K inhibitors and SHIP-1 activator currently in clinical trials. Details 
for PI3K/mTOR pathway inhibitors that are currently in clinical trials, including their 
associated companies, their isoform targets, clinical indication, reported side effects 
and phase of clinical development. SHIP-1 activator is highlighted in pink. First 
approved in series highlighted green and inhibitors developed for inflammatory disease 
highlighted blue. Abbreviations: chronic lymphocytic leukaemia, (CLL) small 
lymphocytic lymphoma (SLL) Indolent non-Hodgkin lymphoma (iNHL) mantle cell 
lymphoma (MCL) glioblastoma multiforme (GBM) multiple myeloma (MM), renal cell 
carcinoma (RCC) non-Hodgkin lymphoma (NHL), idiopathic pulmonary fibrosis 
(IPF).References: Pictilisib (Wallin et al., 2012; Munugalavadla et al., 2014), Taselisib 
(Ndubaku et al., 2013), Idelalsib (Inman, 2014; Okoli et al., 2015), Buparlisib (Bendell 
et al., 2012) Dactolisib (Chen et al., 2014; Wang et al., 2014) Copanlisib (Cheng et al., 
2011; Glauer et al., 2013) IPI-145 (Dong et al., 2014) Omipalisib (Leung et al., 2011; 
Norman, 2014), RP6530: (Savona et al., 2013), AMG-319 (Castillo et al., 2014; Sinclair 
A et al., 2011) and TG-1202 (Burris et al., 2014). SHIP-1 activator AQX-1125 (Stenton 
et al., 2013a; Leaker et al., 2014). 




IC50 values (nM) 
PI3K isoforms 
 
Compound p110α p110β p110δ p110γ References 
ZSTK474 16 44 4.6  49  
(Kong et al., 
2007) 
LY294002 5500  1100  160 1200 “ 
AS-605240 3400 >20,000 >20,000 190 
(Bilancio et 
al., 2006) 
IC87114 >100,000 1820 70 1240 “ 
Table 1.3 IC50 values of commonly used pan PI3K inhibitors and selective p110γ 
and p110δ inhibitors.  Individual IC50 values from in vitro assays with either purified or 
recombinant proteins. 
 
1.4.6 Novel approaches to manipulate PI3K signalling in the immune system 
The lack of effective PI3K inhibitors in the treatment of inflammatory pathologies has 
led to increased interest in other candidates within the PI3K signalling cascade such as 
the lipid phosphatase SH2 domain containing inositol phosphatase 1 (SHIP-1) which 
physiologically modulates PI3K-dependent signalling (Blunt et al., 2012a; Blunt et al., 
2012b).  
PI(3,4,5)P3 accumulation is counteracted by two intracellular lipid phosphatase 
families; namely phosphatase and tensin homology (PTEN) and SH-2 domain 
containing inositol phosphatase (SHIP). Enzymatically, lipid phosphatase PTEN 
functions to directly inhibit PI3K-dependent signalling by removing the 3’ phosphate 
group of PI(3,4,5)P3 and converting it back to PI(4,5)P2 (Figure 1.11). In contrast, 
SHIP hydrolyses 5’ phosphate from PI(3,4,5)P3 to produce PI(3,4)P2. Activation of 
either PTEN or SHIP-1 is proposed to mimic the effect of a pan PI3K inhibitor as they 
encourage a reduction of cellular PI(3,4,5)P3 accumulation, however SHIP-1 is a highly 
attractive target for the treatment of autoimmune and inflammatory diseases and blood 
cancers due to its primarily restricted expression in hematopoietic cell lineages (Blunt 
et al., 2012a). 





Figure 1.11 Regulation of PI3K signalling. 1. Recruitment and activation of PI3K 
occurs upon stimulation of receptor tyrosine kinases (i.e. cytokine or antigen 
receptors), tyrosine coupled-receptors and GPCRs (chemokine receptors). 2. Active 
PI3K phosphorylates the 3’ region of PI(4,5)P2 to the signalling lipid PI(3,4,5)P3. 3. 
Recruitment and phosphorylation of the PH domain containing Akt mediates a plethora 
of signalling cascades which regulate cell migration, proliferation, survival, glucose 
metabolism and cytokine synthesis. 4. Ligation of GPCR chemokine receptors and 
receptor tyrosine kinases/ tyrosine-coupled receptors evokes the relocation of lipid 
phosphatase SHIP-1 to the plasma membrane. 5. SHIP-1 dephosphorylates the 5’ 
region of PI(3,4,5)P3 to PI(3,4)P2 and thus negatively regulates PI3K-dependent 
signalling. 6. However, PI(3,4)P2 still has signalling properties and is able to 
exclusively recruit TAPP1 & TAPP2 which can also negatively regulate PI3K signalling. 
In addition, PI(3,4)P2 has a putative role in cell survival pathways and is suggested to 
be required for full activity of Akt. 




There are three known isoforms of SHIP; SHIP-1 is restricted to hematopoietic cells, 
SHIP-2 is widely expressed with particularly high levels in the brain, heart and skeletal 
muscles and s-SHIP is primarily reported to be restricted to stem cells, their structures 
are shown in Figure 1.12. In addition to its catalytic role, SHIP-1 is a scaffolding protein 
which interacts with Growth factor receptor-bound protein (Grb), SH2 domain-
containing protein-tyrosine phosphatase (SHP-2), Docking proteins (Doks), GRB2-
associated-binding protein (Gab) and immunoreceptor tyrosine-based 
inhibition/activation motifs (ITIMs and ITAMs). As such, SHIP-1 acts as a pluripotent 
regulator of hematopoietic cell function (Ming-Lum et al., 2012). Most of these 
interactions contribute to the negative regulation of PI3K signalling by SHIP 
independently of its catalytic activity. For example, binding of SHIP-1 to ITAM 
containing adaptor proteins via the SH2 domain, can prevent PI3K recruitment via the 
p85 regulatory subunit (Peng et al., 2010) and impaired recruitment of the tyrosine 
phosphatase SHP1 to the SLAM family receptor 2B4 in NK cells (Wahle et al., 2007). 
However, there is evidence that the scaffolding role of SHIP-1 can potentiate EGF-
induced PLC-gamma1 activation (Song et al., 2005) and facilitates a positive regulatory 
role in TLR-induced cytokine production (Ruschmann et al., 2010). In addition, a 
pleckstrin homology (PH)-related (PH-R) domain binds PI(3,4,5)P3 and is required for 
localization of SHIP-1 to the phagocytic cup and SHIP-1 mediated inhibition of FcγR-
mediated phagocytosis by macrophages (Ming-Lum et al., 2012). 
Although SHIP-1 is catalytically active in the cytosol, physical recruitment to the plasma 
membrane is required for its ability to function upon its substrate PI(3,4,5)P3. Ligation 
of chemokine, antigen, co-stimulatory and cytokine receptors as well as IgG 
engagement by FcγRIIB are all able to recruit SHIP-1 to the plasma membrane 
(Bruhns et al., 2000) and phosphorylate the C terminal NPXY region of SHIP-1. 
Compounds which restrict or enhance SHIP-1 recruitment could function as activators 
or inhibitors of PI3K signalling respectively. Interactions between CD3 and the TCR ζ 
chain with the SH2 domain of SHIP-1 have been observed in vitro (Osborne et al., 
1996). In addition, the stimulation of CD3 and CD28 has been shown to cause tyrosine 
phosphorylation, increased catalytic activity, and a marked re-distribution of SHIP-1 
from the cytosol to the surface membrane (Edmunds et al., 1999).  




Figure 1.12 Schematic representation of structure of the lipid phosphatase 
regulators of PI3K mediated signalling. SHIP-1 structure includes a N-terminal SH2 
domain, which can bind phospho-tyrosine, and a recently identified PH-related domain, 
which can associate with PI(3,4,5)P3. The catalytic phosphatase region of SHIP-1 is 
centrally located next to a C2 domain which can bind PI(3,4)P2 and allosterically 
enhance SHIP-1s catalytic activity. The C-terminal of SHIP-1 has a proline rich domain 
and NPXY motifs. In contrast to SHIP-1, SHIP-2 also processes a Ubiquitin-interacting 
motif and a SAM-SAM interaction domain and s-SHIP lacks a SH2 domain. PTEN 
structure contains a 3’ phosphatase region, a C2 region which binds to the 
phospholipid membrane in order to bring PTEN into close proximity with PI(3,4,5)P3 
and a PDZ domain.  
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1.5.1 Evidence for the role of SHIP-1 in disease pathogenesis 
 
(a) Cancer 
PI3K-dependent signalling presents a compelling target for the treatment of cancers 
due to known roles in cell survival, proliferation and differentiation (Yuan et al., 2008). 
In addition, PI3K/AKT/mTOR signalling is consistently over-active in various cancers. It 
is therefore unsurprising that PTEN is a well characterised tumor suppressor gene (Li 
et al., 1997; Choi et al., 2002; Sulis et al., 2003; Downes et al., 2007)  and this would 
also imply that hematopoietic restricted SHIP-1 could exhibit a role in blood cancer 
treatment. Inactive SHIP-1 mutants are present in lymphoblastic and acute myeloid 
leukaemia (Luo et al., 2003; Luo et al., 2004). Likewise, SHIP-1 is lost in 
erythroleukaemia development (Lakhanpal et al., 2010), murine pancreatic cancer 
(Pilon-Thomas et al., 2011) and myelodysplastic syndrome progenitor cells. 
Consistently, over-expression of SHIP-1 inhibits myeloid leukemic growth (Lee et al., 
2012). Therefore, similarly to PTEN, SHIP-1 has indeed been indicated as a tumour 
suppressive gene.  
However, to suggest that SHIP-1 only functions to suppress PI3K dependent signalling 
is a vast simplification. The SHIP-1 product PI(3,4)P2 has its own signalling properties 
such as the recruitment of DAPP1 (dual adaptor of phosphotyrosine and 3-
phosphoinositides) and TAPPs (tandem PH domain containing protein) (Dowler et al., 
2000; Thomas et al., 2001). Interestingly, low levels of PI(3,4)P2 are potentially 
required for the full activation of Akt and Akt actually has a higher affinity for PI(3,4)P2 
than PI(3,4,5)P3. SHIP-1 inhibition results in apoptosis of blood cancer cells which 
express SHIP-1 such as KG-1 (human myeloid cell line), suggesting PI(3,4)P2 was 
actually required for their survival (Brooks et al., 2010). In addition, PI(3,4)P2 levels are 
increased in leukemic cells and increasing the level of PI(3,4)P2 promotes the 
transformation and tumourigenicity of mouse embryonic fibroblasts. As such, there is 
currently significant interest in developing SHIP-1 inhibitors as a putative treatment of 
multiple myeloma; a disease with a high unmet medical need due to lack of effective 
treatment. 
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(b) Autoimmune or inflammatory disease 
 
SHIP-1 is also proposed to be important in autoimmune and inflammatory diseases as 
evidenced by its role in: (1) immune cell development and homeostasis, (2) immune 
cell chemotaxis and (3) inflammatory mediator production. 
The characterization of SHIP-1 knock out ((-/-)) mice has provided a vital insight into its 
function in immune cells. SHIP-1(-/-) mice are viable and fertile however their lifespan is 
significantly shortened with only 40% survival at 12 weeks. Interestingly, 
myeloproliferative disorder and massive infiltration of myeloid cells into the lungs is the 
main cause of the premature death (Helgason et al., 1998). SHIP-1 deficient mice 
exhibit altered immune cell homeostasis with an imbalance between pro-inflammatory 
and anti-inflammatory myeloid and lymphoid cells. For example, SHIP-1(-/-) mice have 
an increase in type 2 macrophages (M2) (Liu et al., 1999).  
In addition, comparing germline and conditional SHIP-1 null mice has been 
instrumental in identifying an important role of SHIP-1 in immune function (Helgason et 
al., 2000; Wang et al., 2002b; Tarasenko et al., 2007; Leung et al., 2009). In T 
lymphocytes, SHIP-1 has a crucial role in the development of Th17 cells and in 
regulating the balance between pro- and anti- inflammatory T lymphocyte populations 
(Locke et al., 2009). Mice carrying a T lymphocyte-specific deletion of SHIP-1 
uncovered a regulatory role for SHIP-1 in controlling Th1/Th2 bias and cytotoxic 
responses as a result of its inhibitory effect on T-bet expression. Hence, SHIP-1 null T 
lymphocytes do not skew efficiently to a Th2 phenotype and display Th1-dominant 
immune responses in vitro and in vivo (Tarasenko et al., 2007). This is in contrast to 
evidence from germline SHIP-1 null mice, which indicates that SHIP-1 can also repress 
Th2 skewing by inhibiting IL-4 production from basophils. T lymphocyte-specific 
deletion of SHIP-1 using CD4CreSHIPflox/flox mice, had no effect on T-lymphocyte 
development, activation state or Treg-cell numbers (Tarasenko et al., 2007). However, 
a recent study using in LckCreSHIPflox/flox mice reported significant reduction in the 
frequency of splenic CD3+ T lymphocytes and CD4+ and CD8+ T cells in the peripheral 
blood relative to SHIPflox/flox controls (Collazo et al., 2012). The discrepancy may be 
because deletion of SHIP in CD4CreSHIPflox/flox mice may occur at a different time 
point during T-lymphocyte development compared to SHIP deletion in 
LckCreSHIPflox/flox mice. 
PI3K-dependent Akt phosphorylation is vital in cells due to its importance in regulating 
inflammatory cell activation and survival. Reducing Akt dependent signals would be a 
method of reducing immune cell over-activation in autoimmune and inflammatory 
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disease. SHIP-1 overexpression reduces Akt phosphorylation and SHIP-1 deficiency 
markedly increases Akt phosphorylation in T lymphocytes, macrophages and mast 
cells. In addition, SHIP-1 activation decreases Akt phosphorylation in multiple immune 
cells types (Kerr, 2011). Consistently with their reduced Akt phosphorylation, over 
expression of SHIP-1 in macrophages, mast cells, T lymphocytes, B lymphocytes and 
dendritic cells elicit a reduced activation to bacterial mitogens. Likewise, SHIP-1 
activation has been observed to reduce the secretion of inflammatory mediators GM-
CSF, TNF- α, IFNγ and IL-2 in murine splenocytes as wells reducing LPS-mediated 
TNF-α release from macrophage (Leung et al., 2009).  
Immune cell migration is often observed to be dysregulated in immune pathologies. In 
addition, the ability of T cells to polarise and migrate is essential for the homing of 
lymphocytes to lymph nodes during immune-surveillance as well as to peripheral 
tissues during an immune response. PI(3,4,5)P3 production is evident at the leading 
edge of polarized neutrophils (Wang et al., 2002a; Ward, 2006), whilst PI3K is 
activated by most chemokine receptors expressed by T lymphocytes (Ward et al., 
2009) and is crucial in lymphocyte adhesion (Mazerolles et al., 1996). Ectopic 
expression of constitutively active SHIP-1 into leukemic cells normally deficient in 
SHIP-1 impeded chemokine mediated signalling and migration (Wain et al., 2005). 
Remarkably, the silencing of SHIP-1 expression in primary human T cells had no effect 
on directional migration, though basal migration was significantly impaired and this 
correlated with disassembly of microvilli and dephosphorylation of the actin associated 
proteins ezrin, radixin and moesin (Harris et al., 2011).  
Several opportunistic pathogens have exploited SHIP-1s regulatory role at inhibiting 
immune cell function to avoid immune detection. Gram negative bacteria Actinobacillus 
actinomycetemcomitans, which is involved in the pathology of meningitis and 
bronchopneumonia, avoids being detected by the immune system by producing 
Cytolethal distending toxin subunit (CdtB). CdtB mechanistically acts like SHIP-1, to 
dephosphorylate the 5’ position of PI(3,4,5)P3, which causes cell-cycle arrest and 
apoptosis (Shenker et al., 2007). In a similar fashion, the measles virus produces SIP-
110, a SHIP-1 homolog, to reduce PI(3,4,5)P3 dependent T lymphocyte activation 
(Avota et al., 2006). SHIP1 has been directly implicated in the pathogenesis of a variety 
of diseases including allergic inflammation, asthma, acute lung injury and inflammatory 
bowel disease (Kerr, 2011).   
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1.5.2 Pharmacological manipulators of SHIP-1 
(a) SHIP-1 activators 
To date, most genetic strategies to silence SHIP-1 protein expression have not been 
able to make a satisfactory distinction between effects caused by the ablation of SHIP-
1 catalytic activity versus the removal of the various non-catalytic structural roles of 
SHIP-1 (Blunt et al., 2012b). The SHIP-1 activators are known to target the C2 domain 
of SHIP-1, a region which binds the SHIP-1 catalytic product PI(3,4)P2 inducing 
allosteric activation (Ong et al., 2007). Adaptor functions of SHIP-1 are unlikely to be 
altered by pharmacological targeting and so, may offer the opportunity to discriminate 
between functions dependent on catalytic versus adaptor roles of SHIP-1.   
The first SHIP-1 activator, named pelorol, was isolated from the marine invertebrate 
Dactylospongia elegans in 2005. The development of more potent and synthetic 
activators has since been undertaken by Aquinox Pharmaceuticals Inc, (Richmond, 
BC, Canada; (Ong et al., 2007). Their lead compound AQX-1125 (1S,3S,4R)-4-
[(3aS,4R,5S,7aS)-4-aminomethyl)-7a-methyl-1-methylidene-octahydro-1H-inden-5-yl]-
3(hydroxymethyl-4-methylcyclohexan-1-ol; acetic acid salt [Figure 1.13]) reduces Akt 
phosphorylation in human leukemic T lymphocyte lines and murine B lymphocytes and 
importantly has been observed to inhibit several immune cells migration in vitro. 
Mechanistically, AQX-1125 was found to bind directly to SHIP-1, but failed to activate 
the enzyme when the C2 domain was deleted, suggesting it function is mediated 
through the C2 domain. In addition AQX-1125 was observed to activate SHIP-1 by 
inducing a concentration dependent reduction in the Km of the enzyme, rather that 
affecting kcat or Vmax. Hence, Aquinox suggest that AQX-1125 induces a conformational 
change of SHIP-1, which results in better substrate binding and enzyme efficiency 
(Stenton et al., 2013a). AQX-1125 has completed phase 2a trials for the treatment of 
mild to moderate asthma and significantly attenuated the late-phase response and 
improved FEV1 following allergen challenge (Meimetis et al., 2012; Stenton et al., 
2013a; Leaker et al., 2014) In addition, AQX-1125 is in two ongoing phase II trials for 
the treatment of interstitial cystitis /bladder pain syndrome and COPD (Table 1.1). 
Aquinox Pharmaceuticals are also recruiting participants for a Phase II pilot efficacy 
and safety study of AQX-1125 in atopic dermatitis [Aquinox Pharmaceuticals press 
release (Pharmaceuticals, 2015)]. 
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(b) SHIP-1 inhibitors  
The first SHIP-1 inhibitor was identified in 2010 using high throughput screening and 
termed 3α-aminocholestane (3AC) (Brooks et al., 2010) (Figure 1.13). 3AC increased 
the number of erythrocytes, neutrophils and platelets in myelosuppressed mice and 
increased the number of T regulatory cells which inhibited allogeneic T lymphocyte 
responses in vivo. Surprisingly, 3AC was observed to induce the apoptosis of leukemic 
cell lines and multiple myeloma cells. Given that the enzymatic product of SHIP-1, 
PI(3,4)P2, has been shown to be able to activate Akt (Brooks et al., 2010), this might 
be explained by the idea that a set amount of both PI(3,4,5)P3 and PI(3,4)P2 are 
required for optimal Akt activation. Therefore inhibiting SHIP-1 could disrupt the 
balance and promote cell apoptosis. At present the site at which 3AC binds to SHIP-1 
is unknown. 
 








                  AQX-1125                                   3α-aminochlolestane (3AC) 
 
Figure 1.13 Chemical structures of SHIP-1 modulators. (A) SHIP-1 activator AQX-
1125 (Stenton et al., 2013a) and (B) 3α-aminochlolestane (3AC) (Brooks et al., 2010). 
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1.6 Reactive oxygen species in cell signalling 
Reactive oxygen species (ROS) is the collective term for all reactive oxygen 
derivatives, and includes radicals such as superoxide (O2·-) hydroxyl (.OH) and 
perocxyl (RO2
.) and non-radicals such as hydrogen peroxide, hypochlorous acid 
(HOCl) and singlet 1O2. ROS are short-lived, highly electrophilic molecules generated 
by the partial reduction of oxygen. Some ROS are highly oxidising (e.g. OH, HOCl) and 
can form radical chain reactions; others are a rather mild oxidants (e.g. H2O2) 
(Winterbourn et al., 2008). ROS species are known to induce bifurcate responses 
within cells. High concentrations evoke cell death and low concentrations are required 
for cell survival and signalling. Thus, regulation of ROS production must be very tightly 
controlled. The following sub-sections describe cellular sources and anti-oxidant 
defence mechanisms of ROS (Figure 1.14).   
 
Figure 1.14 Reactive oxygen species. Superoxide (O2−) is generated from various 
sources, which include NADPH oxidase (NOX) and the mitochondria. Hydrogen 
peroxide (H2O2) is generated from dual oxidase (DUOX) enzymes and when two 
molecules of superoxide undergo dismutation, which is catalysed by superoxide 
dismutase (SOD). Catalase catalyses the breakdown of H2O2 into H2O and O2 In the 
presence of iron (Fe2+), superoxide and hydrogen peroxide react in a metal-catalysed 
reaction to generate hydroxyl radical (OH), termed the Fenton reaction. In addition, 
hypochlorous acid (HOCl), hypothiocyanus acid (HOSCN) and nitrogen dioxide (NO2) 
are formed from hydrogen peroxide and peroxidase reactions. Nitric oxide (NO) can 
react with superoxide to form peroxynitrite (ONOO−). The green colour indicates the 
ROS with reported signalling roles, whereas the red molecules are highly reactive and 
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1.6.1 Sources of intracellular ROS  
Various organelles within the cell can produce ROS, including the mitochondria, a by-
product of aerobic metabolism, the endoplasmic reticulum from cytochrome P-450 and 
Ero1p enzymes (Gross et al., 2006) and peroxisomes as part of their metabolism of 
long-chain fatty acids (Boveris et al., 1972). In addition, there are many intracellular 
enzymes that generate ROS as part of their enzymatic reaction cycles, namely 
lipoxygenase (O'Donnell et al., 1996), xanthine oxidase (McNally et al., 2003), 
cyclooxygenase, cytochrome P450 monooxygenase, nitric oxide synthase and NADPH 
oxidase family (NOX). Mitochondria and NOX enzymes are described in more detail 
below. 
 
(a) Mitochondria  
The ROS generated in the mitochondria occurs during normal respiration and is 
generated at multiple sites in complex I and III. Early measurement of ROS production 
using isolated mitochondria in vitro suggested that ROS generation would account for 
approximately 1% of respired oxygen, indicating that mitochondria are the largest 
generators of ROS (Boveris et al., 1972). However, recent estimates from mitochondria 
in living cells suggests normal mitochondria produce far lower levels of ROS (Nohl et 
al., 2003). They likely provide a low basal level of ROS that can increase when the cell 
is highly active, ageing or exposed to hypoxia. In T lymphocytes mitochondria-derived 
ROS have been observed to be indispensable for the activation of NFκB, expression of 
cytokines and the CD95 ligand (Roth et al., 2014). In addition, blocking mitochondrial 
ROS, specifically at Complex III result in the inhibition of CD3/CD28-induced IL-2 
expression (Sena et al., 2013) 
 
(b) NADPH oxidase family (NOX) 
NOX enzymes rapidly produce oxidants in response to receptor stimulation and thus 
have been termed professional ROS producers. Stimulation of several receptor 
including growth factors, Toll-like, cytokine and antigen receptors induce NOX enzyme-
dependent ROS production, which is required for the activation signalling cascades 
(Ogier-Denis et al., 2008). NOX enzymes are a family comprised of 5 NOX (NOX1-5) 
and 2 Dual oxidase enzymes (DUOX1-2) sub-types which differ in their expression, 
types of ROS released and mechanisms to control activity (Lassegue et al., 2012). T 
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lymphocytes are known to express NOX2 (Jackson et al., 2004) and DUOX1 (Kwon et 
al., 2010), which are shown in Figure 1.15 with their corresponding regulatory subunits. 
NOX enzymes require interaction with regulatory subunits to allow their maturation and 
trafficking to the membrane, the 5 NOX subtypes require six different subunits that 
interact to form an active enzyme complex (Babior, 1999), whereas DUOXs associate 
with one other regulatory subunit. The activation of the NOXs is complex and requires 
small GTPase Rac, Rac1 (non-myeloid cells) and Rac2 in leukocytes, and 
phosphorylation events downstream PKC, Akt and PKA (Martyn et al., 2005). Whereas, 
distinct to all other NOX enzymes, NOX5 and DUOX1/2 are directly activated by Ca2+ 
through EF hands (Sumimoto, 2008). 
NOX enzymes are expressed both in plasma membranes and the membranes of 
intracellular vesicles, providing ROS production at localised sites. Indeed, receptors 
and signalling proteins have been observed to physically interact with NOX enzymes to 
form a complex, which could further enhance the specificity of signalling to the 
interacting receptor (Pawate et al., 2004). NOXs are flavocytochromes (i.e. they 
contain both flavin adenine nucleotide and heme) and require electrons from cytosolic 
NADPH to reduce molecular oxygen, to generate superoxide which is rapidly 
dismutated to H2O2 by superoxide dismutase. DUOX enzymes directly generate H2O2 
(Terada, 2006; Takac et al., 2011).  
In T lymphocytes, NOX has been shown to be an important signalling component in 
modulating differentiation into Th17 and Th1 lymphocytes. CD3 and CD28 ligation 
resulted in primarily Th17 phenotype in NOX-deficient mice, whereas the majority were 
the Th1 phenotype in NOX-intact cells (Tse et al., 2010). In addition, T cells from mice 
deficient in the NOX catalytic subunit gp91 (phox) are more resistant to apoptosis 
(Purushothaman et al., 2009). 










Figure 1.15 NOX2 and DUOX1 and their associated regulatory subunits.  
 
1.6.2 ROS as a second messenger 
To be able to function as a signalling agent ROS must have certain properties. Second 
messengers are required to be rapidly generated, and their concentration regulated by 
co-ordination of their production and destruction. There are several professional ROS 
producers and anti-oxidants within cells that regulate the rapid induction and 
accumulation and degradation of ROS (Section 6.1.1 & 1.3). Both superoxide and H2O2 
have been indicated to signal, however it is generally accepted that H2O2 is the 
predominant signalling ROS. This is due to its greater stability and longer half-life of 
approximately 1ms allowing H2O2 time to encounter and react with signalling targets. 
H2O2 is also highly ubiquitous, small and can readily diffuse through aquaporin 
channels to access intracellular targets (Bienert et al., 2006; Bienert et al., 2007; 
Bienert et al., 2014).  
The traditional view was that ROS induces random and indiscriminate oxidation of 
intracellular lipids, proteins and DNA which led to cellular damage. However, more 
recently it was observed that H2O2 is able to induce reversible oxidation of specific 
protein targets. Sulphur containing amino acids, such as cysteine are the most easily 
oxidised (Janssen-Heininger et al., 2008), however not all cysteine residues are equally 
susceptible which further enhances the selectivity of oxidative signalling. The PKa of 
each individual cysteine depends upon whether it is surrounded by acidic or basic 
amino acids and dictates whether the residue is more likely to exist as a thiol (SH) or 
more reactive thiolate anion (S-) at physiological pH. Thus, cysteine residues with low 
PKa (5.1-5.6) are more susceptible to oxidation.  
Oxidation can alter charge, size and structural conformation of a protein which can in 
turn regulate a proteins signalling and indicates a role for ROS in divergent biological 
responses. The redox regulation of protein tyrosine phosphatases (PTPs) has been 
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widely studied and it is accepted that ROS inactive PTPs. The consequence of PTP 
inactivation is the enhancement of un-regulated tyrosine phosphorylation by protein 
tyrosine kinases (PTKs) and the activation of downstream signalling (Denu et al., 1998) 
(Figure 1.16). Interestingly, the selective oxidation of other signalling molecules has 
been observed and includes both activation and inhibition of kinases such as SFKs 
(Yoo et al., 2011), MAPK (Galli et al., 2008), Akt (Wani et al., 2011), transcription 
factors (Haddad, 2002) and ion channels (Bogeski et al., 2010). ROS are currently a 
rapidly expanding field of research due to high interest in determining mechanisms of 
oxidative signalling.  












Figure 1.16 Redox dependent signalling. (A) Protein tyrosine phosphatases (PTPs) 
undergo oxidation of critical cysteine to inactivate their enzymatic activity, which can be 
reversed by glutathione or reducing thiols (RSH). (B) Protein tyrosine kinases (PTKs) 
can also undergo oxidation/regulation of critical cysteine residues which either 
activates or inhibits their activity. (C) The result of altering PTPs and PTKs activity 
changes the phosphorylation state of proteins and can lead to activation of their 
downstream signalling. Figure adapted from (Truong et al., 2013). 
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1.6.3 Control of ROS accumulation within cells 
To maintain ROS levels at an acceptable, non-damaging concentration cells have 
developed a variety of anti-oxidant mechanisms that commonly fall into two categories, 
enzymatic or non-enzymatic. The non-enzymatic are often small compounds often 
found in our food and drink, including ascorbic acid, vitamin E, glutathione, methionine, 
carotenoids and polyphenolic compounds (Seifried et al., 2007). Cells can also 
increase expression of proteins and peptides which are cysteine rich to function as 
redox sinks when under oxidative stress, such as glutathione and peroxiredoxins. The 
enzymatic antioxidants include superoxide dismutase, catalase and peroxidases.  
(a) SOD dismutase  
Superoxide dismutase (SOD; (SOD E.C.1.15.1.1) is an anti-oxidant enzyme that 
catalyses the dismutation of highly reactive superoxide radicals into less reactive H2O2 
and O2. SOD exists as three isoforms that have different cellular locations, cytosolic 
Cu/Zn SOD (SOD1), mitochondria Mn-SOD (SOD2) and SOD3 which is secreted to the 
extracellular environment. SOD enzymes contain copper, zinc, manganese or iron 
which facilitate electron transfer. SOD are biologically very important, SOD1 (-/-) mice 
exhibit a shortened life span and an increased incident of cancer. SOD1 mutations are 
observed in some patients with amyotrophic lateral sclerosis (Furukawa et al., 2005). 
SOD2 (-/-) mice die soon after birth and develop a severe neurodegeneration disorder 
and SOD3 is important in preventing oxidative-stress induced diseases (Zou et al., 
2009). A T cell specific SOD2 conditional knock-out mouse exhibited increased 
superoxide production, apoptosis and development defects in the T lymphocyte 
population, resulting in immunodeficiency and susceptibility to influenza A virus H1N1 
infection. This result indicates that the lack of mitochondrial SOD2 results in aberrant T 
cell development and function (Case et al., 2011).  
(b) Catalase 
Catalase (EC 1.11.1.6) catalyses the decomposition of H2O2 to water and oxygen and 
thereby reduces the levels of H2O2 and prevents the formation of hydroxyl radicals via 
the Fenton reaction. The predominant catalase-containing organelle in mammalian 
cells is the peroxisome. A typical catalase is a tetrameric enzyme consisting of four 
heme containing identical subunits (Scibior et al., 2006). Catalase is very important in 
protecting cells from oxidative stress. T lymphocytes transduced with catalase using a 
retroviral vector enhanced the survival of CD4+ T lymphocytes under oxidative stress 
(Ando et al., 2008).  
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1.6.4 ROS in T lymphocytes 
There is a growing body of evidence to suggest that reactive oxygen species (ROS) 
are actually required for a vast number of physiological processes, including TCR 
activation and signalling. In a concentration dependent manner, oxidation can elicit 
positive responses, such as cellular proliferation or activation, as well as negative 
responses, inhibiting growth inhibition and cell death (Figure 1.17). 
 
Figure 1.17 Fate of peripheral T lymphocytes to increasing concentrations of 
ROS. Low concentrations of ROS (colour coded orange) leads to improper TCR 
signalling with decreased proliferation and survival, whereas high concentrations (red) 
result in increased T lymphocyte death as a result of DNA damage. ROS concentration 
has been observed to affect the differentiation of T lymphocytes Adapted from 
(Kesarwani et al., 2013) 
 
ROS are critical for a wide spectrum of cellular processes including signalling, tumour 
progression and innate immunity. However, the roles of ROS in the human adaptive 
immune system development and function remain largely unknown. Recent studies 
have indicated that ROS affects the plasticity and differentiation of naïve T lymphocytes 
by altering IL-2 and IL-4 expression and cytokine secretion (Frossi et al., 2008; 
Kaminski et al., 2010; Tse et al., 2010). In addition, the differentiation to different T 
lymphocyte subsets also appears to alter the cells relative sensitivity to oxidation. 
Interestingly, antioxidants inhibit T lymphocyte proliferation and IL-2 production in 
human and mice (Dornand et al., 1989; Tatla et al., 1999; Sena et al., 2013). A very 
recent study has indicated that ROS is not required in TCR-induced proliferation, 
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activation and cytokine secretion of primary human T lymphocytes (Belikov et al., 
2014); before this study the roles of ROS and antioxidants on TCR signalling and 
responses had not been extensively investigated in primary human T lymphocytes 
isolated from the peripheral blood.  
ROS production and scavenging has been detected using ROS sensitive fluorescent 
dyes. In T lymphocytes ROS is produced from a variety of stimuli, including mitogens 
(Williams et al., 1996), viral and bacterial super-antigens (Weber et al., 1995; Hildeman 
et al., 1999), TCR peptide agonists (Devadas et al., 2002; Kwon et al., 2003) and 
CXCL12 (Hara-Chikuma et al., 2012). ROS production has also been observed down-
stream of TGFβ (Thannickal et al., 2000), insulin (Mahadev et al., 2001) and 
angiotensin II (Ushio-Fukai et al., 1999). T lymphocytes are known to express NADPH 
oxidase enzymes NOX2 (Jackson et al., 2004) and DUOX 1 (Kwon et al., 2010) 
(Section 1.6.2). This implies that ROS might have a diverse and underappreciated role 
in the adaptive immune system.  
 
1.6.5 H2O2 is a wound cue in in vivo models of inflammation  
Generation of ROS, specifically H2O2, has been observed at sites of tissue damage 
across phylogenetically diverse organisms, including plants (Orozco-Cardenas et al., 
2001), Drosophila (Moreira et al., 2010), zebrafish (Niethammer et al., 2009) and 
mammals (Roy et al., 2006). Historically it was thought that ROS was present at sites 
of tissue damage due to cell-rupture following injury or as part of an innate immune cell 
defence mechanism, termed respiratory burst, which provides toxicity to microbes 
attempting to enter the damage site. However, due to the recent identification of 
diverse biological signalling roles of ROS in immune cells, ROS has been intensely 
researched and observed to initiate leukocyte migration to wounds. Given the 
complexity of the human immune system and the inability to observe human immune 
cells in their intact environments (i.e. surrounded by maintained gradients of highly 
diffusible ROS species) scientists have relied upon animals to model inflammation and 
wound repair in vivo.  
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a) In vivo models of inflammation  
Two important models of inflammation and wound repair have been utilised to indicate 
important roles of ROS in leukocyte recruitment. Briefly, zebrafish (Danio rerio) have 
many advantages for live imaging of leukocyte migration because their embryos 
develop externally and they are transparent allowing non-invasive observation of 
cellular behaviour in vivo by use of high-resolution imaging (Deng et al., 2012). 
Furthermore, the immune system of zebrafish closely resembles that of mammals on a 
cellular and molecular level (Lieschke et al., 2009). Tissue damage is achieved in 
zebrafish embryo by cutting the embryonic tailfin. Immune cell recruitment to tissue 
damage can be observed in transgenic zebrafish embryos with fluorescently labelled 
neutrophils and macrophages. A robust and rapid recruitment of neutrophils (Renshaw 
et al., 2006), and a slower but more directional migration of macrophages to the tissue 
damage is observed (Ellett et al., 2011). In addition, recent work has indicated that 
macrophages can repel neutrophils from inflamed tissues and are important in 
resolution of neutrophil mediated inflammation (Tauzin et al., 2014) (Figure 1.18). 
The second model uses fruit flies, Drosophila melanogaster, which also allow for live 
imaging of leukocyte migration as embryos are transparent and their genes are easily 
manipulated to study the genetics of inflammation and tissue repair. However 
Drosophila lack embryonic vasculature, mammalian chemokine orthologues and an 
adaptive immune system; instead they possess a very simplistic immune system which 
is easier to study. The main components the Drosophila immune system are 
hemocytes (macrophage-like innate immune cells). The wounding model in Drosophila 
consists of creating a laser induced epidermal wound (approximately 40μm diameter) 
in a late developmental stage 14 Drosophila embryo. Hemocytes within a further 20-
30μm circumference abandon their previous position and are rapidly recruited to the 
wound site. The attraction of wounds is transient and within two hours post-wounding, 
hemocytes migrate back to their original locations. Similarly to the zebrafish model 
hemocytes can be fluorescently labelled and tracked by high resolution live imaging 
(Moreira et al., 2010). 
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(b) In vivo models indicate a role for H2O2 as a wound cue 
The mechanism of determining how H2O2 is produced at sites of tissue damage is not 
well understood. It was commonly believed that the main sources were ruptured cells 
after direct injury or inflammatory burst of innate immune cells, however new evidence 
using the Drosophila wounding model has indicated that ROS release requires a Ca2+ 
wave triggered in the epithelium. Reducing the Ca2+ signal with chelators impairs 
hemocyte migration to the wound and the Ca2+ signal was proposed to activate DUOX 
through EF hands in its extracellular domain to produce the H2O2 accumulation at the 
wound site (Razzell et al., 2013) [Figure 1.18A].  
In addition, a particularly eloquent study was performed using the zebrafish tailfin 
wounding model. Initially, zebrafish were genetically encoded with a H2O2 sensitive 
reporter, HyPer, to allow real-time spatial and temporal accumulation of H2O2 at a 
wound edge to be observed (Niethammer et al., 2009). HyPer is highly selective for 
H2O2 over other ROS (Belousov et al., 2006). A sustained rise in H2O2 was observed 
that started 3 minutes, peaked 17 minutes and was maintained until 61 minutes post 
wounding. The H2O2 formed a gradient about 100-200μm into the tailfin with a 50μM 
H2O2 concentration predicted at the wound edge. The presence of high H2O2 after 17 
minutes indicated that the respiratory burst of the leukocytes could not be the source of 
the H2O2 as this represents the average time required for the first leukocyte which was 
not proximal to the wound edge to migrate into the vicinity of the wound. In addition, 
cell rupture is unlikely to maintain a H2O2 gradient over 60 minutes. Both the H2O2 
gradient and leukocyte migration was lost in zebrafish embryos lacking DUOX or 
treated with NADPH oxidase inhibitor DPI, suggesting both H2O2 and DUOX are 
required for the recruitment of leukocytes to the wound site (Niethammer et al., 2009) 
[Figure 1.18]. Consistently, a H2O2 gradient has since been observed to be required for 
hemocyte migration to a wound edge and treatment of the wound DPI inhibited 
leukocyte migration (Moreira et al., 2010), consistently indicating that the H2O2 gradient 
is generated by DUOX. 
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(c) How does the cell detect the H2O2 gradient? 
The mechanism by which H2O2 is detected by immune cells is not well established. 
Neithammer proposed the leukocytes could express H2O2 sensitive receptors. However 
alternatively H2O2 could manipulate innate cell migration through entering the 
cytoplasm and directly modulating intracellular mediators; several proteins have been 
indicated to be redox sensitive (Section 1.6.2). In particular, SFK member Lyn has 
been indicated as a redox sensor involved in early neutrophil recruitment to H2O2 at 
wounds. Mutation of a single conserved cysteine residue to alanine at position Cys466 
abolished the ability of Lyn to be oxidised by H2O2. This mutation resulted in an inability 
of the cell to detect and migration towards the H2O2 gradient (Yoo et al., 2011). 
Activation of Lyn leads to the activation of MAPK kinase and PI3K signalling pathways 
which are both required for neutrophil wound attraction. It has been speculated that 
asymmetric activation of PI3K signalling, by Lyn, could drive cell polarisation and 
migration along a H2O2 gradient (Yoo et al., 2011) [Figure 1.18 B]. 
 Cys466 is highly conserved across species (Zebrafish Lyn, Drosophila Src-42A and 
human SFK members) thus oxidation-dependent activation may be a general method 
of activation for all SFK members, however this has not been fully established. 
However ROS also activates the SFK, Fyn to aid the regeneration of wounded 
epithelium (Yoo et al., 2012) and ROS activated-Yrk has been observed in 
macrophage migration to the wound site which is important in resolution of neutrophil 
driven inflammation (Tauzin et al., 2014). Collectively these finding implicate ROS-SFK 
pathways as key regulators in multiple phases of the wound healing response. It is also 
not known how oxidation of SFKs alters their activity; however oxidation could provoke 
a conformational change in the protein.  
In addition to inducing migration, DUOX induced H2O2 is required for the transcriptional 
activation of genes involved in epidermal tissue repair (Juarez et al., 2011). In addition 
a mitochondrial ROS exhibits a cytoprotective role for in Caenorhabditis elegans skin 
epidermal repair. Local inhibition of mitochondrial ROS production blocked actin-based 
wound closure, whereas elevation enhances survival of mutant animals with defective 
wound healing. Xu indicates that mitochondrial ROS promotes wound closure by 
inhibition of redox sensitive Rho GTPase activity (Xu et al., 2014). Interestingly, H2O2 
has also been implicated in regulating leukocyte migration to transformed cancerous 
cells (Feng et al., 2010).  




Figure 1.18 In vivo models indicate a role for H2O2 in leukocyte migration A) Laser 
ablation of Drosophila embryo epithelium drives the recruitment of hemocytes to the 
wound edge. Tissue damage triggers a rapid (ms) Ca2+ flash in epithelial cells proximal 
to the wound edge. This is following by the production of a H2O2 gradient 100-200μm 
from the wound edge which is maintained for at least 60 minutes post wounding. B) A 
cut of the zebrafish larve tailfin triggers the early recruitment of neutrophils (0-2h) 
followed by a more directional recruitment of macrophages (3-6h). Early neutrophil 
migration occurs along a gradient of H2O2 produced by DUOX enzymes in the 
damaged and surrounding epithelium. H2O2 oxidises Lyn kinase to activate signalling 
involved in cytoskeleton re-organisation and chemotaxis. Later macrophage arrival 
requires Yrk oxidation and is important in the resolution of neutrophil inflammation. 
Finally, ROS-activation of Fyn and genes transcription is important in epithelial 
regeneration (Adapted from Archer 2014). 
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1.6.6 H2O2 as a migratory cue for the adaptive immune system 
H2O2 has been observed as a migratory cue in in vivo models of inflammation however, 
the organism used have a simplistic or immature immune systems and do not have 
functioning adaptive immune systems at the development stages investigated. In 
addition, they are clearly distinct from humans on an evolutionary scale. Interestingly, 
H2O2 has also been shown to act as a chemoattractant for mouse peritoneal 
neutrophils at low concentrations (Klyubin et al., 1996). Furthermore, human 
neutrophils chemotaxis to gradients of H2O2 has been observed in vitro (Yoo et al., 
2011) 
Thus H2O2 appears to be required for innate immune cell migration, however little is 
known about whether hydrogen peroxide is required for the migration of the adaptive 
immune system or human immune cells. Recently, H2O2 uptake, through aquaporin-3, 
was observed to be required for successful mouse T lymphocyte migration towards a 
chemoattractant, which suggests that H2O2 is also involved in the migration of adaptive 
immune cells. This H2O2 transport is essential for activation Cdc42 and subsequent 
actin rearrangement (Hara-Chikuma et al., 2012). As H2O2 also appears to be 
important in the detection of transformed cells (Feng et al., 2010) and ROS are 
involved in many other diseases (Section 1.6.8), it is particularly important to expand 
our knowledge on the effects of ROS in human T lymphocytes. 
 
1.6.7 H2O2 and calcium mobilisation 
Activation of DUOX has been recently linked to Ca2+ elevation and signalling. The 
intracellular loop of DUOX contains two canonical calcium EF hands, which bind 
cytosolic Ca2+ (Sumimoto, 2008). Section 1.6.5 describes that a Ca2+ wave precedes 
DUOX activation, H2O2 production and immune cell migration to a tissue damage site 
in the Drosophila embryo (Razzell et al., 2013). In addition, DUOX has been shown to 
act in concert with SFKs and Ca2+ to signal and drive wound repair in zebrafish 
(Niethammer et al., 2009; Yoo et al., 2011).  
Interestingly, exogenous H2O2 can induce calcium mobilisation and signalling, which 
has been postulated to be due to i) influx through voltage gated Ca2+ channels, ii) non-
specific changes in membrane permeability, iii) alteration of Ca2+-Na2+ exchange iv) 
changes in Ca2+ release from intracellular stores (Krippeit-Drews et al., 1995; Herson et 
al., 1999; Wang et al., 1999; Sato et al., 2009). However, is important to establish the 
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concentration of H2O2 which causes necrosis in each cell type, as intracellular Ca
2+ 
overload is an early marker of necrotic cell death (Zhivotovsky et al., 2011)  
 
1.6.8 ROS associated with disease 
The link between oxidative stress and disease has been recognised for several 
decades. In disease conditions, natural human antioxidants defences are not always 
sufficient to maintain ROS balance which can lead to excessive and uncontrolled 
production of ROS. In particular, ROS are involved aging (Brieger et al., 2012) as well 
as autoimmune diseases, leukaemia, carcinoma, cardiovascular diseases and 
neurological disorders (Kesarwani et al., 2013). Interestingly, ROS and oxidative 
products are associated with the progression and severity of rheumatoid arthritis 
(Griffiths, 2005; Filippin et al., 2008).  
In light of recent experiments indicating that H2O2 acts to positively modulate immune 
cell migration (Section 1.6.5), ROS could be a factor in diseases presenting excessive 
immune cell recruitment (i.e. diseases that present with a high white blood cell count), 
such as asthma and COPD. Both these conditions are proposed to exhibit a high 
production of H2O2 due to chronically irritated tissues (Murata et al., 2014). Cancerous 
cells often overproduce ROS, possibly due to elevated expression or overactive of 
NOX enzymes downstream of growth factor receptors. Oxidative stress is linked to 
genomic instability, chemo-resistance and growth mutation (Yang et al., 2014). In 
addition, the link between inflammation and cancer has been suggested by 
epidemiological and experimental data and confirmed by anti-inflammatory therapies 
showing efficacy in cancer prevention and treatment (Bartsch et al., 2006; Grivennikov 
et al., 2010). Even the tradition Ayurvedic medical system, which was written 5000 
years ago, described that continuous irritation over long periods of time could lead to 
cancer (Garodia et al., 2007). Continuous irritation and wound healing are still a topic of 
intense interest in cancer research (Coussens et al., 2002; Gonda et al., 2009). Recent 
studies have focused on developing therapeutics to enhance the anti-oxidants within 
the cells and restore proper immune cell function. However clinical evidence and in 
vivo studies for not always support anti-oxidants reducing the inflammatory response 
(Higgins et al., 1995; Gelderman et al., 2007; Kesarwani et al., 2013).  
 
 




Oxygen concentrations can become very low in pathological sites with low vasculature 
and sites of infection (Vaupel, 1977; Semenza, 2001; Via et al., 2008). Under hypoxic 
conditions, mitochondria produce higher levels of ROS from the respiratory complex III 
(Guzy et al., 2005). Therefore, in addition to being a relevant environmental setting for 
an activated T lymphocyte, exposure to hypoxia presents a method of manipulating the 
redox environment of the cell. Dysregulation of oxygen homeostasis is observed in 
inflammatory and cardiovascular disease, cancer, cerebrovascular disease and chronic 
obstructive pulmonary disease (Semenza, 2001).  
Hypoxia inducible factor (HIF-1α) is the key transcription factor mediating responses to 
hypoxia. In normal oxygen conditions, the alpha subunits of HIF are hydroxylated at 
conserved proline residues by HIF-prolyl-hydroxylases, allowing their ubiquitination, 
which labels them for rapid degradation by the proteasome. In hypoxic conditions HIF-
prolyl-hydroxylases are inhibited, due to their use of oxygen as a co-substrate. HIF-1α 
expression is stabilised and mediates the transcription of hypoxic sensitive genes to 
promote cell survival in low-oxygen conditions (Semenza, 2004).  
 
1.7 Aims and Objectives  
Adaptive immune responses are highly co-ordinated and rely upon efficient intracellular 
communication to induce cell functions. The experimental work in the thesis is divided 
into three sections which all focus on furthering our knowledge of signalling within 
human T lymphocytes. The first part dissects the roles of SHIP-1 in human T 
lymphocyte biology. The second focuses on the functional outcomes of ROS 
manipulation in human T lymphocytes and the final section examines signalling roles of 
H2O2 to explore the mechanisms underlying functional outcomes observed in part 2.  
Both SHIP-1 and ROS-induced signalling and functional roles are not well understood 
in primary human T lymphocytes, with the majority of publications using animal cells, in 
vivo animal models or leukaemic cell lines. Both SHIP-1 activators and anti-oxidants 
are in clinical trials for the treatment of immune cell related pathologies, thus our intent 
is to improve the understanding of their signalling and define their potential as 
therapeutic targets for T lymphocyte driven pathologies such as autoimmune/ 
inflammatory disease and cancer.  
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1. Determine whether SHIP-1 activator, AQX1, or SHIP-1 inhibitor, 3-AC, alter 
human T lymphocyte biology and indicate their therapeutic potential in T 
lymphocyte driven pathologies. Hypothesis:-SHIP-1 has pleiotropic functional 
roles in T lymphocyte function. The objectives to explore this hypothesis are to: 
 establish the functional roles of SHIP-1 in human T lymphocyte viability and 
TCR activation including investigating downstream Ca2+ elevation, proliferation 
and adhesion.  
 assess the functional importance of SHIP-1 as a regulator of basal and 
chemotactic migration, chemokine signalling, polarisation and cytoskeletal 
protein rearrangement. 
 evaluate the potential of SHIP-1 as a novel therapeutic route to influence T 
lymphocyte driven inflammatory and autoimmune diseases. 
 
2. Identify the functional roles of ROS manipulation in human T lymphocyte 
biology. Hypothesis: Non-toxic concentrations of H2O2 will activate survival, 
proliferation, signalling and migration in human T lymphocytes. The objectives to 
explore this area are to:  
 establish the functional roles of ROS manipulation on ligand mediated cellular 
responses including viability, activation, downstream Ca2+ elevation, 
proliferation and adhesion using human T lymphocyte.  
 determine whether human naïve or activated T lymphocytes migrate towards a 
H2O2. 
 establish the effect of ROS species upon directional T lymphocyte migration. 
 
3. To examine the contribution of SFKs, SYKs, PI3K and SHIP-1 in ligand and 
H2O2-mediated signalling in human T lymphocytes. Hypothesis: Activation of 
SFK is a key signalling event in H2O2 mediated activation of T lymphocytes. The 
objective to address this area are to: 
 Analyse the contribution of SFKs, SYKs and PI3K isoforms in T lymphocyte 
chemotaxis using pharmacological manipulators. 
 Interpret the responses of ROS manipulation on intracellular signalling and 
receptor expression. 
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2.1 Cell culture  
 
2.1.1 Human leukemic T lymphoblast cell lines  
Human leukemic T cell line Jurkat (American Type Culture Collection, ATCC; 
Manassas, Virginia, USA) were cultured in RPMI-1640 media (Invitrogen # 11875-093; 
Paisley, UK)  supplemented with 10% (v:v) heat inactivated fetal bovine serum (FBS; 
Source Bioscience #7.01 Hi), 2mM L-glutamine [to provide energy supply for rapidly 
proliferating cells] 20mM HEPES (Sigma-Aldrich, Poole, UK) [a buffering agent used to 
maintain physiological pH] and 100U/ml of penicillin and 100µg/ml streptomycin 
(Invitrogen # 15140-122) [to protect against infection]. Culture flasks with a surface 
area of 75cm2 were used to culture the cells at 37oC with a constant supply of 
humidified air containing 5% CO2. The cell culture was maintained by changing the 
media every 2-3 days and cells were kept at a confluence of approximately 1 million 
cells per ml. Cells were discarded after 3 months of culturing and replaced with frozen 
cell stocks stored in cryo-tubes in liquid nitrogen tanks.  
 
2.1.2 Peripheral blood mononuclear cells (PBMC) isolation from whole blood 
Blood (50-100ml) was collected aseptically from healthy volunteers (donors were 
questioned to ensure they were not feeling unwell on the day of collection and 
volunteers with chronic health conditions were asked not to participate) of both sexes 
[who had not received any medication for at least 72h prior to donating] with a age 
range of 21-65, via a 21-gauge butterfly cannula (Bunzl Heathcare, Leicester, UK) into 
a sterile disposable 50ml syringe prepared with 2U/ml heparin (Sigma-Aldrich # 
84020). The blood was subsequently diluted with warm sterile RPMI-1640 media 
without supplements in a ratio of 1:1. 25-35ml of the diluted blood was carefully layered 
onto 15ml of lymphoprep (Axis Shield # S1105, Dundee, UK) in 50ml plastic tubes 
(Figure 2.1.A). Preparations were spun at 250g for 30 minutes with braking deactivated 
upon deceleration for an unassisted stop (Figure 2.1.B). Following centrifugation, the 
mononuclear cell rich interface containing the PBMCs was removed by a sterile 
Pasteur pipette into a fresh 50ml falcon tube and diluted 1:1 with RPMI-1640 media. 
PBMCs were washed three times by centrifugation at 250g for 10 minutes, removal of 
the supernatant and addition of un-supplemented RPMI-1640 media to ensure 
complete removal of the lymphoprep solution.  
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2.1.3 Naïve CD4+ T lymphocyte isolation  
“Naïve CD4+ T lymphocytes” were isolated from the freshly isolated PBMC using a 
naïve CD4+ T cell isolation kit II human (Miltenyi Biotec, Bisley Ldt., Surrey #130-094-
131). This kit uses a negative selection method whereby a cocktail of biotinylated 
monoclonal antibodies (targeting CD45RO, CD8, CD14, CD15, CD16, CD19, CD25, 
CD34, CD36, CD56, CD123, anti-TCRγ/δ, anti-HLA-DR, and CD235a /glycophorin A) 
indirectly label all the non-T-lymphocytes in the isolated PBMC (Figure 2.1). After 
washing, freshly isolated PBMC were counted using a haemocytometer. PBMCs were 
re-suspended in 40µl sterile ice cold MACS buffer (PBS + 2mM EDTA + 0.5% BSA, pH 
7.4) per 10 million cells. 10µl of cocktail biotinylated monoclonal antibody per 10 million 
cells was then added for 10 minutes at 4oC to label all non-naïve CD4+ cells. 10ml 
MACS buffer was added and cells centrifuged at 250g for 10 minutes before 
supernatant was completely removed and cells re-suspended in 80µl ice cold MACs 
buffer and 20 µl biotinylated micro-beads per 10 million cells for 15 minutes (Figure 
2.1). After which another 10ml of ice cold MACs buffer was then added and the cells 
centrifuged at 250g for 10 minutes. The supernatant was discarded and cells re-
suspended in 500µl fresh MACs buffer. An LS column [#130-042-401] was prepared by 
washing through 3ml of ice cold MACs buffer. The cells were then added to the column 
and output collected in a 15ml falcon tube. The column was then washed three times 
by the repeated addition of 3ml MACs buffer (Figure 2.1). Cells were centrifuged and 
re-suspended into supplemented RPMI-1640 media for immediate use.  
 
2.1.4 Clonal expansion of CD4 and CD8 T-lymphocytes 
To clonally expand CD4+ and CD8+ lymphocytes, the washed PBMCs were re-
suspended in fully supplemented RPMI-1640 media at an equal volume to that of the 
original volume of whole blood collected from the donor.  Staphylococcal enterotoxin B 
(SEB; Sigma # S4881) was added at a final concentration of 1µg/ml for 72 hours. The 
suspension cells were then collected in a 50ml falcon and washed three times in un-
supplemented RPMI-1640 media and placed in a fresh cell culture flask the same 
volume of complete media supplemented with interleukin-2 (IL-2; Chemicon; 
Hampshire, UK) at 36U/ml. Any contaminating adhering cells (such as monocytes) 
were removed by plastic adherence to the original flask. The cells were washed, re-
suspended and supplemented with fresh IL-2 every two days for 10-14 days maintain 
cell confluency between 0.1 to 1 million cells per ml.  Cells were used 8-14 days post 
isolation and rested in complete media without IL-2 overnight before use.  





Figure 2.1 Isolation of naïve T lymphocytes from whole blood. Left hand panel is a 
schematic representing non-naïve CD4+ T lymphocytes (in green and orange) bound 
by a cocktail of biotinylated monoclonal antibodies (targeting CD14, CD16, CD19, 
CD36, CD56, CD124) and anti-biotin (avidin) coated micro-beads. Naïve CD4+ T 
lymphocytes are untouched and represented in purple. Right hand panel is a schematic 
representing the naïve T lymphocytes passing through a LS column selection, whilst 
cells bound to the beads will remain inside the magnetic column (Original graphic).  
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2.2 Cellular viability assays  
2.2.1 Propridium iodide and annexin V staining  
SEB activated T lymphocytes were washed three times into un-supplemented media. 
Cells were treated with compounds as stated in the figure legends for 3 hours. Cells 
were then re-suspended at 1 million cells per ml in Annexin V binding buffer (10mM 
HEPES, 140mM NaCl 2.5mM, CaCl2, 0.1 % (w:v) BSA; pH 7.4). Cy5 conjugated 
Annexin V (Life Technologies) was then added at 10μl per 1 million cells for 20 minutes 
on ice protected for light. After 20 minutes, 2.5µg/ml propidium iodide PI (Sigma Aldrich 
# 81845) was added to the cells and fluorescence emission read immediately using 
flow cytometry and emission read at 488nm (Cy5) and 617nm (PI). 
 
2.2.2 MTT assay  
Cells were re-suspended in fresh complete RPMI media at 1 million cells per ml. 100µl 
of cells were added in triplicate for each condition to a 96 well-plate. Triplicate wells 
were treated for either 3 or 24 hours with either vehicle or stated concentrations of 
compounds at 37oC. The plate was centrifuged at 250g for 10 minutes and supernatant 
aspirated. Cells were re-suspended in 100µl MTT mix (RPMI, 10% FBS and 500µg/ml 
3-4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT) Sigma Aldrich # 
M2003) and incubated for 3 hours. Background absorbance was determined from a 
well containing only the MTT mix. In living cells, yellow MTT is reduced by 
mitochondrial succinic dehydrogenases to blue formazan; fluorescence intensity is 
therefore proportional to the number of living cells. After 3 hours 100µl DMSO (Sigma 
Aldrich # D8418) was added to each well to lyse the cells. Absorbance at 540nm was 
then read using a FluoStar Optima plate reader  
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2.3 Proliferation  
Cell proliferation was measured using the Cell Trace CFSE Cell Proliferation Kit 
(Invitrogen #C34554) according to the manufacturer’s instructions. Carboxyfluorescein 
diacetate N-hydroxysuccinimidyl ester (CFSE) is a cell permeable, non-fluorescent pro-
dye. Intracellular esterases cleave the acetate groups which results in fluorescent 
carboxyfluorescein which is membrane impermeant. The succinimidyl ester groups 
binds covalently to intracellular amines and emit fluorescence at 517nm when excited 
at 492nm. The result is live fluorescently labelled cells. As the cells divide the CFSE is 
partitioned between the two daughter cells. Hence, by tracking mean CSFE 
fluorescence intensity over time cell proliferation can be determined.  
Freshly isolated naïve CD4+ T lymphocytes were re-suspended at 1 million cells per ml 
in PBS and 0.1% BSA. CFSE was added for a final concentration of 5µM and cells 
incubated at room temperature in the dark for 15 minutes. Cells were washed once into 
fresh RPMI and incubated at 37oC for 30 minutes. Cells were washed again into fresh 
complete RPMI media at 1 million cells per ml. Freshly labelled naïve T lymphocytes 
were taken and analysed by flow cytometry to ensure dye incorporation and determine 
mean fluorescence intensity on Day 0. The remaining cells were treated with vehicle or 
stated concentrations of drugs. Cells were then activated by the addition of anti-
CD3/CD28 coated beads (methods described below) at a ratio of 3 beads to each cell 
and 36U/ml recombinant IL-2. After either 4 or 5 days (stated in the figure legends) 
cells were analysed for CFSE fluorescence using flow cytometry, excitation at 492nm 
and emission at 517nm. Population gates were used to determine the percentage of 
cells in each cell division observed. 
2.3.1 Coupling of anti-CD3/CD28 antibodies to micro-beads 
75μg of antibodies raised against human CD3 (clone UCHT-1) and human CD28 
(clone 9.3) were added to a 0.1M borate buffer (pH 9.5). This antibody cocktail was 
added to 400 million magnetic Dynabeads (Invitrogen) and rotated overnight at 37oC. 
Then the beads were held with a magnet and the borate buffer removed. Using the 
bead wash solution (Phosphate buffered saline without Ca2+ and Mg2+, 3% (v:v) human 
AB serum, 1% (v:v) sodium azide, 2mM EDTA pH 8.0) and beads were washed three 
times for 10 minutes and once for 30 minutes and then overnight at 4oC whilst rotated. 
The following day beads were re-suspended in 10 ml bead wash solution. Storage of 
Anti-CD3/CD8 coated beads at 40 million per ml at 4oC. Before use, beads were 
washed three times in phosphate buffered saline, re-suspended in RPMI-1640 and 
added to the cells at indicated ratios.  
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2.4 Cell stimulation protocol 
Cells used for stimulations were re-suspended at a concentration of 2 million cells per 
ml in supplement free RMPI-1640 media with HEPES (1mM) and rested for 30 minutes 
in a 37oC water bath. Vehicle control (Ethanol/DMSO as appropriate at the same 
concentration as present in the highest drug treatment), drug treatments were carried 
out for the indicated times before the additions of stimulants. After stimulation, cells 
were placed immediately on ice, washed once in ice cold PBS before cell lysis for 
Immunoblotting.  
 
2.4.1 Cell lysis 
Stimulated and PBS washed cells were then centrifuged for 1 minute at 250g, the 
supernatant was discarded and cell pellet re-suspended in 50μl lysis buffer (50mM 
Tris-HCl [pH 7.5], 150mM NaCl, 1% (v:v)  Nonidet-P40  [BDH], 5mM EDTA, 
phosphatase inhibitors, 1mM sodium vanadate, 1mM sodium molybdate, 10mM 
sodium fluoride and protease inhibitors 40μg/ml PMSF, 0.7μg/ml pepstatin A, 10μg/ml 
aprotinin, 10μg/ml leupeptin, 10μg/ml soybean trypsin inhibitor [All from Sigma]). 
Samples were rotated for 30 minutes at 4oC to assist cell lysis after which cells were 
centrifuged 153g, 4oC for 10 minutes. The supernatant containing protein was removed 
and insoluble material discarded.  5μl 5× sample buffer (60mM TRIS-HCl, 2% 
[w:v]SDS, 10 % [v:v] glycerol, 5% [v:v] 2-mercaptoethanol and 0.01% bromophenol 
blue sodium salt; pH 6.8) was added to 20μl protein in lysis buffer and boiled at 100oC 
for 5 minutes. Samples were briefly centrifuged at 250g. Supernatant containing protein 
and boiled samples containing sample buffer were stored briefly at -20oC before 
Immunoblotting. 




Proteins were separated using 10% (w:v) acrylamide gels 
 
Table 2.1 Composition of a 10% (w:v) SDS-acrylamide gel. 
 
10% SDS acrylamide gels were prepared using the Mini PROTEAN Tetra 
Electrophoresis System (BioRad, Hemel Hempstead, UK). The resolving gel (Table 1) 
was cast first and milliQ water gently layered on top. The gel was left to polymerize for 
approximately 20 minutes. Once the resolving gel has set the water was poured off and 
replaced with stacking gel (Table 2.1) containing a 10 or 15 well comb to create the 
wells for protein loading. The stacking gel was left to set for another 20 minutes. Once 
set the comb was removed and wells cleaned with milliQ water to remove non-
polymerized acrylamide. The gel was then loaded into the apparatus and tank filled 
with running buffer (250mM Tris base, 1.92M Glycine and 1% (w:v) SDS). 20µl of 
sample and 2µl EZ-run protein ladder (Gibco) were then loaded and electrode lid 
attached to the tank. The gels were run at 75V for 15 minutes or until the proteins had 
passed through the stacking gel. The voltage was then increased to 150V to separate 
the proteins by electrophoresis through the resolving gel until the dye in the loading 
buffer emerged from the bottom of the gel.  
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2.4.3 Semi dry protein transfer 
Protein was transferred to a nitrocellulose membrane using a semi dry transfer 
protocol. Firstly the graphite electrodes of the transfer apparatus were dampened with 
semi-dry transfer buffer (480mM Tris base, 390mM Glycine, 0.375% (w:v) SDS and 
20% (v:v) methanol). Whatman paper (Fisher) and the nitrocellulose membrane (GE 
Healthcare UK) were cut to the same size as the gel and pre-soaked in semi-dry 
transfer buffer. 3 pieces of Whatman paper were layered on the graphite electrode, and 
the nitrocellulose membrane was placed on top and gently rolled to remove air 
bubbles. The gel was carefully placed on top and covered by another 3 pieces of 
Whatman paper which again was rolled to expel air bubbles. The transfer was run for 1 
hour at 0.8A/cm2. The nitrocellulose membrane was blocked from non-specific antibody 
binding by incubation in either 2% (w:v) BSA in TBS-Tween (200mM Tris Base, 1.5M 
NaCl and 0.05% (v:v) Tween pH 7.4; Sigma-Aldrich) or 5% (w:v) milk in TBS-Tween. 
The membrane was then washed briefly in TBS-Tween to remove excess blocking 
buffer and incubated at 4°C overnight with the relevant primary antibody (Table 2.2). 
 
Table 2.2 Primary antibodies used for Immunoblotting. For Cell Signalling 
Technology antibodies dilution factors are reported as the initial antibody concentration 
is not available. Primary antibodies are diluted in 5ml TBS-Tween, 0.01% (w:v) BSA 
and 0.001% Sodium Azide.  
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The membranes were washed 3 times for 5 minutes in TBS-Tween to remove any 
excess primary antibody and then exposed to the secondary antibody 0.001% (v:v) 
HRP conjugated anti-rabbit IgG (Dako #P0448). The membranes were incubated for 1-
2h with the secondary antibody and washed again 3 times for 5 minutes in TBS-Tween. 
Membranes were then placed in Chemiluminescent Lumigen reagent (Amersham 
Bioscience) for 1 minutes and then exposed by X-ray film (Fuji Medical X-Ray Film 100 
NIF 18x24; Fisher Scientific) inside a film cassette for between 30sec-2hr and then 
developed using a film developer (Photon Imaging Systems, Swindon, Wilts, UK). Band 
intensity was quantified using ImageJ, whereby the rectangular selection tool from the 
Image J toolbar was used to detect set areas around each band. The pixel intensity of 
each rectangle was measured and calibrated against the pixel intensity of the 
background.  
Alternatively, nitrocellulose membranes were placed in Chemiluminescent Lumigen 
reagent (Amersham Bioscience) for 1 minutes and then imaged using an ImageQuant 
developer (GE Healthcare, Life Sciences). Band intensity measured using 1D gel 
ImageQuantTL analysis software version 7.  
Alternatively, nitrocellulose membranes were blocked for 2h in 5% (w:v) milk then 
placed in fluorescence secondary antibody (LICOR Donkey anti Rabbit) (1:5000) in 
TBS tween 1% (w:v) BSA. Blots were then washed 4 times for 5 minutes in TBS tween 
then once in PBS before fluorescence intensity at 680nm was imaged using the Licor 
Infrared developer (Odyssey). 
 
2.4.4 Membrane stripping and reprobing  
The membranes were placed in a sealed container including at least 25ml of stripping 
buffer (100mM 2-Mercaptoethanol, 2% [w:v] SDS, 62.5mM TRIS-HCl; pH 6.7) and 
placed in a water bath at 60oC for 30 minutes. The membrane was then washed 6 
times over the course of 1hr in TBS tween. The membranes were then blocked for 1hr 
in 5% (w:v) milk in TBS tween and then exposed to a different primary antibody. 
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2.5 Immunoprecipitation of SHIP-1  
By immunoprecipitating SHIP-1 from human T lymphocytes the compounds can be 
assessed directly on the catalytic activity of SHIP-1. SHIP-1 was immunoprecipitated 
from the SEB activated T lymphocytes. Cells were centrifuged 250g and re-suspended 
in serum free RMPI-1640 media. 1 million cells were lysed for used for each reaction of 
the malachite green assay. Samples were rotated for 30 minutes at 4oC to assist cell 
lysis after which cells were centrifuged 153g, 4oC for 10 minutes. The supernatant 
containing protein was removed and insoluble material discarded. After centrifugation 
the supernatant was incubated overnight in 0.01% (v:v) SHIP-1 monoclonal antibody 
(Cell Signaling Technology). A/G Agarose beads (Peprotech) (5μl per point of 
malachite green) were washed twice in lysis buffer without inhibitors, re-suspended in 
100μl and added to the cell lysis of the MOLT-4 cells for at least 2 hours. Samples 
were then washed 3 x in 1ml lysis buffer and 3 x in malachite green reaction buffer (5% 
(v:v) glycerol, 20mM Tris HCl, 10mM MgCl2; pH 7.4) to remove all proteins not attached 
to the A/G agarose beads and re-suspended in 20μl of reaction buffer/point.  
 
2.5.1 Malachite green assay 
The immunoprecipitated SHIP-1 was then used in the malachite green phosphate 
assay. Full length recombinant SHIP-1 (Gift from GlaxoSmithKline) was diluted to 1μM 
in reaction buffer and assessed in the malachite green reaction. SHIP-1 can 
dephosphorylate the in vitro substrate D-Ins(1,3,4,5) tetrakisphosphate to produce 
Ins(1,3,4)P3 and free phosphate.  A malachite green solution can react with the free 
phosphate to give a rapid colour change from yellow to green. 20μl of 
immunoprecipitated SHIP-1 solution, or 1μM recombinant SHIP-1 was added to each 
of the required wells of a 96 well plate and incubated with SHIP-1 activators, inhibitors 
or H2O2 at given concentrations for 5 minutes at room temperature. 100µM substrate 
D-Ins (1,3,4,5)P4 (Echelon Biosciences, Salt Lake City, USA #Q-1345) was added for 
30 minutes at 37oC. 100µl malachite green solution (Echelon, # K-1501) was added to 
each well and incubated for 15 minutes at room temperature in the dark. The plate was 
then read at 650nm using a FluoStar Optima plate reader.  
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2.6 Flow cytometry  
Freshly isolated naïve CD4+ and SEB-activated T lymphocytes were washed three 
times by centrifugation at 250g and re-suspended in non-supplemented RPMI-1640 
media. After treatment with vehicle or activator as described in the figure legends, cells 
were fixed using BD Fixation and Permeabilization solution (containing formaldehyde; 
BD Biosciences, Oxford, UK) for 30 minutes at 4°C to allow intracellular staining of 
proteins. Cells were washed twice in BD PERM/Wash solution (containing sodium 
azide and saponin; BD Biosciences) solution and incubated with 0.02% (v:v) anti-
phospho ERM (Cell Signalling Technology #3141), anti-phospho-SHIP-1 (Cell 
signalling #3941) diluted in BD PERM/Wash for 30 minutes at 4°C. Cells were washed 
twice by centrifugation at 250g and re-suspension BD PERM/Wash solution and then 
incubated with 0.01% (v:v) anti-rabbit IgG FITC conjugated secondary antibody (Sigma 
#F9887) for 30 minutes at 4°C. Alternatively, cells were stained with TRITC conjugated 
phallodin for 30 minutes. Cells were washed twice in BD PERM/Wash solution, re-
suspended in 400μl ice cold PBS + 1% (v:v) FBS in 5ml rounded bottom FACs tubes 
(BD Falcon, Willford, Nottingham) for analysis by BD FACS Canto II flow cytometer and 
BD FACS DIVA software (BD Biosciences). TRITC stained cells were excited at 547nm 
and emission recorded at 573nm whereas FITC stained cells were excited at 495nm 
and emission recorded at 519nm. Mean fluorescence index (MFI) was used to describe 
the level of phosphorylated ERM, SHIP-1 protein or actin polymerisation. 
  
2.6.1 Surface receptor expression by flow cytometry 
SEB activated T lymphocytes were re-suspended in fully supplemented RMPI-1640 at 
a concentration of 1 million cells per ml. Cells were treated with either vehicle or stated 
concentrations of drugs for 30 minutes. Cells were washed twice with ice cold FACs 
buffer (PBS + 2% FCS) then re-suspended in diluted 1/50 (v:v) phycoerythrin (PE) 
conjugated anti-CXCR3 antibody (R&D biosciences # FAB16OP) or PE conjugated IgG 
isotype control (1/50 v:v dilution; R&D biosciences #1COO2P). Alternatively cells were 
labelled with either Anti-human CD11a PE-conjugated monoclonal antibody (1/50 v:v 
dilution; ImmunoTools # 21270114), anti-human CD49d PE-conjugated monoclonal 
antibody (ImmunoTools # 21488494) or PE conjugated IgG antibody. Cell were 
labelled on ice for 1 hour then washed twice more in FACs buffer. Alternatively, cells 
were incubated with primary antibody 10μg/ml KIM127 mAb (Gift from Nancy Hogg) for 
30 minutes then washed and incubated to secondary anti-mouse FITC conjugated 
antibody  (dilution 1/50 v:v). Finally, cells were re-suspended in PBS and placed in 5ml 
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round bottomed tubes (VWR, Lutterworth, Leicestershire, UK) for analysis by flow 
cytometry. PE-fluorescence was detected by exciting cells at 496 nm and emission 
recorded at 576 nm recorded by BD FAC Aria flow cytometer and analysed by BD 
FACs Diva Software. Mean fluorescence index (MFI) was used to describe the level of 
CXCR3, CD11a and CD49d expression. 
 
2.7 In vitro cell migration assays 
2.7.1 Neuroprobe assay 
A Boyden chamber 96 well plate assay can be used to determine in vitro cell migration. 
Cells were washed three times in non-supplemented RPMI-1640 medium, re-
suspended at 3.2 million cells per ml in phenol red free RPMI-1640 media and treated 
with either vehicle or inhibitor at the indicated concentrations for 30 minutes. Whilst 
preparing the cells, a 96 well Neuroprobe chemotaxis plate (Chemo® Tx101-5; 
Receptor Technologies, Warwick UK; [Figure 2.2 A]) was equilibrated by the addition of 
29µl of PBS to the lower chamber and incubation at 37oC for 1 hour. PBS was 
aspirated from the wells and replaced with either chemotaxis media (phenol red free 
RPMI-1640 media; Invitrogen) or chemokines CXCL11, CXCL12 or CXCL10 
(Peprotech, London UK) diluted in chemotaxis media. This was overlaid with a supplied 
5-μm pore-size filter membrane and 25μl of the cell suspension (total cell number 
80,000) was added over each required well (Figure 2.2 B). The plate was then 
incubated at 37°C in 5% CO2 for 3 hours. A single piece of Whatman blotting paper 
was then passed evenly over the membrane to remove the cells which have not moved 
from the top 25μl cell suspension. The plate was then centrifuged at 250g for 10 
minutes with the brake deactivated to allow an unassisted stop. This allows the cells 
which have migrated through the membrane to be collected in the bottom well. The 
membrane was carefully removed and cells re-suspended from each well and placed 
into 300µl PBS.  Cells were then counted for 30 seconds for each well by flow 
cytometry whereby cells were selected by a gate to eliminate debris.  




A             B 
 
 
Figure 2.2 Apparatus and schematic for determining in vitro cell migration. A. 
Photograph of the apparatus supplied by Receptor Technologies to undertake cell 
migration. The 96 well plate system contains a lower chamber containing plate, a sheet 
containing 96 circular membranes with 5µM pores surrounded by black hydrophobic 
rings and a plastic lid. B. Schematic side on view of the preparation of a Neuroprobe 
experiment. The cell suspension is placed in the upper chamber, if cells are able to 
migration they move towards the chemokine CXCL11 in the lower chamber. Cells are 
retained in the lower chamber and counted by flow cytometry.  
 
2.7.2 IBIDI microscopy assay 
For multi-parameter analysis of a migrating cells’ velocity, directionality and total 
distance travelled a 2D IBIDI μ-slide (IBIDI, #80301, Martinsried, Germany) system was 
utilised. Each slide was coated in 45μg/ml fibronectin (R&D Systems; diluted in PBS) 
overnight at room temperature. Then fibronectin coated slide was pre-warmed at 37oC 
for 1 hour before washing twice with ultra-pure MilliQ water. Basal cell migration was 
observed by completely filling the slide with media (phenol red free RPMI-1640 with 
0.1% BSA; Figure 2.3.A). Whereas to observe chemotaxis, 18µl of chemokine CXCL11 
(100nM; Peprotech, Table 2.3) was added to the top well of the IBIDI chamber (Figure 
9.B). According to the manufacturer the chemokine will diffuse to give a gradient with 
an approximate concentration of 33nM reaching the cells (Figure 2.3.C). SEB activated 
T lymphocytes were washed three times in RPMI media and then re-suspended in 
chemotaxis media to give a concentration of 10 million cells/ml. 5μl of the cell 
Chapter 2: Methods and Materials 
77 
 
suspension (total of 50 cells) was pipetted into the slide observation platform (Figure 
2.3A & B). The IBIDI µ-slide was then place in an environmental chamber heated to 
37oC and left for 15 minutes to allow the chemokine gradient to develop. An area 
containing at least 25 cells was selected upon the cell platform. A time series of images 
(Zeiss LSM 510 META microscope) were captured with a recording every 15 seconds 
for 15 minutes to allow a movie of cell migration to be generated. A total of 20 cells 
were tracked per condition using ImageJ software, the Manual Tracker plug-in (Fabrice 
















Figure 2.3 IBIDI µ slide for measuring in vitro cell migration. A. Top down view of 
IBIDI µ slide assessing basal migration with arrow indicating location to pipette cell 
suspension onto the central observation platform, blue colour indicates chemotaxis 
buffer without chemokine. B. Top down view of an IBIDI µ slide with arrow to indicating 
where chemokine and cells were added, pink colour represents the presence of 
chemokine. A chemokine gradient should develop across the slide indicated by the 
blue line C. Side view of an IBIDI µ slide showing a chemokine gradient between C0-100 
across the observation platform. Images taken from (Image taken from 
http://.com/xtproduc ts/en/ibidi-Labware/Channel-Slides/m-Slide-Chemotaxis-2D)  
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2.8 Confocal microscopy 
1 million cells were stimulated as required and fixed in BD Fixation and 
Permeabilization (PERM) solution (which contains formaldehyde; BD Biosciences) for 
30 minutes at 4°C. Cells were washed twice via centrifugation at 250g and re-
suspension in BD PERM/Wash solution (containing sodium azide and saponin; BD 
Biosciences) and then incubated with 0.02% (v:v) anti-phospho ERM antibody (Cell 
Signalling Technology #3141) in BD PERM/Wash solution overnight at 4°C. Cells were 
washed twice in BD PERM/Wash solution, re-suspended in 0.01% (v:v) Goat anti-
rabbit Fluorescein isothiocyanate (FITC) conjugated secondary  antibody diluted in 
PERM/Wash solution overnight at 4°C. Cells were then washed twice in PERM 
solution, re-suspended in 20μl PERM solution and cells pipetted into Mowiol to adhere 
coverslips to slides then allowed to set overnight. Cells were visualized using a Zeiss 
LSM 510 Meta confocal microscope using Plan-Apochromat 63x/1.4 Oil DIC objectives. 
Cells were excited by 488nm light and fluorescence emission was collected at 520nm 
with a band pass filter of 530 ± 15nm. Images were collected at 2 x zoom. 
 
2.9 Measurement of intracellular calcium  
SEB-activated T lymphocytes were re-suspended in HBSS (Gibco) supplemented with 
25mM HEPES and 0.1% BSA, pH 7.4 at 4 million cells per ml and loaded with 10μM 
cell permeant Fluo-4 acetoxymethyl (AM) [Invitrogen #F14201] for 45 minutes at 37oC, 
cells were protected from light. Fluo-4 is a calcium indicator which fluoresces upon 
binding to Ca2+. Attaching Fluo-4 to an acetoxymethyl ester derivative allows the dye to 
pass through the cell membrane where it becomes cleaved by non-specific esterases 
and becomes trapped within the cell. Following incubation, cells were washed twice in 
Ca2+ free HBSS to remove any unloaded dye and density adjusted to either 1 million or 
5 million cells per ml. Extracellular Ca2+ was adjusted to 1mM using CaCl2 solution. 
Cells were loaded into a black flat bottomed 96 well plate at 100μl per well at allowed to 
rest at 37OC for 30 minutes. Cells were treated as stated in the figure legends and then 
plate was loaded into FluoStar Optima plate reader. Fluo-4 fluorescence was 
measured every 15s by exciting the cells at 485 nm and collecting emitted fluorescence 
at 520 nm. 20 cycles after starting the recording, stated concentrations of UCHT-1, 
CXCL11 or H2O2 were added and recording temporally paused, compounds were 
manually added into corresponding wells and recording restarted. 1µM ionomycin 
(Sigma #I-24222), an effective Ca2+ inophore, was added to the cells to ensure 
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sufficient loading of Fluo-4. Each compound response was normalised to its respective 
ionomycin response. 
 
2.10 Measurement of reactive oxygen species generation  
SEB activated T lymphocytes were re-suspended in supplement free RMPI-1640 and 
labelled with 10µM 2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA, Invitrogen, 
Paisley, UK) at room temperature protected from light for 45 minutes. Following 
incubation cells were washed twice into PBS to removed unloaded dye and re-
suspended at 1 million cells per ml. 100μl of cell suspension was placed in each well of 
a pre-warmed black bottom 96 well plate and allowed to rest at 37OC for 30 minutes. 
Cells were treated with stated concentrations of reagents for 30 minutes before 
endpoint recordings were taken on the FluoStar Optima plate reader at 
excitation/emission 490/515nm. 
 
2.11 Adhesion assay 
A flat bottomed 96 well plate was coated with either 10µg/ml recombinant human 
fibronectin (R & D systems #1918-FN) or 10µg/ml recombinant human ICAM-1 (R & D 
systems #ADP4-500) overnight. Plate was washed twice with pre-warmed PBS, then 
un-supplemented RPMI media (without phenol red). SEB activated cells were washed 
twice into un-supplemented media and treated with the stated concentrations of 
compounds for 30 minutes. Cells were the added to the 96 well plate and stimulated 
with UCHT-1 (10μg/ml). The plate was sealed and incubated for 30 minutes at 37oC to 
allow cells to adhere. The plate was then inverted for 15 minutes after which seal was 
removed whilst the plate was still inverted, all media and non-adherent cells removed 
from plate and wells washed gently with PBS. Then adherent cells quantified using the 
MTT assay, where cells are treated with MTT mix (RPMI, 10% FBS and 500µg/ml 
MTT) for 3h and then lysed in 100µl DMSO. Absorbance was read using a FluoStar 
Optima plate reader at 540nm 
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2.12 Hypoxic chamber experiments 
The hypoxic chamber was equilibrated with either 5% O2, 5% CO2, 90% N2 for 1 hour at 
37OC. Cells were washed three times in plain media resuspended at 3.2 million per ml 
and then incubated in either standard cell culture conditions or in hypoxia for 1 hour 
prior to their migration being assessed using the methods describe for the Neuroprobe 
migration assay (Section 2.7.1). The migration assays were carried out in either 
hypoxic chamber or in standard cell culture conditions for the course of the experiment. 
Cells were also incubated in the hypoxic chamber for three hours prior to the evaluation 
of CXCR3 expression (2.6.1). 
 
2.13 Data analysis 
Data was normalised as described in the figure legends. Values are presented as 
mean ± standard error of the mean (SEM) and n represents the total number of donors 
or individual repeats of each study. Statistical analysis was undertaken using 
GraphPad Prism software. Data was analysed using a One Way ANOVA followed by a 
Dunnett’s post-test to determine significant difference as compared to control or when 
there were two independent variables a two-way ANOVA with Bonferrori post-test was 
used Differences were considered significant when * P<0.05, **P<0.01 ***P<0.001. 
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2.14 Pharmacological compounds  
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3.1 Rationale  
PI3K signalling is involved in numerous cellular functions, such as growth, proliferation, 
migration and cytokine production (Fruman et al., 2009; So et al., 2012b; Okkenhaug, 
2013) and is crucial for the normal functioning of the immune system. However, over-
active PI3K signalling is observed in chronic inflammation, immune-mediated disorders 
as well as cancer (Yuan et al., 2008; Ghigo et al., 2010; Marwick et al., 2010; Suarez-
Fueyo et al., 2011). The use of PI3K inhibitors to treat inflammatory disorders has to 
date been disappointing (Blunt et al., 2012a). This has led to the search for alternative 
targets with which to selectively modulate PI3K activity in leukocytes. One such target, 
the lipid phosphatase SHIP-1, has particular promise due to its restricted expression in 
cells of hematopoietic linage, limiting the activity of SHIP-1 targeted drugs specifically 
to the immune system. SHIP-1 de-phosphorylates PI(3,4,5)P3, (the major product of 
receptor stimulated PI3K), at the D-5 position (Damen et al., 1996; Lioubin et al., 1996) 
leading to its degradation to PI(3,4)P2. Activation of SHIP-1s phosphatase activity 
would therefore be predicted to decrease PI(3,4,5)P3 levels, thus mimicking the effects 
of a PI3K inhibitor (Blunt et al., 2012b). Thus, pharmacological SHIP-1 activation has 
been proposed as a potential therapeutic for use in diseases with over-active PI3K 
signalling.  
Little is known about SHIP-1 in primary human T lymphocytes; to date the majority of 
work investigating SHIP-1 has been undertaken using genetic mouse models or 
shRNA SHIP-1 targeting, both of which have indicated pleotropic roles for SHIP-1 in T 
lymphocyte biology. However, SHIP-1 silencing approaches are likely to disrupt 
adaptor/scaffolding roles of SHIP-1 (i.e. properties of SHIP-1 which are unique from its 
catalytic ability to negatively regulate PI3K). Therefore, we sought to determine the 
effect of pharmacological targeting the catalytic domain of SHIP-1, which should 
maintain the phosphatase-independent functions of SHIP-1. SHIP-1 activators are not 
commercially available; here a small molecule allosteric SHIP-1 activator, which is 
closely related to AQX1125 (henceforth referred to as AQX1) was supplied by Aquinox 
Pharmaceuticals for research purposes only. The SHIP-1 activator, AQX1 will be 
directly compared to inhibitor, 3-aminocholestane (3AC) to allow side by side 
evaluation of the effect of SHIP-1 activation and inhibition upon T lymphocyte biology. 
Overall, the potential of SHIP-1 activation as a putative treatment of T lymphocyte 
driven pathologies will be assessed.  
 
 




This chapter aims to determine the consequences of SHIP-1 manipulation on human T 
lymphocyte biology. An allosteric SHIP-1 activator, which is closely related to AQX1125 
(henceforth referred to as AQX1) was synthesized and supplied by Aquinox 
Pharmaceuticals for research purposes only (Stenton et al., 2013a) and SHIP-1 
inhibitor, 3-aminocholestane (Echelon Biosciences) will be used to: 
 establish the functional roles of SHIP-1 in human T lymphocyte viability and 
TCR activation including investigating downstream Ca2+ elevation, proliferation 
and adhesion. 
 assess the functional importance of SHIP-1 as a regulator of basal and 
chemotactic migration, chemokine signalling, polarisation and cytoskeletal 
protein rearrangement. 
Overall, we will evaluate the potential of SHIP-1 as a novel therapeutic route to 
influence T lymphocyte driven inflammatory and autoimmune diseases. 
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3.2 SHIP-1 modulators alter recombinant SHIP-1 catalytic activity 
SHIP-1 is a lipid phosphatase which is responsible for de-phosphorylating PI(3,4,5)P3 
to generate PI(3,4)P2 and free phosphate. In vitro the phosphate product generated by 
SHIP-1 can be measured using malachite green molybdate; a chemical which reacts 
with free organic phosphate to form molybdophosphoric acid which absorbs light at 
650nm. As such, malachite green molybdate can be used to determine the catalytic 
activity of SHIP-1.  
Here, malachite green molydbate has been used to verify that free phosphate is 
generated when recombinant SHIP-1 is incubated with a surrogate in vitro substrate, 
inositol 1,3,4,5-tetrakisphosphate (IP4) (Damen et al., 1996) for 30 minutes at 37
oC. 
Firstly, a significant increased the absorbance at 650nm was observed when IP4 was 
incubated with recombinant SHIP-1 alone (Figure 3.1). This confirmed that the 
recombinant SHIP-1 was de-phosphorylating the in vitro substrate.   
After validating the assay, it was necessary to verify the respective activity of both 
pharmacological manipulators of SHIP-1. The SHIP-1 activator used in this study is 
closely related to AQX-1125 and henceforth referred to as AQX1. AQX1 was 
synthesized and supplied Aquinox Pharmaceuticals for research purposes only  
(Stenton et al., 2013b). The activity of AQX-1125, which was provided by 
GlaxoSmithKline was also validated. Both SHIP-1 activators (1mM) significantly 
enhanced the catalytic activity of SHIP-1, whilst lower concentrations of AQX1 had no 
effect upon catalytic activity of recombinant SHIP-1 (Figure 1 A). The SHIP-1 inhibitor, 
3α-aminocholestane (3AC; Echelon Biosciences) induced concentration dependent 
reduction in SHIP-1 catalytic activity, which was significant at all concentrations above 
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Figure 3.1 SHIP-1 modulators alter SHIP-1 catalytic activity. 1μg/ml 
recombinant human SHIP-1 (full length) was treated with vehicle control (DMSO 
[A] & ethanol [B]) or stated concentrations of (A) SHIP-1 activators or (B) SHIP-
1 inhibitor for 30 minutes at 37oC in a 96 well plate. Inositol(1,3,4,5) 
tetrakisphosphate (IP4) (100μM) was added for 30 minutes at 37
oC. 100μl 
malachite green solution was added to each well, left for 15 minutes at room 
temperature and absorbance read at 650nm. The background absorbance of 
H2O was subtracted from each well. Note that there is no change in absorbance 
in recombinant SHIP-1 alone or recombinant SHIP-1 treated with compound in 
the absence of IP4, which is labelled no substrate (NS) and shown in black. Data 
are three independent experiments undertaken in duplicate. Statistical analysis 
was performed by a one-way ANOVA with a Dunnett’s multiple comparisons 
post-test where ***p<0.001 relative to control.  





































































































3.3 SHIP-1 modulation has no effect upon SEB-activated T lymphocyte 
viability 
PI3K signalling has known roles in cell growth and survival (Krasilnikov, 2000), which 
has led to interest in the role of SHIP-1 in cell survival. SHIP-1 has been shown to elicit 
a role in survival of mucosal and malignant T cells (Brooks et al., 2010), with SHIP-1 
inhibition preventing extrinsic cell death of mucosal T cells via the CD95/Fas/Caspase8 
pathway (Park et al., 2014) Therefore the effect of SHIP-1 modulators upon cellular 
viability of primary peripheral T lymphocytes was examined. To this end, MTT assays 
and Annexin V/Propridium iodide staining was utilized.  
 
3.3.1 SHIP-1 modulators had no effect upon the MTT assay 
Firstly, SEB-activated T lymphocytes were treated with increasing concentrations of 
SHIP-1 modulators and the MTT assay, a commonly used colorimetric enzyme assay, 
was used to assess cell viability. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) is reduced by NAD(P)H dependent cellular oxidoreductase enzymes to 
formazan which has a purple colour and absorbs light at 550nm. Although PI3K 
signalling is important in cell viability, 24hr treatment with AQX1 and 3AC had no 
significant effect upon cell viability as assessed by the MTT assay at any of the 
concentrations studied (Figure 3.2). This suggested that functional effects of AQX1 and 
3AC shown in this chapter are not due to the compounds altering cellular viability. 
 
3.3.2 SHIP-1 modulators had no effect upon Annexin V or PI staining 
The impact of SHIP-1 modulators upon cellular apoptosis or necrosis was also 
examined using annexin V and propidium iodide (PI) staining. Apoptotic cell death is a 
tightly controlled process whereby cells are destroyed without leaking their contents 
into the extracellular space (Elmore, 2007). A key early step in apoptosis is a change in 
the lipid membrane structure, whereby phosphatidylserine (PS) which are normally 
held on the inner leaflet are presented on the outer leaflet of the cell membrane to aid 
phagocytosis. Externalised PS can be measured by binding of a fluorescently tagged 
form of Annexin V and quantified by flow cytometry. SEB-activated T lymphocytes were 
treated with stated concentrations of AQX1 and 3AC for 3 hours, there was no effect 
upon Annexin V fluorescence at any of the concentrations studied and thus they did not 
evoke cell apoptosis (Figure 3.3).   
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Necrotic cell death occurs in pathological conditions and results in un-restrained 
“bursting” of cells to release their intracellular content. PI uptake is an early marker for 
cellular necrosis, which emits fluorescence at 617nm when bound to nucleic acids. 
Positive control 10% Triton X, a detergent, significantly induced necrotic cells death.  
However, neither AQX1 nor 3AC had any effect upon T lymphocyte necrosis (Figure 
3.3).This confirmed that observations obtained with AQX1 or 3AC were not due to them 



















Figure 3.2 SHIP-1 modulators had no effect upon SEB-activated T lymphocyte 
viability. 1 million SEB-activated T lymphocytes (8-12 days post isolation) were treated 
with increasing concentrations of (A) AQX1 or (B) 3AC for 24 hours. Cells viability was 
assessed using the MTT assay. Vehicle control is indicated with the white bars and is 
(A) DMSO and (B) ethanol. Data are mean ± SEM from three independent donors. 
Statistical significance was determined for treatment versus control using test one-way 
ANOVA indicating no significant difference between groups (A p=0.6544, B p=0.09). 








































































Figure 3.3. SHIP-1 modulators had no effect upon PI & Annexin V staining in 
SEB-activated T lymphocytes. 1 million SEB-activated T lymphocytes (8-12 days 
post isolation) were treated with the stated concentrations of (A) AQX1 or (B) 3AC, plus 
1% TRITON-X as a positive control for 3 hours. T lymphocyte viability was established 
by staining cells with annexin V for 20 minutes at 4oC. Then, 2.5µg/ml propidum iodide 
(PI) was added to the cells and fluorescence emission read immediately using flow 
cytometry and laser excitation of 488nm (Cy5) and 617nm (PI). Viable cells are 
represented in green, annexin V+ cells in yellow, orange bars are PI+, and double 
positive cells are red. The bar chart shows the mean ± SEM from three donors. (C) 
Representative FACs plots from one donor. 
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3.4 Effect of SHIP-1 modulation upon TCR induced responses 
Ligation of the TCR receptor induces the activation of the PI3K/Akt signalling cascade 
which is crucial for driving lymphocyte clonal expansion and proliferation (Okkenhaug 
et al., 2006). SHIP-1 has previously been observed to be recruited to the surface 
membrane upon CD3/CD28 ligation (Edmunds et al., 1999), implicating a possible role 
of SHIP-1 in the regulation of TCR/CD3 signalling.  
 
3.4.1 SHIP-1 modulation inhibits TCR/CD3 stimulated Akt phosphorylation 
SEB T lymphocytes were pre-treated with stated concentrations of SHIP-1 modulators 
for 30 minutes. Cells were then stimulated with anti-CD3 antibody (UCHT1) for 5 
minutes. Cell were fixed, permeabilised and levels of Akt phosphorylation determined 
by flow cytometry. The SHIP-1 activator AQX1 significantly inhibited UCHT1 stimulated 
Akt phosphorylation at 10 and 30μM AQX1 (Figure 3.4 A). Interestingly, the SHIP-1 
inhibitor 3AC also caused a significant reduction in UCHT-1 stimulated Akt 
phosphorylation (Figure 3.4 B).  
 
















Figure 3.4 SHIP-1 modulation inhibits Akt phosphorylation in SEB-activated T 
lymphocytes. 1 million SEB-activated T lymphocytes (8-12 days post-isolation) were 
washed three times in serum free media and treated with stated concentrations of (A) 
AQX1 or (B) 3AC for 30 minutes. Cells were washed in ice cold PBS, then fixed using 
BD fixation reagent for 20 minutes. Cells were washed once and then treated with BD 
permeabilization reagent for 15 minutes. Cells were then incubated pAkt antibody for 
30 minutes, washed twice in PERM reagent then incubated with FITC conjugated 
secondary antibody. Mean fluorescence intensity per 10,000 cells was measured using 
flow cytometry. Data are (left panel) representative FACs plot and (right panel) mean ± 
SEM minus IgG control, normalised to untreated control from three independent 
donors. Statistical analysis was determined by one way-ANOVA with Dunnett’s post-
hoc test where *p<0.05 or ***p<0.001 relative to control. 
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3.4.2 SHIP-1 modulation has no effect upon TCR/CD3 induced Ca2+ release 
An important signal produced upon TCR ligation is the elevation of intracellular Ca2+. 
PLCγ1 recruitment activation via SFKs and SYK signalling produces inositol 1,4,5-
trisphosphate (IP3), which upon binding to the IP3 receptor releases Ca2+ from 
intracellular stores and induces subsequent Ca2+ dependent Ca2+ entry through 
membrane channels. These signals are vital in Ca2+ dependent gene transcription, 
such as nuclear factor of activated T cells (NFAT) and MAPK mediated activating 
protein-1 (AP-1) (Negulescu et al., 1994) and initiate the expression of important genes 
involved in TCR-induced proliferation, differentiation and viability. Thus, Ca2+ 
mobilisation was evaluated to determine the effect of SHIP-1 targeting pharmacological 
tools affected TCR signalling potential.  
SEB-activated T lymphocytes were loaded with a Ca2+ sensitive dye Fluo-4, and 
fluorescence measured over time using a plate reader to measure intracellular free 
Ca2+. Initially, Ca2+ elevation following exposure to anti-CD3 antibody UCHT-1 was 
validated. UCHT-1 induced a concentration dependent and sustained increase in 
intracellular Ca2+ (Figure 3.5 A). The ionophore ionomycin was used as a loading control 
to indicate maximal Fluo-4 signal. To test whether SHIP-1 modulation could affect the 
UCHT-1 elevated intracellular Ca2+, SEB T lymphocytes were pre-treated with either 
the SHIP-1 activator AQX1 or SHIP-1 inhibitor 3AC. AQX1 appeared to partially 
suppress the initial peak Ca2+ elevation but this observation was not significant across 
the three donors (Figure 3.5 B). 3AC also had no effect upon the UCHT-1-induced Ca2+ 
signal (Figure 3.5 C).  
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Figure 3.5 SHIP-1 modulators had no effect upon TCR agonist UCHT-1-induced 
intracellular Ca2+ release in SEB-activated T lymphocytes. SEB-activated T 
lymphocytes (8-12 days post isolation) were washed into PBS and loaded for 45 
minutes with 1μM Fluo-4. Cells were washed 3 times and re-suspended at 1 million 
cells per ml in Ca2+ free-HBSS and extracellular Ca2+ adjusted to 1mM. Cells were 
plated in a black 96 well plate and either (A) allowed to rest or treated with stated 
concentrations of (B) AQX1 or (C) 3AC for 30 minutes. Stated concentrations of UCHT-
1 were added after a baseline was established and 1µM ionomycin was used as a 
loading control. Left panel is a kinetic trace indicating change in fluorescence from 
basal (∆F/F0) from one representative donor. The right panel is the peak change in 
fluorescence generated by UCHT-1 as a percentage of the peak change generated by 
ionomycin and is mean ± SEM from averaged duplicates of three independent donors. 
One-way ANOVA followed by Dunnett’s post-test was used to determine statistical 
significance where *p<0.05 and ***p<0.001 relative to control.    
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3.4.3 SHIP-1 modulation significantly impairs TCR driven proliferation 
Given the crucial role of PI3K/Akt in cell proliferation (Okkenhaug et al., 2006; 
Okkenhaug, 2013) and the ability of SHIP-1 compounds to affect TCR-induced Akt 
phosphorylation, the effect of SHIP-1 modulation on TCR/CD3-mediated clonal 
expansion of human T lymphocytes was investigated. Cells were labelled with the 
fluorescent probe CFSE and flow cytometry used to track the dilution of the CFSE as 
the cells divide. CFSE binds covalently to intracellular amines and the probe splits 
equally into each daughter cell.  
Naïve T lymphocytes were treated with stated concentrations of the SHIP-1 modulators 
for 30 minutes before stimulation with anti-CD3/CD28 coated Dynabeads and IL-2. 
Initial CFSE intensity was determined on the day of isolation. CFSE intensity was 
quantified four days post isolation with plots from control conditions showing four 
distinct peaks, indicating four generations of cell division (Figure 3.6). The SHIP-1 
activator AQX1 increased the percentage of cells retained in generation 1, whereas 
fewer cells were seen to progress to generation 4 (Figure 3.6 A). This indicates that 
activation of SHIP-1 inhibited the ability of human CD4 lymphocytes to proliferate and 
progress through cell divisions upon TCR/CD3 stimulation. Surprisingly, the SHIP-1 
inhibitor 3AC only inhibited proliferation at high concentrations. 20μM 3AC increased 
the percentage of cells retained in generation 1; whereas no cells were observed to 
progress to generation 4 (Figure 3.6 B). To fully understand whether this observation 
relates to an issue with toxicity additional concentrations of 3AC between 2 and 20µM 
should have been examined.  






Figure 3.6 Activation of SHIP-1 inhibits TCR/CD3 mediated T lymphocyte 
proliferation. 1 million freshly isolated naïve CD4 cells were treated with increasing 
concentrations of (A) AQX1 or (B) 3AC for 30 minutes then stimulated with anti-
CD3/anti-CD28 Ab-coated Dynabeads and IL-2 (36U/ml) for 4 days. Cell proliferation 
was assessed using CFSE staining and flow cytometry. Each panel shows a 
representative FACS plot. The numbers stated in the top left corner represent the 
mean fluorescence index of CFSE, and bar charts are the mean ± SEM of the % of 
cells in each generation from three independent experiments in the absence of 
presence of indicated concentrations of AQX1 or 3AC.  
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3.4.4 SHIP-1 modulation impairs basal and TCR-induced adhesion of SEB T 
lymphocytes 
Pharmacological modulation of SHIP-1 could also inhibit other functional outcomes of 
TCR activation. Ligation of the TCR is known to increase adhesion of lymphocytes 
(Simonson et al., 2006), whilst the ability of lymphocytes to adhere to extracellular 
matrix components like fibronectin and adhesion molecules such as ICAM-1 is a crucial 
step in their extravasation (Stanley et al., 2008; Nourshargh et al., 2010), stabilising 
cellular contacts and facilitating accumulation of lymphocytes at sites of inflammation 
(Rodriguez et al., 1992).  
SEB-activated T lymphocytes were treated with increasing concentrations of SHIP-1 
modulators for 30 minutes and their ability to adhere to either fibronectin or ICAM-1 
was determined under basal and UCHT-1 stimulated conditions. UCHT-1 significantly 
enhanced the adherence to fibronectin by 5.6 ± 0.5 fold and ICAM-1 by 5.67 ± 1.1 fold. 
The SHIP-1 activator AQX1 abrogated both basal and TCR/CD3-induced adhesion of 
previously activated T lymphocytes to both fibronectin (Figure 3.7 A) and ICAM1 
(Figure 3.7 B). Remarkably, the SHIP-1 inhibitor 3AC also abrogated basal and 
TCR/CD3-mediated adhesion to both fibronectin (Figure 3.7 C) and ICAM1 (Figure 3.7 
D). This implies that a balance of PI(3,4,5)P3 and PI(3,4)P2 signalling is required for T 
lymphocyte adhesion. Interestingly, 3AC appears to have a more pronounced effect 
upon UCHT-1 induced adhesion, which suggests SHIP-1 induced PI(3,4)P2 signalling 
is required for TCR induced adhesion.  




Figure 3.7 SHIP-1 modulation attenuates adhesion of SEB-activated T 
lymphocytes. 1 million SEB-activated T lymphocytes (8-12 days post-isolation) were 
treated with increasing concentrations of (A & B) SHIP-1 activator AQX1 or (C & D) 
SHIP-1 inhibitor 3AC for 30 minutes. Cells were allowed to adhere to either a (A & C) 
fibronectin (10μg/ml) or (B & D) ICAM-1 coated 96 well plate for 30 minutes. The plate 
was sealed and turned upside down for 15 minutes. Wells were washed gently to 
remove any un-adhered cells. Cell were scrapped and counted using FACSCanto flow 
cytometry. Data are represented as percent change from basal conditions and is mean 
± SEM of three independent experiments. Statistical significance was determined by 
one-way ANOVA with a Dunnett’s multiple comparisons post-test where *p<0.05 
**p<0.01, ***p<0.001 as compared to control. 
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3.4.5 SHIP-1 has no effect upon integrin expression but alters the affinity state of 
LFA-1 
In an attempt to unravel the mechanism underlying the decreased adhesion, the effect 
of SHIP-1 modulation upon the expression of the adhesion receptors CD11a and 
CD49d was examined. CD11a is the αL subunit which along with CD18 (β2) forms the 
integrin dimer LFA-1 (αLβ2). LFA-1 binds to ICAM-1, present on leukocytes and the 
endothelium, to aid intercellular contacts and extravasation. CD49d is the α4 subunit, 
which along with CD29/β1, forms the integrin dimer VLA-4 (α4β1) (Larson et al., 1990). 
VLA-4 is one of several integrins that can bind to the extracellular matrix protein 
fibronectin. Interestingly, neither the SHIP-1 activator AQX1 nor SHIP-1 inhibitor 3-AC 
had any effect on the expression of CD11a or CD49d (Figure 3.8 A & B).  
However, LFA-1 exists in different states of affinity which determines the strength of 
ICAM1-LFA-1 interactions. The result of SHIP-1 modulation upon the affinity state of 
LFA-1 was examined using monoclonal antibodies (mAb) that recognize differentially 
exposed epitopes expressed upon activation. Following activation, LFA-1 extends, 
exposing an epitope that is recognised by mAb KIM127, located in the EGF-like 
domain 2 at the bend in the β2 subunit (Robinson et al., 1992; Beglova et al., 2002). 
The extended KIM127+ LFA-1 adopts both closed and open conformations 
corresponding to intermediate- and high-affinity forms of LFA-1, respectively (Kinashi, 
2006; Luo et al., 2007). Interestingly, the SHIP-1 activator AQX1 significantly reduced 
the detection of KIM127+ LFA-1 expression, thus indicating a reduced amount of LFA-
1 in its activated affinity state (Figure 3.8 C). Consistent with its effect on adhesion, 
SHIP-1 inhibitor 3AC also reduced detection of KIM127+ LFA-1 in previously activated 
T lymphocytes (Figure 3.8 D). This suggests that SHIP-1 modulates T lymphocyte 
adhesion to ICAM-1 by changing the confirmation and affinity state of LFA-1. 
 




Figure 3.8 SHIP-1 modulation attenuates adhesion of T lymphocytes by reducing 
the affinity state of LFA-1. 1 million SEB-activated T lymphocytes (8-12 days post-
isolation) were treated with either increasing concentrations of SHIP-1 activator AQX1 
or SHIP-1 inhibitor 3AC for 30 minutes and then expression of surface receptors (A) 
CD11a and (B) CD49d was assessed using PE-conjugated antibodies. SEB-activated 
T lymphocytes were treated with increasing concentrations of (C) AQX1 or (D) 3AC for 
30 minutes, blocked for 1 hr in 1% BSA and the stained with the primary antibody 
KIM127 (10μg/ml) for 30 minutes at 4°C and washed twice in PBS. Cells were then 
incubated for 30 minute with anti-mouse FITC conjugated antibody at 4°C, washed 
twice in PBS and analysed by FACSCanto flow cytometry. Data are represented as 
percent change from basal conditions and is mean ± SEM of three independent 
experiments. Statistical significance was determined by one-way ANOVA with 
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3.5 Effect of SHIP-1 modulation upon CXCL11 driven responses  
In addition to regulating PI3K signalling downstream of tyrosine kinase-coupled antigen 
receptors, SHIP-1 has previously been demonstrated to regulate PI3K-dependent 
signalling activated by G protein-coupled receptor (GPCRs), including CXCR3. 
Following antigen encounter, the chemokine receptor CXCR3 is up-regulated on T 
lymphocytes and is crucial for their recruitment into inflamed tissues (Marwick et al., 
2010). The role of SHIP-1 in CXCL11/CXCR3 signalling, migration and polarisation of T 
lymphocytes was therefore examined.  
 
3.5.1 SHIP-1 modulation inhibits CXCL11-induced Akt phosphorylation in SEB T 
lymphocytes  
Akt phosphorylation is used an indirect measure of PI3K activity. SEB-activated T 
lymphocytes were pre-treated with SHIP-1 modulators for 30 minutes, stimulated with 
CXCL11 for 5 minutes and the effect of SHIP-1 modulation on Akt phosphorylation was 
determined by Western Blot. Importantly, SHIP-1 activator AQX1 caused a 
concentration dependent reduction in CXCL11 stimulated Akt phosphorylation (Figure 
3.9 A). Similarly, SHIP-1 inhibitor 3AC also abrogated CXCL11-stimulated Akt 
phosphorylation (Figure 3.9 B), indicating that SHIP-1 modulation can alter CXCL11-
induced signalling.  
3.5.2 SHIP-1 modulation had no effect upon CXCL11 induce Ca2+ elevation 
Another important signal produced upon CXCR3/CXCL11 stimulation is the elevation of 
intracellular Ca2+ concentration. Elevated intracellular Ca2+ is important in directed cell 
migration as local Ca2+ pulses near the leading edge of the cell activate myosin and to 
modulate focal adhesions (Tsai et al., 2014). Therefore intracellular Ca2+ levels were 
measured to assess whether SHIP-1 modulation affected CXCR3/CXCL11 signalling 
potential. SEB-activated T lymphocytes were loaded with a Ca2+ sensitive reporter 
Fluo-4, and fluorescence was measured over time using a plate reader to measure 
intracellular Ca2+. CXCL11-induced a transient concentration dependent, albeit modest, 
increase in intracellular Ca2+ (Figure 3.10 A). The number of cell in each well was 
increased to 500,000 to boost the signal (i.e. the total level of Ca2+ elevation) for the 
CXCL11 experiment. To test whether SHIP-1 modulation could affect the CXCL11 
elevated intracellular Ca2+, SEB T lymphocytes were pre-treated with either SHIP-1 
activator AQX1 or inhibitor 3AC for 30 minutes. Neither compound had any effect upon 
CXCL11-induced Ca2+ signal (Figure 3.10 B & C). 






Figure 3.9 Modulation of SHIP-1 inhibits chemokine receptor mediated Akt 
phosphorylation. 1 million SEB-activated T lymphocytes (8-12 days post isolation) 
were treated with either vehicle control (labelled C) or increasing concentrations of (A) 
AQX1 or (B) 3AC for 30 minutes then stimulated with CXCL11 (10nM) for 5 minutes. 
Cells were then lysed and the level of phosphorylated Akt (serine 473) and total ERK 
levels determined by immunoblotting. The blot was quantified by densitometry using 
ImageJ software. Data are presented as a representative blot, the numbers of the left 
are kDa (Left panel) and a bar chart of the mean ± SEM of three independent 
experiments (Right panel). Statistical significance was determined is by one way 
ANOVA with Dunnett’s post-test where *p<0.05 as compared to control. 




























































































Figure 3.10 SHIP-1 modulators had no effect upon CXCL11-induced intracellular 
Ca2+ release in SEB-activated T lymphocytes. SEB-activated T lymphocytes (8-12 
days post-isolation) were washed into PBS and loaded for 45 minutes with 1μM Fluo-4. 
Cells were washed 3 times and re-suspended at 5 million cells per ml in Ca2+ free-
HBSS and extracellular Ca2+ adjusted to 1mM. Cells were plated in a black 96 well 
plate and either (A) allowed to rest or treated with increasing concentrations of (B) 
AQX1 or (C) 3AC for 30 minutes. Fluorescence was recorded over time using a 
FluoStar Optima plate reader at 37oC. Stated concentrations of CXCL11 were added 
after a baseline was established and 1µM ionomycin was used as a loading control. 
Left panel is a kinetic trace indicating change in fluorescence from basal (∆F/F0) from 
one representative donor. The right panel is the peak change in fluorescence 
generated by UCHT-1 as a percentage of the peak change generated by ionomycin 
and is the mean ± SEM from averaged duplicates of three independent donors. One-
way ANOVA followed by Dunnett’s post-test was used to determine significance where 
*p<0.05 as compared to control. 
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3.5.3 SHIP-1 modulation attenuated both basal and CXCL11 directed migration in 
SEB-activated T lymphocytes 
Consistent with the reduction in chemokine driven Akt signalling, SHIP-1 modulation 
altered basal and chemokine-induced lymphocyte migration. First, using a Neuroprobe 
plate-based assay that measured migration across a synthetic membrane, SHIP-1 
activator AQX1 reduced basal and chemotactic migration with an IC50 of 9.9μM and 
970nM, respectively. SHIP-1 inhibitor 3-AC reduced basal and chemotactic migration of 
previously activated T cells with an IC50 of 29nM and 4.3μM, respectively (Figures 3.11 
A & B).  
Second, migration was also assessed using the IBIDI μ-slide chemotaxis assay which 
allows tracking of individual cells across a fibronectin-coated surface (Figure 3.12 A & 
B). AQX1 and 3AC abrogated CXCL11 mediated migration as measured by 
accumulated distance and velocity. Using the IBIDI assay, a reduction in basal 
migration in the presence of AQX1 or 3AC was not observed. However, this assay has 
negligible basal migration compared to the NeuroProbe assay.  
 
3.5.4 SHIP-1 modulation had no effect upon the surface expression of CXCR3 in 
SEB-activated T lymphocytes   
As SHIP-1 modulation significantly impaired CXCL11 driven migration and signalling, 
its effect upon cognitive receptor CXCR3 expression was observed. A 30 minute 
treatment of SHIP-1 manipulators was used in an attempt to limit any transcriptional 
changes which would be unlikely to occur within this short timeframe, and instead 
focused upon determining the effect of SHIP-1 upon receptor trafficking. Neither AQX-
1125 nor 3AC had any effect upon CXCR3 expression (Figure 3.13). 
















Figure 3.11 SHIP-1 modulation inhibits basal and chemokine stimulated 
migration in SEB-activated T lymphocytes. SEB-activated T lymphocytes (8-12 days 
post isolation) were washed in serum free media and resuspended at 3.2 x 106 cell/ml. 
Cells were pre-treated with increasing concentrations of (A) AQX1 or (B) 3AC 30 
minutes at 37oC. The basal and chemokine CXCL11 (10nM)-induced migration of cells 
was then determined using the Neuroprobe assay. Left panel is expressed as 
chemotactic index where the number of cells migrated with each drug condition is 
divided by the vehicle control and the right panel is the percentage of vehicle control 
migration. Data are the mean ± SEM of three independent donors. Right panel shows 
migration as a percent of vehicle control. Statistical significance was determined by one 
way ANOVA with a Dunnett’s post-test where *p<0.05, **p<0.01, ***p<0.001 as 
compared to control. 
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Figure 3.12 Chemotaxis on a fibronectin-coated surface is reduced by SHIP-1 
modulation. SEB-activated T lymphocytes (8-12 days post-isolation) were washed and 
pre-treated with either vehicle, 30μM AQX1 or 20μM 3AC 30 minutes at 37oC. 
Migration of cells was observed using IBIDI μslides coated in 10μg/ml fibronectin. Cells 
were added to the slides and allowed to adhere for 15 minutes. Cells were imaged 
using the bright-field channel of a 40x objective on a confocal microscope. Time-lapse 
images were taken every 15s and cell migration stimulated either PBS or CXCL11 
(100nM). Cell tracking was performed using the ImageJ Manuel tracking plugin. (A) 
Shows a representative ImageJ tracking plot from one donor.  Data are the mean ± 
SEM of three independent donors with (B) accumulated distance and (C) velocity. 
Right panel shows migration as a percent of vehicle control. Significance was 
determined by two-way ANOVA with Bonferroni's post-test where *p<0.05 as compared 
to vehicle control.  
























































Figure 3.13 SHIP-1 modulation has no effect upon surface receptor expression of 
CXCR3 in SEB-activated T lymphocytes. 1 million SEB-activated T lymphocytes (8-
12 days post-isolation) were washed three times in serum free media and treated with 
AQX1125 (30μM) or 3AC (20μM) for 30 minutes. Cells were washed in ice cold PBS, 
then blocked in 1% BSA for 30 minutes. Cells were then incubated in either IgG control 
antibody or Alexa-PE-conjugated CXCR3 antibody on ice for 30 minutes and washed 
twice in ice cold PBS. Mean fluorescence intensity per 10,000 cells was measured 
using flow cytometry. Data are (A) representative FACS plots with MFI in top right 
corner and (B) mean ± SEM minus IgG control, normalised to untreated control from 
three independent donors. Statistical significance was determined by one way-ANOVA 
with Dunnett’s post-test. 
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3.5.5 SHIP-1 modulation reduces chemokine dependent de-phosphorylation of 
Ezrin, radixin and moesin in SEB-activated T lymphocytes 
 
Phosphorylation of ezrin, radixin and moesin (ERM) proteins, which link the actin 
cytoskeleton to the cell surface membrane, have previously been implicated in cell 
migration and adhesion (Arpin et al., 2011). In T lymphocytes, phosphorylation of ERM 
proteins is rapidly reduced by chemokine stimulation (Brown et al., 2003). In addition, 
silencing of SHIP-1 expression in T lymphocytes was found to cause the de-
phosphorylation of ERM proteins (Harris et al., 2011). The impact of pharmacological 
SHIP-1 activation or inhibition upon the phosphorylation of ERM proteins was therefore 
examined. Naïve T lymphocytes were treated with SHIP-1 activator AQX1, followed by 
visualisation of ERM phosphorylation by confocal microscopy. CXCR4 is highly 
expressed on naïve T lymphocytes and therefore the effect of CXCL12 on ERM 
proteins was examined. CXCL12 caused a significant de-phosphorylation of ERM 
proteins. Interestingly, AQX1 pre-treatment prevented CXCL12 dependent de-
phosphorylation (Figure 3.14 A) 
Consistently, immunoblots indicated that 3AC or AQX1 treatment enhanced the 
phosphorylation of ERM proteins in SEB-activated T lymphocytes under un-stimulated 
conditions, whilst exposure to chemokine CXCL11 (Figure 3.14 B and C) caused a de-
phosphorylation of ERM proteins. However, both pharmacological activation and 
inhibition of SHIP-1, with AQX1 or 3AC respectively, prevented CXCL11 mediated 
ERM de-phosphorylation (Figure 3.14 B & C). 50nM calyculin A (CalyA), a potent 
serine/threonine phosphatase inhibitor prevents ERM dephosphorylation and was used 
as a positive control to indicate high ERM phosphorylation.  






Figure 3.14 SHIP-1 modulation alters the phosphorylation state of ERM proteins 
in T lymphocytes. (A) Naïve T lymphocytes were treated with AQX1 (30µM) for 30 
minutes the stimulated with CXCL12 (10nM) for 5 minutes. Cells were fixed in BD 
cytofix for 30minutes at 4oC and then exposed to anti-phospho-ERM overnight. Cells 
were stained with FITC conjugated secondary antibody and ERM phosphorylation 
detected by confocal microscopy. Left panel is representative of 6 images per 
treatment from 3 different donors. Scale bar = 10µm. Right panel is mean intensity of 
FITC fluorescence determined by using LSM 510 analysis software. SEB-activated T 
lymphocytes were incubated either with vehicle control (labelled C) or increasing 
concentrations of (B) AQX1 or (C) 3AC for 30 minutes prior to stimulation with CXCL11 
for 5 minutes. 50nM Calyculin A (CalyA) was used as a positive control to indicate high 
ERM phosphorylation. Levels of phosphorylated ERM and total ERK were then 
assessed using Immunoblotting. Left panels are representative Westerns Blot from a 
single experiment, numbers on the left are kDa. The right panel are mean ± SEM of 
phosphorylated ERM relative to total ERK, from three independent experiments. 
Statistical significance was determined by a one way ANOVA with Dunnett’s post-test 
where *p<0.05 & **p<0.01 as compared to control. 
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3.6 Chapter 3 Results Summary 
 Compounds alter SHIP-1 catalytic activity in the malachite green assay 
 Neither SHIP-1 activation or inhibition had any effect upon T lymphocyte 
viability 
 TCR-induced Akt phosphorylation was inhibited by either SHIP-1 activation or 
inhibition 
 Neither SHIP-1 activation nor inhibition had any effect upon TCR or CXCL11-
induced Ca2+ elevation  
 SHIP-1 activation inhibited CD3/CD28-induced proliferation of naïve T cells, but 
inhibition had no effect 
 Basal and UCHT-1 stimulated adhesion to fibronectin and ICAM-1 were 
inhibited by SHIP-1 activation and inhibition 
 Expression of CD11a and CD49d were unaffected by activation and inhibition of 
SHIP-1 
 Activation and inhibition of SHIP-1 reduced the affinity state of LFA-1 
 CXCL11 induce Akt phosphorylation was inhibited by SHIP-1 activation and 
inhibition  
 SHIP-1 activation and inhibition attenuated basal and directed migration  
 SHIP-1 activation and inhibition enhanced basal ERM phosphorylation and 
prevented CXCL11-induced de-phosphorylation  
 Both activation and inhibition of SHIP-1 have the same functional 
consequences in SEB-T lymphocytes 
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3.7 Chapter 3 - Discussion 
 
Validation of SHIP-1 modulators on malachite green absorbance 
The SHIP-1 activator, AQX1 and inhibitor, 3α-aminocholestane (3AC) were 
successfully validated to alter the catalytic activity SHIP-1 using the malachite green 
assay. Interestingly, the cell-based studies confirmed that SHIP-1 compounds were 
membrane permeant and that they manipulate cell responses at lower concentrations 
than in isolated protein conditions. Although the structure of AQX1 has not been 
disclosed due to a material transfer agreement with Aquinox Pharmaceuticals, in their 
hands AQX1 significantly enhanced the catalytic activity of recombinant SHIP-1 at 
1μM, which is consistent with the concentrations of AQX1 that are active in our 
functional assays. The structure of AQX1 is related to the published compound 
AQX1125, which is currently in phase II clinical trials. AQX1125 (30μM) has been 
shown to be highly selective in a range of selectivity and specificity investigations 
(Stenton et al., 2013a). 
3AC was identified though a high-throughput fluorescence polarisation assay and 
shown to inhibit the catalytic activity of recombinant SHIP-1 by 50% at 10μM, but not 
affect effect PTEN or SHIP-2 at any of the studied concentrations (Brooks et al., 2010). 
Intracellular modification or protein interactions might be required for full efficacy of 
SHIP-1 compounds in cell-based assays. To further quantify the compounds cellular 
potency upon SHIP-1 the cellular levels of PI(3,4,5)P3 and PI(3,4)P2 could have been 
investigated using integrated high performance liquid chromatography mass 
spectrometry.  
 
SHIP-1s roles in cell survival, TCR signalling and proliferation 
(a) Survival 
Pharmacological activation and inhibition of SHIP-1 had no effect upon cell viability of 
primary human T lymphocytes isolated from the peripheral blood of healthy human 
donors. This implies that in peripheral T lymphocytes that altering the balance between 
level of phospholipid PI(3,4,5)P3 and PI(3,4)P2 signalling has no effect upon cell 
viability. This result is consistent with shRNA silencing of SHIP-1 in human T cells 
which also had no effect upon cell viability (Harris et al., 2011) and in line with reports 
of T cell specific SHIP-1 knockout mice, where T cell numbers are unaffected 
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(Tarasenko et al., 2007). Although it is in contrast to germline deletion of SHIP-1 in 
mice which leads to a decrease in the T lymphocyte population especially in the 
periphery (Helgason et al., 1998; Kashiwada et al., 2006). However lymphocyte 
abnormalities observed in SHIP-1 null mice could be a consequence of the severe 
myeloid pathology these mice present (i.e. interaction and cytokine release from other 
affected immune cells could lead a reduction in T lymphocytes).  
Furthermore, recent evidence actually suggests a role for SHIP-1 product PI(3,4)P2 in 
T lymphocyte survival. SHIP-1 expression was observed to prevent extrinsic cell death 
of mucosal T lymphocytes via the CD95, Fas, Capase 8 pathway (Park et al., 2014). In 
addition, enhanced SHIP-1 activity and elevated PI(3,4)P2 levels have been observed 
in several leukaemias (Luo et al., 2003; Fukuda et al., 2005; Brauer et al., 2012); cells 
which exhibit high survival and proliferation. It some cases, PI(3,4)P2 has been shown 
to promote Akt activation (Franke et al., 1997) and tumorigenicity (Ivetac et al., 2009). 
In addition, SHIP-1 inhibitor 3AC induces the apoptosis of human acute myeloid 
leukaemic cell lines (Brooks et al., 2010) and inhibits multiple myeloma cell growth in a 
tumour xenograft model in mice (Fuhler et al., 2012), suggesting SHIP-1 activity and 
thus PI(3,4)P2 is required for the survival of these cells. As we did not observe any 
effect of 24hr treatment of 3AC on peripheral T lymphocyte survival, it could be 
interesting to further this work and investigate whether there is a differential 
requirement of SHIP-1 signalling in survival of malignant and peripheral T lymphocytes. 
If a differential requirement exists it could be beneficial in using SHIP-1 inhibitors to 
specifically kill malignant cells, sparing the normal adaptive T lymphocyte function 
required to combat opportunistic pathogens. 
 
(b) TCR-dependent Akt phosphorylation 
SHIP-1 is a major negative regulator downstream of cytokine (Lioubin et al., 1996), Fc 
(Kiener et al., 1997) and B cell receptors (Helgason et al., 2000), but the evidence 
indicating SHIP-1 role in regulating TCR/CD3 signalling has proven more contradictory, 
with its exact biological functions poorly understood. Firstly, in agreement with SHIP-1 
eliciting a role in TCR activation, interactions have been observed between both CD3 
and the TCR ζ chain with the SH2 domain of SHIP-1 (Osborne et al., 1996). Moreover, 
the stimulation of CD3 and CD28 caused both tyrosine phosphorylation and increased 
catalytic activity of SHIP-1, as well as a marked re-distribution of SHIP-1 from the 
cytosol to the surface membrane (Edmunds et al., 1999). Restoration of membrane 
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localised SHIP-1 in Jurkats, leukemic T cells which lack SHIP-1 expression, reduces 
basal and TCR-induced PI3K signalling through Akt (Edmunds et al., 1999) . 
SHIP-1 activation and inhibition reduced TCR/CD3 mediated Akt phosphorylation and 
proliferation human peripheral T lymphocytes, validating the importance of SHIP-1 in 
TCR dependent signalling. This is consistent with the observation that shRNA silencing 
of SHIP-1 also inhibits T lymphocyte Akt phosphorylation and proliferation (Harris et al., 
2011). Moreover, AQX1125 has also been shown to reduce Akt phosphorylation in the 
leukemic T cell line MOLT-4 (Stenton et al., 2013a). However, in contrast conditional 
silencing of SHIP-1 in T lymphocytes in mice was found to cause no differences from 
wild-type controls in terms of TCR-induced signalling or proliferation (Tarasenko et al., 
2007) suggesting SHIP-1 is un-important in TCR signalling. These conflicting results 
could be due to differences between human and mouse T lymphocytes and highlight 
the fact that there are often substantial differences between the immune systems of 
mice and humans. This study indicates the importance of studying the role of proteins 
in human cells, even if the assays available are somewhat limited compared to animal 
models.  
It is important to note that the product of SHIP-1 is distinct from the phospholipid which 
is generated from the direct antagonism of PI3K signalling (i.e. PI(4,5)P2). PI(3,4,5)P3 
and PI(3,4)P2 have both been shown to interact with the PH domain of Akt, with 
phosphorylation at Serine-473 in Akt dramatically reduced in the absence of PI(3,4)P2 
(Franke et al., 1997; Scheid et al., 2002; Ma et al., 2008; Kerr, 2011). It has been 
suggested that a balance of these phospholipids is required maximal Akt activation 
which may explain, in part, why both the activator and inhibitor of SHIP-1 abrogated Akt 
phosphorylation and inhibited proliferation of T lymphocytes (Figure 3.15).  





3.15 Activation and inhibition of SHIP-1 leads to the same functional outcomes. 
Under normal conditions, PI3K and SHIP-1 regulate the levels and localisation of 
PI(3,4,5)P3 and PI(3,4)P2 to co-ordinate the normal functions of T lymphocytes. The 
balance between PI(3,4,5)P3 and PI(3,4)P2 appears to be vital. Due to its abundance 
in basal cells PI(4,5)P2 is not believed to have a signalling role. Activation of the 
endogenous negative regulator of PI3K, SHIP-1 with pharmacological tools such as 
AQX1 leads a decrease in PI(3,4,5)P3 and an accumulation of PI(3,4)P2 and inhibition 
of T lymphocyte function. Similarly, inhibition of SHIP-1 with 3AC leads to 
downregulation of PI(3,4)P2 signalling and an accumulation of PI(3,4,5)P3 signalling, 
which also reduces T lymphocyte function. 
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PI(3,4)P2 has a prominent positive signalling role in cells (Franke et al., 1997; Tiwari et 
al., 2009; Brooks et al., 2010) and is able to recruit and activate unique PH-domain 
containing proteins to PI(3,4,5)P3, including TAPP1/TAPP2 (Marshall et al., 2002; 
Zhang et al., 2009; Li et al., 2013), lamellipodin (Lpd) (Krause et al., 2004; Law et al., 
2013), and SNX9 (Posor et al., 2013), indicating that instead of producing the same 
effect as PI3K inhibition, SHIP-1 activation could drive distinct signalling (Figure 3.16). 
PI3K inhibitors inhibit the accumulation of PI(3,4,5)P3 within cells, therefore 
conceptually they also eliminate PI(3,4)P2 dependent signalling, as SHIP-1 no-longer 
has a substrate to de-phosphorylate (Scheid et al., 2002). It is interesting to compare 
our observations with SHIP-1 modulation to the literature on PI3K inhibition to 
determine the potential benefits of both methods in treating diseases of the immune 
system and this is touched upon in different sections in the discussion. TCR/CD8 
mediated Akt activation has been shown to be dependent on PI3K regulatory subunit 
p85s and p110 in peripheral T cells (Okkenhaug et al., 2006; Deane et al., 2007; 
Garcon et al., 2008). p110δ-deficient mice T lymphocytes also exhibit deficient clonal 
expansion to CD4 T lymphocytes (Okkenhaug et al., 2006). The p110δ inhibitor 
IC87114 inhibits proliferation of both mouse and human T lymphocytes (Soond et al., 
2010). Thus Inhibition of p110δ appears to exhibit a similar phenotype to SHIP-1 










Figure 3.16 Chemical structures and downstream signalling proteins of 
phosphoinositides. Phosphatidylinositol (PI) consists of a phosphatidic acid 
backbone, linked via a phosphate group to an inositol ring head group (green). R1 and 
R2 denote fatty acid groups. PI can be phosphorylated at various hydroxyl groups of 
the inositol ring. Phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) and PI(3,4)P 
phosphatidylinositol-3,4-biphosphate (PI(3,4)P2) are illustrated alongside the PH 
domain containing proteins which can recruited to each phospholipid sub-type. 
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It is also interestingly to point out that although PI(3,4,5)P3 is necessary for full 
activation of Akt, Akt can be activated and phosphorylated by serine/threonine kinase, 
inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) independently of a 
PI3K/PH domain mediated mechanism (Guo et al., 2011). Thus PI3K inhibition or 
SHIP-1 modulation may not fully silence Akt signalling. Direct inhibition of Akt has also 
been explored as a putative cancer treatment (Hers et al., 2011; Tan et al., 2011). 
However, paradoxically direct inhibition of Akt could actually increase PI3K-dependent 
activation of its other effectors. This is because Akt activation leads to increased 
mTORC1 activity, which operates a well-known negative feedback mechanism (Guo et 
al., 2011). When mTORC1 is active, the PI3K-Akt pathway is suppressed, whereas if 
mTORC1 is inhibited (for instance, with rapamycin), PI3K-Akt signalling can actually be 
enhanced (Guertin et al., 2009), thus modulating SHIP-1 appears to be a better method 
of manipulating Akt activation and downstream signalling than direct Akt inhibition.  
(c) Proliferation 
Actin rearrangement is known to be important in cell division with dysregulation causing 
failure of centrosome separation and spindle assembly in the S phase of the cell cycle 
(Bendris et al., 2015). SHIP-1 modulation impairs ERM cytoskeletal protein 
phosphorylation and rearrangement and SHIP-1 silencing inhibits actin rearrangement 
(Hogan et al., 2004; Harris et al., 2011) which could underlie why SHIP-1 modulation 
affects T lymphocyte proliferation. Proliferation of peripheral T lymphocytes may also 
be reliant upon suppressed TCR-induced Akt phosphorylation) (Xu et al., 2012). During 
the cell cycle, a number of checkpoints ensure that proliferation is regulated, in 
particular the G1 checkpoint and G1 to S phase transition, which in general prevents 
unhealthy cells from proceeding further through the cell cycle (Foster et al., 2010). 
Hypothetically, high levels of either PI(3,4,5)P3 or PI(3,4)P2 present in SHIP-1 
modulated cells could indicate that the cell is unhealthy and in order to limit the chance 
of developing leukaemias these cells are prevented from proliferating. Furthermore, 
PI3K activity is key to progression through the G1 checkpoint, so a lack of PI(3,4,5)P3 
or PI(3,4)P2 may also contribute to cell cycle arrest (Foster et al., 2010). To further this 
work it would be interesting to use cell cycle analysis to determine the effect of SHIP-1 
activation and inhibition upon the cell cycle. Interestingly, expression of complete SHIP-
1 protein in Jurkat cells reduced cellular proliferation, notably by affecting the G1 cell 
cycle regulators Rb and p27Kip1 ,(Horn et al., 2004) and KLF2 (Garcia-Palma et al., 
2005) factors implicated in T cell quiescence. The possible reasons for that both 
pharmacological activation and inhibition SHIP-1 inhibited human T lymphocyte 
proliferation are summarised in Figure 3.17. 




Figure 3.17 Model for SHIP-1 activation and inhibition causing decreased T 
lymphocyte proliferation  
 
Importantly, although we have indicated that the pharmacological manipulation of 
SHIP-1 can alter TCR signalling and proliferation, no inappropriate T cell mediated 
autoimmunity or T cell neoplasm have thus far been demonstrated in either the 
pharmacological or genetic strategies implemented to manipulate SHIP-1. This 
includes four independently generated germline SHIP−/− mice strains (Helgason et al., 
1998; Liu et al., 1998; Wang et al., 2002b; Karlsson et al., 2003) and conditional T 
lymphocyte knock out mice, CD4Cre+SHIPflox/flox, or CD8Cre+SHIPflox/flox mice 
(Tarasenko et al., 2007; Kerr, 2011). It could be argued that such neoplasms are not 
observed in germline SHIP−/− strains due to their substantially reduced lifespan; 
however, in the T cell conditional SHIP deletion strains a normal life span is observed. 
Nor are T cell neoplasms found in primary and secondary hosts reconstituted with 
SHIP-deficient BM cells (Hazen et al., 2009). Finally, clinical trials with SHIP-1 
activator, AQX-1125 have only indicated minor side effects of mild nausea, abdominal 
pain and dyspepsia (Leaker et al., 2014).  
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(d) Ca2+ signalling 
Unlike Akt phosphorylation, TCR-induced Ca2+ production was unaffected by SHIP-1 
modulation which firstly indicates that Ca2+ mobilisation is unlikely to be reliant upon 
Akt mediated signalling. Consistently to SHIP-1 activation, PI3K deficiency only exhibits 
a modest effect on Ca2+ release into the cytosol in T lymphocytes (Deane et al., 2007). 
The modest decrease suggests PI3K signalling may not be the only mechanism 
regulating Ca2+ mobilisation. Protein tyrosine kinases SFKs, SYKs and Tec kinase Itk 
prominently feature in PLCγ activation in T lymphocyte, and although Itk activation and 
regulation has been associated with both PI3K and SHIP-1 signalling (August et al., 
1997; Shan et al., 2000), due to the inability of PI3K deficiency and SHIP-1 modulation 
to supress Ca2+ release, these roles maybe redundant.  
 
SHIP-1 modulates T lymphocyte adhesion by altering the confirmation of the 
LFA-1 receptor 
The adhesion of lymphocytes to components of the extracellular matrix and other cells 
is critical for cell migration, extravasation and the formation of immunological synapses 
(Hogg et al., 2011). PI3K-induced signalling is known to be crucial in leukocytes 
adhesion (Mazerolles et al., 1996), whilst the loss of SHIP-1 expression in neutrophils 
enhanced adhesion due to up-regulated fibronectin mediated PI(3,4,5)P3 signalling. 
SHIP-1-/- neutrophils lose their polarity upon cell adhesion and are extremely adherent 
which impairs chemotaxis (Mondal et al., 2012). Furthermore, it has been shown that 
overexpression of full length SHIP-1 had no effect on expression of LFA-1 but 
increased LFA-1 activity which led to enhance adhesion to ICAM-1 in a manner which 
was dependent upon the catalytic activity of SHIP-1. However although shRNA SHIP-1 
of SHIP-1 reduced expression of CD11a but not CD49d in primary human T 
lymphocytes it had no effect to adhesion of T lymphocytes to ICAM1 or fibronectin 
(Harris et al., 2011). Therefore, it was important to address whether pharmacological 
activation or inhibition of SHIP-1 could alter the ability of human T lymphocytes to 
adhere.   
Surprisingly, both to SHIP-1 activators and inhibitors both potently inhibited the ability 
of basal and TCR-stimulated T lymphocytes to adhere to ICAM1 and fibronectin. 
Interestingly, 3AC had a more pronounced effect upon TCR stimulated adhesion, 
supporting the observation that SHIP-1 is important in TCR induced signalling. These 
two different adhesion molecules were selected due to their roles in different stages of 
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T cell extravasation. Fibronectin, a glycoprotein of extracellular matrix and is involved in 
cell migration, differentiation and early attachment, whereas ICAM-1 is a glycoprotein 
which is expressed on endothelial and immune cells and is important in stabilising cell 
contacts. SHIP-1 modulation had no effect upon the expression of respective cognitive 
integrin receptors of ICAM and fibronectin, LFA-1 (CD11a expression) and α4β1 
(CD49d expression) respectively. However, the mechanism behind SHIP-1 modulation 
inhibiting adhesion to ICAM is due (at least in part) to SHIP-1 altering the LFA-1 avidity. 
These observations conflict with those previously reported in the literature using 
genetic targeting. This could be due to differences between human and mouse T 
lymphocytes, or that genetic targeting of SHIP-1 expression removes both catalytic and 
non-catalytic functions of SHIP-1, whilst pharmacological manipulation usually leaves 
non-catalytic functions intact. Due to both the activator and inhibitor of SHIP-1 
decreasing the adhesion of T lymphocytes, we propose that, like Akt activation, a 
balance of phospholipid dependent signalling is required for optimal adhesion and LFA-
1 avidity (Figure 3.18). 
It is worth mentioning that in physiological conditions the cells would have to adhere 
under flow and shear stress which could alter requirement/balance of PI3K and SHIP-1 
signalling in T lymphocyte adhesion. However as the assay reliably showed enhanced 
adhesion to TCR stimulation and appeared adequate to determine the effect of SHIP-1 
upon T lymphocyte adhesion.  
 
SHIP-1s roles in activated T lymphocyte migration 
Chemotaxis is a complex process; PI3K signalling and other pathways often fulfil 
redundant roles. It has been shown previously that CXCL11-induced migration in 
human activated T lymphocytes is resistant to pan-PI3K inhibition (Smit et al., 2003; 
Cronshaw et al., 2006), however we observe that a distinct pan PI3K inhibitor inhibits 
CXCL11 driven chemotaxis (Discussed in Chapter 5.1). SHIP-1 activation and 
inhibition abrogated CXCL11-induced directional migration of SEB-activated T 
lymphocytes in two distinct migration assays. Modulation of SHIP-1 impedes migration 
in the absence of altering CXCR3 expression or Ca2+ signalling, but modulation did 
significantly reduce CXCL11 mediated Akt phosphorylation.  
SHIP-1 activation results are in accordance with recent findings by Lam et al, who 
demonstrated that overexpression of SHIP in neutrophils impaired migration (Lam et 
al., 2012), but also with studies indicating SHIP-1 inhibition or genetic targeting with 
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shRNA mediated knock down inhibits migration of naïve T lymphocytes and neutrophils 
(Harris et al., 2011; Mondal et al., 2012; Stenton et al., 2013a). Human T lymphocytes 
migration appears to be highly dependent upon both PI(3,4,5)P3 and PI(3,4)P2 
production and signalling. Asymmetric distribution of PI(3,4,5)P3 at the front of the cell 
is a hallmark of cell polarisation (Wang et al., 2002a; Wang, 2009), and leads to the 
activation of small GTPases to drive cell migration. PI(3,4)P2 is also important in 
migration; it selectively recruits TAPP1 which interacts with cytoskeletal protein 
synotrophin and controls actin polymerisation (Costantini et al., 2009; Li et al., 2013). 
PI(3,4)P2 also recruits Lammelipodin (Lpd) and promotes dynamic actin branching at 
the leading edges of migrating cells by interacting with Arp2/WAVE complex (Krause et 
al., 2004; Law et al., 2013) (Illustrated in Figure 3.18). Thus, both activation and 
inhibition of SHIP-1 may disrupt T lymphocyte migration (Figure 3.15). 
Microvilli on the surface of T lymphocytes collapse in response to chemokine 
stimulation to allow firm adhesion and flattening of the cell during chemotaxis (Brown et 
al., 2003). Upon chemokine stimulation, Rac-1 dependent signalling de-phosphorylates 
ezrin, radixin and moesin (ERM) proteins (Nijhara et al., 2004). When they are 
phosphorylated ERM proteins link the actin cytoskeleton to the cell membrane 
phospholipid PI(4,5)P2. De-phosphorylation de-stabilises this attachment and allows 
microvilli retraction and the formation of a polarised cell (Brown et al., 2003). Thus, 
ERM de-phosphorylation can be used as indirect marker of microvilli retraction and 
cellular polarisation. SHIP-1 activation inhibited chemokine (CXCL11 and CXCL12) 
mediated de-phosphorylation of ERM proteins, this is consistent with shRNA silencing 
of SHIP-1 protein expression led to a de-phosphorylation of ERM proteins in T 
lymphocytes (Harris et al., 2011). However, we also observed that pharmacological 
SHIP-1 inhibition led to abrogated chemokine dependent dephosphorylation of ERM 
proteins in T lymphocytes. The activity of SHIP-1 therefore seems to be a crucial switch 
in the phosphorylation state of ERM proteins and thus microvilli retraction within 
lymphocytes (Figure 3.18).  
Microvillus retraction allows LFA-1 (resident on the cell body) to access its ligand, 
ICAM1 (Lammermann et al., 2014). SHIP-1 activation and inhibition may therefore act 
to inhibit lymphocyte adhesion to ICAM1 via two mechanisms; reduced LFA-1 avidity, 
and the inhibition of chemokine mediated ERM de-phosphorylation. In addition the de-
phosphorylation of ERM proteins has been shown to be crucial for lymphocyte 
polarization. Therefore the inability of chemokine mediated ERM de-phosphorylation to 
occur in the presence of activator and inhibitor, may contribute to the inhibited 
chemokine mediated migration of lymphocytes.  




Figure 3.18 Model of the roles of SHIP-1 in T lymphocyte migration and adhesion. 
This model is based on the results of the thesis and the findings of (Costantini et al., 
2009; Law et al., 2013). 1) PI(3,4)P2 binding protein TAPP is known to maintain 
polarized cell morphology via interaction with utrophin and stable F-actin localized at 
the sides and uropod of migrating cells. 2) Lammelipodin (Lpd), another PI(3,4)P2 
binding protein, promotes dynamic actin branching at leading edges (lammelipodia) of 
migrating cells via its interaction with Arp2/3 WAVE complex. 3) SHIP-1 was 
pharmacologically manipulated by SHIP-1 activator, AQX1 or SHIP-1 inhibitor 3AC. 4) 
SHIP-1 modulation impaired CXCL11-induced Akt phosphorylation and 5) reduced the 
avidity of integrin LFA-1 resulting in reduced basal adhesion. 6) SHIP-1 modulation 
prevented pERM dephosphorylation to CXCL11, which is likely to alter cytoskeletal re-
organisation. No effect upon CXCR3 receptor expression or Ca2+ mobilization was 
observed. SHIP-1 appears to be critical in T lymphocyte migration. 




SHIP-1 has a crucial role in the regulation of ligand mediated signalling, proliferation, 
adhesion, cytoskeletal protein re-arrangement and migration of primary human T 
lymphocytes. Consequently, pharmacological modulation of SHIP-1 offers an exciting 
new mechanism for the targeted modulation of PI3K signalling, with potential 
therapeutic opportunities in T lymphocyte driven pathologies such as autoimmune and 
inflammatory disease.  
Interestingly, over the duration of this project intense research has continued to 
produce evidence that the PI3K, particularly δ and γ isoforms, have important non-
redundant role in multiple cells of the immune system and could be useful in the 
treatment immune pathologies [We have reviewed this area here (Ball et al., 2014)]. 
The growing appreciation of the isoform crystal structures of PI3K, which help define 
the structure-activity rules for obtaining selectivity, continuously enhance our ability to 
design and develop of PI3K inhibitors with greater isoform selectivity and fewer off-
target effects (Sutherlin et al., 2012; Zhao et al., 2014; Somoza et al., 2015; Yang et 
al., 2015).   
However, we believe that even with improved PI3K inhibitors, there are potential 
benefits to targeting SHIP-1. Firstly, there is a large amount of functional redundancy 
and plasticity between PI3K isoforms, thus isoform targeted therapies might not 
warrant successful treatments in disease setting. Moreover, PI3K dysregulation is often 
caused by over-active mutations in PI3K (Pazarentzos et al., 2015; Young et al., 2015), 
these could alter the efficacy and affinity of PI3K inhibitors. Furthermore, the ubiquitous 
nature of PI3K signalling implies that any successful PI3K inhibitors could be 
complicated by off-target effects and worryingly, it has recently been reported that 
resistance mechanisms can be developed to combat PI3K-targeted therapy (Ilic et al., 
2011); although selective pressure driving resistance could vary between cancer and 
inflammatory setting. SHIP-1 exhibits a restricted expression prolife limiting non-
selective effects and modulation of SHIP-1 appears to have prolific effects on the 
immune system. SHIP-1 could be a superior target, and at the very least it will be 














CHAPTER 4: Examining the functional consequences 
of ROS manipulation on T lymphocyte biology  
 




Reactive oxygen species (ROS) are known to influence the outcome of T-cell 
responses. Depending on concentration, exposure time and microenvironment, the 
effects of ROS on T lymphocytes can be very distinct. T lymphocytes produce low 
levels of hydrogen peroxide upon TCR and chemokine stimulation (Hara-Chikuma et 
al., 2012) and are known to express NADPH oxidase enzymes NOX2 (Jackson et al., 
2004) and DUOX 1 (Kwon et al., 2010). High levels of ROS have a putative role in 
several T lymphocyte induced pathologies including autoimmune diseases, 
leukaemias, carcinoma, cardiovascular diseases and neurological disorders. 
Historically, ROS were viewed as an unwanted by-product of aerobic respiration, which 
caused cellular damage via oxidation. However there has been a growing body of 
evidence to suggest that ROS are actually required for a vast number of physiological 
processes, including TCR activation and signalling. Antioxidants inhibit T lymphocyte 
proliferation and IL-2 production in humans and mice (Dornand et al., 1989; Tatla et al., 
1999; Sena et al., 2013). A very recent study has indicated that ROS is not required in 
TCR-induced proliferation, activation and cytokine secretion of primary human T 
lymphocytes (Belikov et al., 2014); before this study the roles of ROS and antioxidants 
on TCR signalling and responses had not been extensively investigated in primary 
human T lymphocytes.  
H2O2 has been observed to be an early danger cue required for neutrophil recruitment 
to wounds in zebrafish (Niethammer et al., 2009). Furthermore, a recent finding 
suggested that H2O2 is required for successful mouse T lymphocyte migration towards 
a chemoattractant (Hara-Chikuma et al., 2012). To date, little is known about whether 
hydrogen peroxide is required for the migration of human T lymphocytes.  
In order to examine the effect of ROS, primary human T lymphocytes were isolated 
from healthy human peripheral blood. Two types of primary T lymphocytes were used 
1) freshly isolated “naïve” and 2) SEB-activated T lymphocytes. Limitations of working 
with naïve T lymphocytes are they have to be used on the day of isolation following a 
lengthy isolation process; it is also difficult to obtain large numbers of naïve T 
lymphocytes. Finally, naïve T lymphocytes function to survey the blood and lymphoid 
systems for antigen and are less likely to be at the site of infection exposed to high 
levels of ROS. Therefore, peripheral blood mononuclear cells were treated with 
staphylococcal enterotoxin B (SEB), a super-antigen produced by the gram-positive 
bacteria Staphylococcus aureus, for 36 hours. SEB is a strong polyclonal activator of T 
lymphocytes and after activation the cells are clonally expanded in the presence of IL-
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2. SEB-activated T lymphocytes were used to model effector T lymphocyte migrating in 
infected tissues which is likely to be exposed to higher levels of ROS.  
 
4.1.1 Aims  
This chapter aims to determine the consequences of ROS manipulation on human T 
lymphocyte biology.  
Several pharmacological manipulators of ROS will be used: 
 to establish the functional roles of ROS in human T lymphocyte viability and 
TCR activation including investigating downstream Ca2+ elevation, proliferation 
and adhesion. 
 to determine whether H2O2 acts as a chemoattractant in T lymphocytes. 
 to assess the functional importance of ROS as a regulator of basal and 
chemotactic migration.  
 to establish whether H2O2 alters CXCL11-induced Ca
2+ elevation or actin 
regulation.  
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4.2 ROS manipulators alter intracellular ROS accumulation in SEB-
activated T lymphocytes 
During Chapter 4 and Chapter 5, pharmacological manipulators of ROS will be 
described and their effects on T lymphocyte functions assessed. Therefore it was 
prudent to determine the compounds efficacy at manipulating intracellular ROS levels. 
Figure 4.1 illustrates the regulation of ROS by the pharmacological manipulators used. 
A 2’7’-dichlorodihydrofluorescein diacetate (H2DCF-DA – “DCF”) based fluorescence 
assay was used to detect intracellular ROS in SEB-activated T lymphocytes. 
Cells were loaded with 1μM H2DCFDA, which is cleaved by intracellular esterases at 
the two ester bonds to produce H2DCF, a polar and cell membrane-impermeable 
product which is retained within the cell. Subsequent oxidation converts H2DCF to the 
highly fluorescent DCF. Cells were plated into a black 96 well plate and incubated with 
increasing concentrations H2O2 for 30 minutes. H2O2 was added to verify the activity of 
the H2DCF dye, which should detect an increased accumulation of ROS due to the 
diffusion of H2O2 into the cell. Positive control H2O2 increased intracellular ROS levels 
as compared to untreated controls (Figure 4.2 A).  
Next, the cell permeable superoxide dismutase (SOD) mimetic, [5,10,15,20-tetrakis(4-
carboxyphenyl)-21H,23H-porphine]manganese(III) chloride (C48H28ClMnN4O8, MnTBAP 
chloride) was validated. This compounds has been previously used here (Liu et al., 
2013; Schrammel et al., 2013; Suresh et al., 2013). SOD is an enzyme that catalyzes 
the dismutation of superoxide radicals into H2O2 and O2, enhancing intracellular H2O2 
levels. MnTBAP chloride has an EC50 of 40μM reported by the manufacturer (Abcam). 
It is important to note MnTBAP chloride is also a peroxynitrite scavenger. Cells were 
treated for 30 minutes with MnTBAP chloride and a significant albeit modest 
intracellular ROS elevation was observed (Figure 4.2 B). However, DCF is unable to 
specifically detect H2O2, the major outcome of MnTBAP chloride on overall ROS level 
is anti-oxidant as it reduces the level of superoxide to produce H2O2.  
Two different compounds were utilised to dampen the redox environment: (1) 
diphenyleneiodonium (DPI), a NOX inhibitor, was used to block superoxide production. 
The Ki for time dependent inhibition of NOX in neutrophils is 5.6μM (O'Donnell et al., 
1993). However, DPI also inhibits other flavoenzymes (2) Catalase, an enzyme that 
rapidly catalyses the decomposition of H2O2 to water and oxygen, was used to reduce 
levels of H2O2. Catalase was used at recommended active concentration reported by 
the manufacturer (Sigma Aldrich). Cells were treated with DPI for 30 minutes and no 
effect upon basal ROS production was observed (Figure 4.2 C). 
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Flow cytometry was used to validate catalase-dependent reductions in intracellular 
ROS, as a previous control experiment indicated that catalase has auto-fluorescence in 
the FITC range. Using flow cytometry the live cell population was gated, avoiding the 
auto-fluorescence of catalase, which has a much smaller forward and side scatter than 
live cells. Cells were treated with 1mg/ml catalase and DCF fluorescence intensity 
measured every 5 minutes for 30 minutes. Catalase significantly reduced basal ROS 
accumulation over time (Figure 4.2 D). Catalase is highly efficient and cannot be 
saturated by H2O2 at any concentration (Lledias et al., 1998). Cells were pre-treated 
with 1mg/ml catalase for 30 minutes then treated with 10mM H2O2 for 30 minutes. 
Catalase pre-treatment completely attenuated the increase in DCF fluorescence 
observed with H2O2 alone (Figure 4.2 E). These findings confirm that these are suitable 












Figure 4.1 Regulation of ROS by pharmacological manipulators. Extracellular 
treatment of H2O2 will increase H2O2 concentration both outside and inside the cell as it 
enters through aquaporins or diffusion. Superoxide dismutase (SOD) is an enzyme that 
catalyzes the dismutation of superoxide radicals into H2O2 and O2. Here SOD mimetic 
MnTBAP chloride is used to enhance the intracellular levels of H2O2. DPI is a 
flavoenzyme inhibitor which inhibits ROS production from NOX/DUOX enzymes (that 
are expressed on cellular membranes) and the electron transport chain in the 
mitochondria. Catalase is an enzyme that rapidly catalyses the decomposition of H2O2 
to water and oxygen which reduce levels of extracellular H2O2.The pharmacological 
mediators are highlight by green boxes. 
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/ MnTBAP chloride and reduced 
by catalase in SEB-activated T lymphocytes. SEB-activated T lymphocytes (8-12 
days post isolation) were loaded with 1μM DCFDA for 30 minutes. Cells were washed 
twice in HBSS, resuspended at 1 million cells per ml and treated with stated 
concentrations of either (A) H2O2, (B) MnTBAP chloride, (C) DPI or Catalase (D & E). 
For (A, B & C) ROS generation was measured after 30 minutes using a plate reader 
and normalised to fold change from basal. For (D & E), ROS generation was measured 
using flow cytometry. (D) Cells were either treated with PBS control or catalase at time 
point 0. Fluorescence intensity was then read every 5 minutes for 30 minutes and 
plotted as percent increase from basal. (E) Cells were pre-treated either with PBS 
control or catalase for 30 minutes and basal fluorescence reading taken. Then cells 
were treated with 10mM H2O2 for 5 minutes before fluorescence was measured. Data 
are the mean ± SEM of three independent experiments. Statistical significance was 
determined by a one-way ANOVA with Dunnett’s post-test where **p<0.01 or 
***p<0.001 as compared to control or ###p<0.001 as compared to H2O2 alone   
















































































































































A.  Exogenous H2O2 B.  MnTBAPchloride
C.  DPI D.  Catalase
E.  Catalase pretreatment
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4.3 Effect of ROS manipulation on SEB-activated T lymphocyte viability 
As ROS are known cytotoxic agents able to induce cellular death, it was imperative to 
observe whether the concentrations of ROS manipulators used in the following 
experiments alter cellular viability. In addition, the roles of ROS in human T lymphocyte 
survival were also examined. Two different cell viability assays were utilised; the (1) 
MTT assay and (2) Annexin V/ propridium iodide staining.  
 
4.3.1 ROS manipulation upon cell viability assessed by the MTT assay 
Firstly, cells were treated with increasing concentration of the ROS manipulators for 
either 3 or 24 hours, followed by determination of cellular viability by MTT assay 
(described in section 3.3.1). Cell viability was determined after 3 hours, as this is the 
maximum exposure time to ROS manipulators in all experiments (with the exception of 
Figure 4.6-9), and after 24 hours. Unfortunately, the effect of MnTBAP chloride upon 
cell viability could not be assessed in the MTT assay due to the compounds brown 
colour affecting the validity of the colorimetric assay by enhancing absorbance 
measurements.  
After a 3 hour treatment, cell viability was unaffected by H2O2 up to concentrations of 
100μM. Cell survival decreased to 38.2 ± 1% following stimulation with 1mM H2O2 
(Figure 4.3 A). However after a 24 hour treatment with H2O2, enzymatic activity was 
significantly reduced at concentrations above 10μM H2O2 (Figure 4.3 B). This implies 
that the survival of T lymphocytes treated with H2O2 dependents on both the 
concentration and the exposure time.  
Cells were treated with increasing concentrations of catalase for either 3 or 24 hours to 
observe the effect of dampening intracellular ROS on cell viability. After a 3 hour 
treatment, catalase had no effect upon cellular viability (Figure 4.3 C). Interestingly, 24 
hour treatment of catalase caused a small but concentration dependent reduction in 
cell viability (Figure 4.3 D). To identify whether responses are catalase-dependent the 
catalase was heat inactivated and denatured by boiling it for 10 minutes. 24 hours 
treatment with heat-inactivated catalase had no effect upon cell viability (Figure 4.3.E).  
Finally, cells were treated with increasing concentrations of DPI, for either 3 or 24 
hours, to determine the effect of inhibiting ROS production on cellular viability. 3 hour 
treatment with DPI had no effect upon cellular viability (Figure 4.3 F), whereas 24 hour 
treatment of DPI resulted a small but significant reduction in cell viability at both 
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concentrations examined (Figure 4.3 G). This implies that ROS production and 
presence is required for optimal cell survival.   
 
4.3.2 ROS manipulators had no effect upon PI/AV staining  
As the MTT assay is redox based, results could be skewed if ROS treatment were still 
present. Therefore, alternative assays were used to assess viability, namely annexin V 
and propidium iodide staining with is described in section 3.3.2. Cells were treated with 
increasing concentrations of ROS manipulators; H2O2, MnTBAP chloride, catalase and 
DPI for 3 hours. Annexin V staining was unaffected at all concentrations of H2O2 below 
10mM and MnTBAP chloride, catalase and DPI had no effect upon annexin V staining 
(Figure 4.4 & Figure 4.5). 
Consistently with the annexin V staining, PI staining was unaffected at all 
concentrations of H2O2 below 10mM and MnTBAP chloride, catalase and DPI had no 
effect upon PI staining at all examined concentrations (Figure 4.4 & Figure 4.5). This 
confirmed that observations obtained with the MTT assay and suggested that 
functional responses observed with ROS manipulation were not due to them altering 
cellular viability.   
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Figure 4.3 Effect of ROS manipulators on SEB-activated T lymphocyte viability 
using the MTT assay. 1 million SEB-activated T lymphocytes (8-12 days post 
isolation) were treated with increasing concentrations of (A, B) H2O2, (C,D) catalase, 
(E) deactivated catalase or (F, G) DPI for either 3 hours or 24 hours, respectively. Cells 
viability was assessed using the MTT assay. Data are mean ± SEM from three 
independent donors. Statistical significance was determined using a one-way ANOVA 
with Dunnett’s post-test where *p<0.05, **p<0.01 or ***p<0.001 compared to control. 

























































































































































































































































Figure 4.4 Measurements of Annexin V and PI staining indicates that high 
concentrations of H2O2 are cytotoxic, but catalase is non-cytotoxic to SEB-
activated T lymphocytes. 1 million SEB-activated T lymphocytes (8-12 days post 
isolation) were treated with increasing concentrations of (B) H2O2 or (C) catalase plus 
1% Triton X as a positive control for 3 hours. Cells were stained with Annexin V and PI, 
and fluorescence quantified by flow cytometry. (A) Representative FACs plots are 
given, including an unstained control (USC) and positive control 1% Triton X (+ve). The 
mean± SEM percentage of cells which were PI-/Annexin V- are shown in green, PI-
/Annexin V+ (yellow), PI+/Annexin V-  (orange), and PI+/Annexin V+ (Red) for cells 
treated with increasing concentrations of (B) H2O2 (n=4) or (C) catalase (n=3). 
 




























































Figure 4.5 Measurement of Annexin V and PI staining indicates that DPI and 
MnTAB chloride are non-cytoxic to SEB-activated T lymphocytes. 1 million SEB-
activated T lymphocytes (8-12 days post isolation) were treated with stated 
concentrations of DPI or MnTBAP chloride for 3 hours. Cells were stained with Annexin 
V and PI, and fluorescence quantified by flow cytometry. (A) Representative dual 
PI/Annexin V stained plots are given, including an unstained control (USC). The mean 
± SEM percentage of cells which were PI-/Annexin V- are shown in green, PI-/Annexin 
V+ (yellow), PI+/Annexin V-  (orange), and PI+/Annexin V+ (Red) for cells treated for 3 
independent experiments.    
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4.4 Effect of ROS manipulation upon TCR-induced responses  
Ligation of the TCR receptor induces signalling required for the activation, survival and 
proliferation of T lymphocytes. TCR ligation has been shown to induce intracellular 
ROS (Jackson et al., 2004) and accumulating evidence suggested ROS are actually 
required for TCR activation and signalling (Kwon et al., 2010; Sena et al., 2013). 
Therefore the functional roles of ROS and antioxidants downstream of CD3/CD28 
signalling in human T lymphocytes were investigated.  
 
4.4.1 H2O2 has no effect upon TCR-induced Ca
2 elevation 
Intracellular Ca2+ was measured to assess whether H2O2 affects TCR signalling 
potential. In Chapter 3 Figure 3.5A, UCHT-1 was observed to induce a sustained, 
concentration dependent increase in intracellular Ca2+. To test whether H2O2 could 
affect this UCHT-1 response, SEB-activated T lymphocytes were pre-treated with H2O2 
for 30 minutes. H2O2 had no effect upon UCHT-1-induced Ca
2+ elevation at any 
concentration studied (Figure 4.6). This implies that H2O2 does not affect TCR 
signalling through Ca2+ signalling.  











Figure 4.6 H2O2 had no effect upon TCR agonist (UCHT-1)-induced intracellular 
Ca2+ release in SEB-activated T lymphocytes. SEB-activated T lymphocytes (8-12 
days post isolation) were washed into PBS and loaded for 45 minutes with 1μM Fluo-4. 
Cells were washed 3 times and re-suspended at 1 million cells per ml in Ca2+ free-
HBSS and extracellular Ca2+ adjusted to 1mM. Cells were plated in a black 96 well 
plate and either allowed to rest or treated with increasing concentrations of H2O2 for 30 
minutes. 10μg/ml UCHT-1 was added after a baseline was established and 1µM 
ionomycin was used as a loading control. Left panel is a kinetic trace indicating change 
in fluorescence from basal (∆F/F0) from one representative donor. The right panel is the 
peak change in fluorescence generated by UCHT-1 as a percentage of the peak 
change generated by ionomycin and is mean ± SEM from averaged duplicates of three 
independent donors.  Statistical significance was tested using a one-way ANOVA with 
Dunnett’s post-test relative to control. 
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4.4.2 TCR-induced proliferation of naïve T lymphocytes is impaired by 
exogenous H2O2 but not by MnTBAP chloride 
Next, the effect of ROS manipulation was assessed in the clonal expansion of human T 
lymphocytes, to examine another TCR/CD3 mediated event. Naïve T lymphocytes 
were treated with increasing concentrations of H2O2 for 30 minutes before stimulation 
with anti-CD3/CD28 Ab coated Dynabeads and IL-2. CFSE intensity was determined 
four days post isolation with plots from control conditions showing four distinct peaks, 
indicating four generations of cell division (Figure 4.7 A). H2O2 (10μM) increased the 
percentage of cells retained in generation 1 resulting in fewer cells progressing to 
generation 4 (Figure 4.7 B). H2O2 (10μM) also caused a significant increase in the 
CFSE mean fluorescence intensity, indicating cells have been unable to divide and 
thus retained a higher level of CFSE (Figure 4.7 C). Together, this suggests that at 
concentrations equal and above 10μM, H2O2 inhibits the ability of human CD4 
lymphocytes to proliferate and progress through cell divisions upon TCR/CD3 
stimulation. As H2O2 (10μM) significantly decreases cell viability at 24 hours, this could 
be due in part to cytotoxicity (Figure 4.3). 
Next, cells were treated with 20μM and 40μM MnTBAP chloride for 30 minutes prior to 
TCR stimulation to observe whether raising intracellular H2O2 would have the same 
effect as exposure to exogenous H2O2. CFSE intensity was determined five days post 
isolation for this experiment and five distinct peaks can be observed in the FACs plots 
from control conditions (Figure 4.8 A). MnTBAP chloride had no effect on the 
percentage of cells within each division, with the majority of cells progressing to 
generation 5 (Figure 4.8 B), and no effect upon CFSE fluorescence, with all conditions 
having a low mean intensity (Figure 4.8 C). Unlike H2O2, MnTBAP chloride had no 
effect upon the ability of naïve CD4 lymphocytes to proliferate, however MnTBAP 
chloride did only induce a marginal increase in intracellular ROS as compared to 
exogenous H2O2 (Figure 4.2) and had no effect upon cellular viability (Figure 4.2).  
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4.4.3 Catalase and NADPH oxidase inhibitor (DPI) inhibit TCR-induced 
proliferation of naïve T lymphocytes  
Naïve T lymphocytes treated with increasing concentrations of catalase for 30 minutes 
before stimulation with anti-CD3/CD28 coated Dynabeads and IL-2 to examine whether 
dampening intracellular ROS impacts T lymphocyte proliferation. CFSE intensity was 
determined five days post isolation with plots from control conditions showing five 
distinct peaks indicating five generations of cell division (Figure 4.9 A). Catalase 
increased the percentage of cells retained in generation 1; whereas fewer cells 
progressed to generation 4 (Figure 4.9 B). Catalase also caused a significant increase 
in the CFSE mean fluorescence intensity indicating cells have retained a higher level of 
CFSE by being unable to divide (Figure 4.9 C). This indicates that decreasing 
intracellular ROS inhibited the ability of human CD4 lymphocytes to proliferate and 
progress through cell divisions upon TCR/CD3 stimulation. 
Finally, the effect of the NOX inhibitor DPI upon naïve T lymphocyte proliferation was 
observed. DPI potently inhibited the ability of human CD4 lymphocytes to proliferate, 
with the CFSE intensity FACs plots only showing two peaks as compared to the five 
distinct peaks in the control condition (Figure 4.10 A). DPI increased the percentage of 
cells retained in generation 1; whereas only a few cells were seen in generation 2 and 
3 and no cells progressed to generation 4 (Figure 4.10 B). DPI also significantly 
enhanced the CFSE mean fluorescence intensity indicating that cells have retained a 
higher level of CFSE by being unable to divide (Figure 4.9 C).This indicates that 
decreasing ROS production inhibits the ability of human CD4 lymphocytes to proliferate 
and progress through cell divisions upon TCR/CD3 stimulation. 





Figure 4.7 H2O2 impairs TCR-induced proliferation of Naive T lymphocytes. 
Freshly isolated naïve CD4+ T lymphocytes were labelled with CFSE. 1 million cells 
were analysed on the same day (Day 0) or pre-treated with vehicle (media) or 
increasing concentrations of H2O2 for 30 minutes, followed by addition of anti-
CD3/CD23 antibody coated beads to cells at a ratio of 3:1. IL-2 was added at a final 
concentration of 36 Units/ml and cells cultured for 4 days before analysis of CFSE 
fluorescence. Data are (A) representative FACs plots from one donor, (B) mean ± SEM 
percentage of cells in each cell division and (C) CFSE mean ± SEM fluorescence 
intensity from three independent donors. Statistical significance was determined by one 
way–ANOVA with Dunnett’s post-test where *p<0.05 and ***p<0.001 compared to 
control. 




































































Figure 4.8 MnTBAP chloride had no effect upon TCR-induced proliferation of 
naive T lymphocytes.  Freshly isolated naïve CD4+ T lymphocytes were labelled with 
CFSE. 1 million cells were analysed on the same day (Day 0) or pre-treated with 
vehicle (media) or increasing concentrations of MnTBAP chloride for 30 minutes, 
followed by addition of anti-CD3/CD23 antibody coated beads to cells at a ratio of 3:1. 
IL-2 was added at a final concentration of 36 Units/ml and cells cultured for 5 days 
before analysis of CFSE fluorescence. Data are (A) representative FACs plots from 
one donor, (B) mean ± SEM percentage of cells in each cell division and (C) CFSE 
mean ± SEM fluorescence intensity from three independent donors. Statistical 
significance was determined by one way–ANOVA with Dunnett’s post-test relative to 
control. 
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Figure 4.9 Catalase significantly impaired naïve T lymphocyte proliferation. 
Freshly isolated naïve CD4+ T lymphocytes were labelled with CFSE. 1 million cells 
were analysed on the same day (Day 0) or pre-treated with vehicle (media) or 
increasing concentrations of Catalase for 30 minutes, followed by addition of anti-
CD3/CD23 antibody coated beads to cells at a ratio of 3:1. IL-2 was added at a final 
concentration of 36 Units/ml and cells cultured for 5 days before analysis of CFSE 
fluorescence. Data are (A) representative FACs plots from one donor, (B) mean ± SEM 
percentage of cells in each cell division and (C) CFSE mean ± SEM fluorescence 
intensity from three independent donors. Statistical significance was determined by one 
way–ANOVA with Dunnett’s post-test where *p<0.05 and ***p<0.001 compared to 
control. 

























































Figure 4.10 DPI inhibits TCR-induced proliferation of naive T lymphocytes.  
Freshly isolated naïve CD4+ T lymphocytes were labelled with CFSE. 1 million cells 
were analysed on the same day (Day 0) or pre-treated with vehicle (media) or 
increasing concentrations of DPI for 30 minutes, followed by addition of anti-CD3/CD23 
antibody coated beads to cells at a ratio of 3:1. IL-2 was added at a final concentration 
of 36 Units/ml and cells cultured for 5 days before analysis of CFSE fluorescence. Data 
are (A) representative FACs plots from one donor, (B) mean ± SEM percentage of cells 
in each cell division and (C) CFSE mean ± SEM fluorescence intensity from three 
independent donors. Statistical significance was determined by one way–ANOVA with 
Dunnett’s post-test where **p<0.01 compared to control. 
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4.4.4 H2O2 had no effect upon SEB-activated T lymphocyte adhesion or integrin 
receptor expression  
Ligation of the TCR is known to increase adhesion of lymphocytes (Simonson et al., 
2006). The adhesion of lymphocytes to components of the extracellular matrix and 
other cells is critical for cell migration, extravasation and formation of immunological 
synapses. However, the roles of ROS in T lymphocyte adhesion are not well 
established and were therefore examined. 
Firstly, UCHT-1 (TCR agonist) significantly enhanced SEB-activated T lymphocyte 
adhesion to fibronectin (Figure 4.11 A). SEB-activated T lymphocytes were pre-treated 
with H2O2 for 30 minutes and allowed to adhere to fibronectin for 30 minutes. The plate 
was turned upside down for 15 minutes and the wells washed with PBS. Adherent cells 
were scraped and counted by flow cytometry. Interestingly, H2O2 had no effect upon 
basal or UCHT-1-induced adhesion to fibronectin (Figure 4.11 B). H2O2 also had no 
effect upon the expression of the α-subunit of integrin receptors LFA-1 (CD11a subunit) 
or α4β1 (CD49 subunit) (Figure 4.11 C & D). 






























Figure 4.11 H2O2 has no effect upon CD11a, CD49d integrin expression and T 
lymphocyte adhesion to fibronectin. 1 million SEB- activated T lymphocyte (8-12 
days post isolation) were treated with vehicle or increasing concentrations of H2O2 for 
30 minutes. Cells were stimulated with UCHT-1 (10μg/ml) for 5 minutes, before being 
allowed to adhere to a fibronectin (10μg/ml) coated 96 well plate for 30 minutes. The 
plate was sealed and turned upside down for 15 minutes. Wells were washed gently 
with PBS to remove any un-adhered cells. Adhered cells were scrapped and counted 
using flow cytometry. (A) Indicates the adhesion observed with UCHT-1 (10μg/ml 
stimulation) compared to control. Statistical significance was determined by Students T 
test and where *p<0.05 as compared to control. (B) Data are represented as percent 
change from basal conditions. (C & D) Cells were treated with increasing 
concentrations of H2O2 for 30 minutes and then expression of the cell surface receptors 
(C) CD11a and (D) CD49d was assessed using PE-conjugated antibodies and 
analysed by flow cytometry. Data are represented as percent change from basal 
conditions and is the mean ± SEM of three independent experiments. Statistical 
significance was determined by one-way ANOVA with Dunnett’s post-test.  
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4.5 Effect of ROS manipulation upon chemoattractant-induced responses  
H2O2 has been observed to be an early danger cue required for neutrophil recruitment 
to wounds in zebrafish (Niethammer et al., 2009) and is required for successful mouse 
T lymphocyte migration towards a chemoattractant (Hara-Chikuma et al., 2012). To 
date, little is known about whether hydrogen peroxide is required for the migration of 
human T lymphocytes. Therefore the functional roles of ROS and antioxidants on 
human T lymphocytes migration were investigated. 
 
4.5.1 H2O2 is not a chemoattractant for SEB-activated T lymphocyte migration 
To determine whether H2O2 acts as a chemoattractant to SEB-activated T 
lymphocytes, an in vitro chemotaxis assay, manufactured by Neuroprobe, was utilised. 
SEB-activated T lymphocytes were placed above a porous membrane and the number 
of cells towards a chemoattractant in a bottom well counted. The effect of ROS were 
initially investigated in SEB-activated T lymphocytes as effector cells are more likely to 
be exposed to the high levels ROS present within inflamed or wounded tissues. Firstly, 
CXCL11 chemokine was used to validate the assay. The migratory response towards 
CXCL11 was bell shaped, with an optimal increase of 16.3 ± 3.7 fold occurring at 10nM 
CXCL11 (Figure 4.12 A).   
 
Next, to determine whether H2O2 could also act as a chemoattractant, H2O2 was placed 
in the bottom well of the migration plate, indicated in schematic of Figure 4.12 B. H2O2 
caused a concentration dependent decrease in SEB-activated T lymphocytes migration 
towards the lower well as compared to media alone. Migration was significantly 
impaired at 10μM H2O2 and by 1mM almost completely inhibited (Figure 4.12 C) with 
an IC50 of 2.5μM (Figure 4.12 D). Interestingly, instead of acting like a chemoattractant 
H2O2 has suppressed the migration of human T lymphocytes   


















Figure 4.12 H2O2 does not act as a chemoattractant instead inhibits basal 
migration of SEB-activated T lymphocytes. SEB-activated T lymphocytes (8-12 
days post isolation) were washed in serum free media and resuspended at 3.2 million 
per ml. Cell migration towards increasing concentrations of (A) CXCL11 or (C & D) 
H2O2 was then assessed by a Neuroprobe chemotaxis assay whereby cells are placed 
on top of a 5μm porous membrane and H2O2 placed in the bottom chamber. The 
number of cells migrated into the bottom well of were counted flow cytometry. (B) (A) 
Schematic illustrating the experimental set-up for data generated in C & D, to highlight 
that H2O2 was placed into the bottom well. Data are (C) Number of migrated cells and 
(B) Chemotactic index with a sigmoidal curve fit using graph Pad Prism 5. Data are 
mean ± SEM from three independent donors. Statistical significance was determined 
using a one-way ANOVA with Dunnett’s post-test where *p<0.05 **p<0.01 compared to 
control.    
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4.5.2 H2O2 inhibits SEB–activated T lymphocyte migration to the inflammatory 
chemokine CXCL11 
Given that exogenous H2O2 previously appeared to impair basal migration of T 
lymphocytes (Figure 4.12), T lymphocytes were pre-treated directly with H2O2 to 
further examine the impact of ROS levels upon basal and CXCL11-induced migration 
(Figure 4.13). Following antigen encounter, the chemokine receptor CXCR3 is up-
regulated on T lymphocytes and is crucial for their recruitment into inflamed tissues 
(Cole et al., 1998; Marwick et al., 2010). 
Basal migration was reduced by between 30-45% across the nanomolar and 
micromolar concentration range by pre-treatment with H2O2, although a significant 
inhibition of 80±1% was not observed until a concentration of 100μM was reached 
(Figure 4.13 B). These results were analogous to Figure 4.12 where H2O2 was present 
in the lower well and acted to suppress migration. However, excitingly CXCL11-
induced SEB-activated T lymphocyte migration was significantly reduced across the 
whole range of H2O2 concentrations tested (Figure 4.13 C & D). 1nM H2O2 suppressed 
migration by 44.8 ± 4% of control conditions and completely inhibited CXCL11-induced 
migration at 1mM H2O2. As T lymphocytes are known to respond to CXCL11 in a bell-
shaped fashion, the sensitivity of SEB-activated T lymphocytes towards increasing 
concentrations of CXCL11 was examined following pre-treatment with 100μM H2O2. 
Maximal migration occurred at 10nM for both vehicle control and H2O2 pre-treated 
cells, suggesting H2O2 does not alter T lymphocyte sensitivity to CXCL11 (Figure 4.13 
E). Maximal migration for the H2O2 pre-treated cells was still significantly lower that the 
control cells.  
4.5.3 MnTBAP chloride inhibits CXCL11-dependent SEB–activated T lymphocyte 
migration  
Cells were directly pre-treated with MnTBAP chloride for 30 minutes, in order to 
increase intracellular H2O2 levels, prior to being plated in the cell migration assay and 
exposed to either basal media or CXCL11. T lymphocyte chemotaxis towards CXCL11 
was significantly impaired to 29 ± 8.6 % of CXCL11 control when treated with 40 μM 
MnTBAP chloride. MnTBAP chloride also caused a significant, concentration 
dependent inhibition of basal SEB lymphocyte migration, with basal T lymphocyte 
migration reduced to 35 ± 9 % of control by 40 μM MnTBAP chloride (Figure 4.13 F & 
G). Increasing intracellular H2O2 levels therefore had a similar effect on SEB-activated 
T lymphocyte migration to exposure to exogenous H2O2 (Figure 4.13 B, C & D).





































Figure 4.13 Exogenous H2O2 and MnTBAP chloride inhibit basal and CXCL11-
induced SEB-activated T lymphocyte migration. (A) Schematic illustrating the 
experimental set-up for data generated in B, C & D, to highlight that cells were treated 
with H2O2 and then exposed basal or CXCL11 containing media. SEB-activated T 
lymphocytes (8-12 days post isolation) were washed in serum free media and (P.T.O) 
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resuspended at 3.2 million cells per ml. Cells were pre-treated with either vehicle or 
increasing concentrations of (B, C & D) H2O2 for 30 minutes. The (B) basal migration of 
cells and (C) migration towards the chemokine CXCL11 (10nM) was then assessed by 
Neuroprobe assay. Data are expressed as chemotactic index where the number of 
cells migrated with each drug condition is divided by the vehicle control. (D) Data are 
shown as percentage of control migration. (E) Cells were pre-treated with 100μM H2O2 
for 30 minutes. Migration was then determined towards increasing concentrations of 
CXCL11. (F & G) Cells were pre-treated with MnTBAP chloride for 30 minutes. The 
basal and CXCL11 (10nM) migration was then assessed by Neuroprobe assay. Data 
are expressed as (F) chemotactic index and (G) percentage of vehicle control. Data are 
the mean ± SEM of at least 3 independent experiments and statistical significance was 
determined by one-way ANOVA with Dunnett’s post-test where *p<0.05, **p<0.01 and 
***p<0.001 compared to control.  
 
4.5.4 Dampening the redox environment upon SEB-activated T lymphocyte basal 
and CXL11-induced migration 
As application of exogenous H2O2 and using a SOD mimetic to increase intracellular 
H2O2 both inhibited migration, the effect of dampening H2O2 levels on T lymphocyte 
migration was examined. Two approaches were utilised; degradation of H2O2 by 
catalase and inhibition of superoxide production, by DPI. Cells were directly pre-treated 
with catalase for 30 minutes prior to being placed in the Neuroprobe assay. Catalase 
pre-treatment of SEB-activated T lymphocytes caused a concentration dependent 
enhancement of basal migration, with 1mg/ml catalase increasing control migration by 
3.8 ± 0.6 fold. Catalase pre-treatment also significantly enhanced CXCL11-induced 
migration. CXCL11 alone increased migration by 8.9 ± 1.4, which was enhanced to 
20.1 ± 3.8 fold with the addition of 1mg/ml catalase (Figure 4.14 A & B). To control for 
possible impurities in the catalase solution, catalase was boiled for 10 minutes to heat-
inactivate the enzyme. Heat-inactivated catalase had no effect upon cell migration 
(Figure 4.14 C). Catalase significantly enhancing both basal and chemokine migration 
suggests there is a source of ROS in both basal and CXCL11-induced T lymphocytes 
that impedes their migration. 
Inhibition of superoxide production by DPI had no significant effect upon SEB T 
lymphocyte basal or CXCL11-induced migration (Figure 4.14 D & E). This suggests 
that the ROS that appears to be impeding migration in the catalase experiments is not 
generated by NOX enzymes.  
























Figure 4.14 Catalase enhanced and DPI had no effect upon basal and CXCL11-
induced SEB-activated T lymphocyte migration. SEB-activated T lymphocytes (8-12 
days post isolation) were washed in serum free media and resuspended at 3.2 million 
cells per ml. Cells were pre-treated with either vehicle or stated concentrations of (A, B) 
catalase, (C) deactivated catalase or (D, E) DPI for 30 minutes. The basal migration 
and migration towards the chemokine CXCL11 (10nM) of SEB-activated T lymphocytes 
was then assessed by Neuroprobe assay. Data are expressed as chemotactic index or 
as percentage of control migration of at least three independent donors, with samples 
performed in duplicate. Data are displayed as the mean ± SEM and statistical 
significance was determined by one-way ANOVA with Dunnett’s post-test where 
**p<0.01 and ***p<0.001 compared to control.    
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4.5.5 Hypoxia significantly impairs SEB-activated T lymphocyte migration 
Inflammation is known to produce a highly hypoxic environment due to high cell 
recruitment and enhanced cellular activity causing large alterations in oxygen supply 
and demand, which ultimately results in cellular exposure to higher levels of ROS. 
SEB-activated T lymphocytes will be exposed to hypoxia and increased ROS levels 
when migrating to an inflammatory environment due to the high number of active cells 
present. The effect of exposing migrating SEB-activated T lymphocytes to a hypoxic 
environment was therefore examined to assess whether this model would have a 
similar effect as pharmacologically increasing ROS levels. The migration of SEB-
activated T lymphocytes towards CXCL11 was examined in “hypoxia” (5% O2, 5% CO2, 
90% N2 37
oC) and compared to cells migrating under standard cell culture conditions or 
“normoxia” (air [approximately 21% O2 & 78% nitrogen]: 5% CO2). 
SEB-activated T lymphocyte migration toward CXCL11 was impaired in cells incubated 
in 5% O2. Chemotactic migration was reduced across the whole range of CXCL11 
concentrations tested, and significantly suppressed to 53.7±18.6% of control migration 
at 100nM CXCL11 (Figure 4.15 A). T lymphocytes normally respond to CXCL11 in a 
bell shaped fashion, however both control and hypoxic treated cells appeared to have a 














Figure 4.15 Hypoxia appears to suppress SEB-activated T lymphocyte migration. 
SEB-activated T lymphocytes (8-12 days post isolation) were washed in serum free 
media and resuspended at 3.2 million cells ml. Cells were incubated in either standard 
cell culture conditions as a control (air: 5% CO2: 37
oC), (A) 5% O2 , 5% CO2, 90% N2 
37oC (n=3) hypoxic chamber for 1 hour. The basal and CXCL11-induced (1-100nM) 
migration was then assessed by Neuroprobe assay. Data are expressed as the 
chemotactic index and are mean ± SEM of (A) three independent donors and (B) Three 
independent donors, with the right panel showing the individual donor responses. 
Statistical significance was determined by two-way ANOVA with Tukey’s post-test 
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4.6 H2O2 has no effect upon SEB–activated T lymphocyte migration to the 
inflammatory chemokine CXCL10 or homeostatic chemokine CXCL12 
As H2O2 significantly impaired migration towards CXCL11, its effect upon chemotactic 
migration to alternative chemokines was investigated. Two chemokines were utilised, 
an inflammatory chemokine CXCL10, which also binds to CXCR3, and a homeostatic 
chemokine CXCL12 which binds to CXCR4 (Figure 4.16 A). In order to properly control 
this experiment, the effect of H2O2 upon CXCL11-induced migration was re-examined 
to eliminate variability between previous experiment being undertaken on different 
donors and at a different time.  
Although CXCL11 and CXCL10 are both induced by IFNγ and thought to promote Th1 
immune responses (Luster et al., 1985; Farber, 1990; Cole et al., 1998), they have 
previously been shown to have distinct expression patterns, potencies and efficacies in 
a number of assays, including internalisation and migration (Xanthou et al., 2003; 
Colvin et al., 2006; Dagan-Berger et al., 2006). CXCL11 significantly increased SEB-T 
lymphocyte migration 6.9 ± 0.9 fold over basal migration, whereas CXCL10 was less 
potent and migration was increased 3.1 ± 0.9 fold over basal migration (Figure 4.16). 
The observation of CXCL10 and CXCL11 exhibiting distinct efficacies to CXCR3 led to 
the suggestion that they interact with CXCR3 in different ways and are likely to stabilize 
different conformations of the receptor (Nedjai et al., 2012). Consistently with previous 
results (Figure 4.12), H2O2 (1nM) significantly impaired CXCL11 migration (Figure 4.16 
B). However interestingly, only toxic concentration of H2O2 (10mM) inhibited CXCL10-
induced migration (Figure 4.16 C). CXCL12 increased migration 5.7 ± 1.1 fold over 
basal. However, similarly to CXCL10, only H2O2 (10mM) significantly inhibited 
migration toward CXCL12 (Figure 4.16 D) and this is likely to be due to toxicity. This 
observation is really interesting and suggests H2O2 is specifically altering CXCL11 
induced migration even though it acts through the same receptor as CXC10.   
























Figure 4.16 CXCL10 and CXCL12-induced migration of SEB-activated T 
lymphocytes is inhibited by high concentrations of H2O2. SEB-activated T 
lymphocytes (8-12 days post isolation) were washed in serum free media and 
resuspended at 3.2 x million cells per ml. Cells were pre-treated with either vehicle or 
stated concentrations of H2O2 for 30 minutes. The basal migration of cells and 
migration towards the chemokine (A) CXCL11 (10nM), (B) CXCL10 (10nM) or (C) 
CXCL12 (10nM) was then assessed by Neuroprobe assay. Data are expressed as 
chemotactic index (Left panel) or as percentage of control migration (Right panel). Data 
are the mean ± SEM of three independent donors. Statistical significance was 
determine using a one-way ANOVA with Dunnett’s post-test where *p<0.05, **p<0.01 
and ***p<0.001 compared to control. 
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4.7 ROS manipulation on naïve T lymphocyte migration  
Given that ROS manipulation alters the migratory responses of SEB-activated T 
lymphocytes to CXCL11, the effect of increasing or decreasing ROS levels was 
examined on naïve T lymphocytes. CXCR4 is highly expressed on naïve T 
lymphocytes and therefore their migration to CXCL12 was examined. 
 
4.7.1 Low concentrations of H2O2 inhibited basal migration of Naïve T 
lymphocytes 
Naïve T lymphocytes were treated with H2O2 for 30 minutes before being placed in the 
migration assay and exposed to either basal media or CXCL12 in the bottom well. 
Similarly to the SEB-activated T lymphocytes (Figure 4.13), basal naïve T lymphocyte 
migration was significantly inhibited at concentrations greater than or equal to 1μM 
H2O2 (Figure 4.17 A).  
Although a concentration dependent suppression of migration was observed across the 
micromolar and millimolar concentration range of H2O2, only 1mM H2O2 caused a 
significant inhibition of CXCL12-induced migration (Figure 4.17 B). Naïve T lymphocyte 
migration appeared to be more resistant to exogenous H2O2 pre-treatment as 1mM 
pre-treatment of H2O2 completely attenuated migration of the SEB- activated T 
lymphocytes (Figure 4.13), whereas 35 ± 8 % of control naïve T lymphocytes still 
migrated. 
To examine the impact of increased ROS levels in naïve T lymphocytes were pre-
treated with MnTBAP chloride for 30 minutes prior to being plated in the cell migration 
assay and exposed to either basal media or CXCL12. Unlike in the SEB-activated T 
lymphocytes, naïve T lymphocyte basal and CXCL12-induced migration was not 
significantly altered when treated with up to 40 μM MnTBAP chloride (Figure 4.17 C & 
D). This could be due to MnTBAP chloride only marginally increasing levels of H2O2 
and naïve T lymphocytes migration being more resistant to H2O2 concentrations. 
 






























Figure 4.17 Effect of H2O2 and MnTBAP chloride upon basal and CXCL12-induced 
Naïve CD4 T lymphocyte migration. Naïve CD4 T lymphocytes were washed in 
serum free media and resuspended at 3.2 million cells per ml. Cells were pre-treated 
with either vehicle or increasing concentrations of (A & B) H2O2 for 30 minutes. The (A) 
basal migration of cells and (B) migration towards the chemokine CXCL12 (10nM) was 
then assessed by Neuroprobe assay. Data are expressed as chemotactic index, where 
the number of cells migrated with each drug condition is divided by the vehicle control. 
(C & D) Cells were pre-treated with MnTBAP chloride for 30 minutes. The basal and 
CXCL12 (10nM)-induced migration was then assessed by Neuroprobe assay. Data are 
expressed as (C) chemotactic index and (D) percentage vehicle control. Data are the 
mean ± SEM of three independent donors, with samples performed in duplicate. 
Statistical significance was determined using a one-way ANOVA with Dunnett’s post-
test where *p<0.05 **p<0.01 and ***p<0.001 compared to control. 

























































































A. Basal B. CXCL12
C D
Chapter 4. Examining the functional consequences of ROS manipulation upon T cell biology 
154 
 
4.7.2 Catalase enhanced but DPI had no effect upon basal and directional 
migration of naïve T lymphocytes 
 
ROS levels were dampened in naïve T lymphocyte by exposure to catalase and DPI, 
and the impact upon migration examined. Consistent with activated T lymphocytes 
(Figure 4.14), catalase caused a concentration dependent enhancement of basal 
migration with 1mg/ml catalase increasing vehicle control migration by 12.5 ± 6.6 fold 
(Figure 4.18 A). Catalase pre-treatment also significantly enhanced CXCL12-induced 
migration. CXCL12 alone increases migration by 6.3 ± 3.4 fold, which was enhanced to 
40.7 ± 10.34 fold following pre-treatment of 1mg/ml catalase (Figure 4.18 A). Similarly 
to SEB-activated T lymphocytes (Figure 4.14), DPI had no significant effect upon naive 
















Figure 4.18 Effect of catalase and DPI upon basal and CXCL12-induced Naïve T 
lymphocyte migration. Naïve T lymphocytes were washed in serum free media and 
resuspended at 3.2 million cells per ml. Cells were pre-treated with either vehicle or 
increasing concentrations of (A) catalase or (B) DPI for 30 minutes. The basal 
migration of cells and migration towards the chemokine CXCL12 (10nM) was then 
assessed by Neuroprobe assay. Data are expressed as the mean ± SEM of 
chemotactic index (Left panel) or percentage of control migration (Right panel) of at 
least three independent donors, with samples performed in duplicate. Statistical 
significance was determined by one-way ANOVA with Dunnett’s post-test where 
*p<0.05 and **p<0.01 compared to control.    
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4.8 Effect of H2O2 upon CXCL11-induced Ca
2+ and actin regulation 
 
4.8.1 H2O2 has no effect upon CXCL11 dependent Ca
2+ signalling 
Following CXCR3/CXCL11 stimulation, elevation of intracellular Ca2+ concentrations 
occurs. Elevated intracellular Ca2+ is required for directed cell migration as local Ca2+ 
pulses near the leading edge of the cell activate myosin and to modulate focal 
adhesions (Tsai et al., 2014). Intracellular Ca2+ was measured to assess whether H2O2 
affected CXCR3/CXCL11 signalling potential. SEB-activated T lymphocytes were 
loaded with a Ca2+ sensitive fluorescent reporter (Fluo-4), and Ca2+ dependent 
fluorescence measured every 15 seconds throughout the experiment. In Chapter 3, 
Figure 3.10, CXCL11-induced a concentration dependent, transient although small 
increase in intracellular Ca2+. Pre-treatment of SEB-activated T lymphocytes with 
increasing concentrations of H2O2 for 30 minutes had no effect upon CXCL11-induced 
Ca2+ at any of the concentrations studied (Figure 4.19), which suggests the defect in 








Figure 4.19 Pre-treatment with H2O2 had no effect upon CXCL11-induced 
intracellular Ca2+ elevation in SEB-activated T lymphocytes. SEB-activated T 
lymphocytes (8-12 days post isolation) were washed into PBS and loaded for 45 
minutes with 1μM Fluo-4. Cells were washed 3 times and re-suspended at 5 million 
cells per ml in Ca2+ free-HBSS and extracellular Ca2+ adjusted to 1mM. Cells were 
plated in a black 96 well plate and either allowed to rest or treated with stated 
concentrations of H2O2 for 30 minutes. Fluorescence was recorded over time using a 
plate reader at 37oC. 10nM CXCL11 was added after a baseline was established and 
1µM ionomycin was used as a loading control. Left panel is a kinetic trace indicating 
change in fluorescence from basal (∆F/F0) from one representative donor. The right 
panel is the peak change in fluorescence generated by UCHT-1 as a percentage of the 
peak change generated by ionomycin and is the mean ± SEM from averaged 
duplicates of three independent donors. Statistical significance was determined by one-
way ANOVA with a Dunnett’s post-test relative to control.  
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4.8.2 H2O2 inhibits T lymphocyte polarisation and enhances basal actin 
polymerisation 
Preventing H2O2 uptake has been previously shown to impair actin polymerisation in 
murine T lymphocytes (Hara-Chikuma et al., 2012) whilst oxidative stress enhances 
actin polymerisation and attenuates actin polarisation to CXCL11 in human naïve T 
lymphocytes (Klemke et al., 2008). As high concentration of H2O2 impeded basal and 
chemokine-induced SEB-activated T lymphocyte migration (Figure 4.13 & 4.16), the 
importance of a high concentration of H2O2 in regulating morphological and structure 
changes required for migration was examined  
Cells were treated with either H2O2 (100μM) or catalase (1mg/ml) for 30 minutes then 
fixed, permeabilized and stained with TRITC tagged phallodin. Mean fluorescence 
intensity of TRITC fluorescence was determined using flow cytometry. Interestingly, 
H2O2 significantly increased the level of polymerised F-actin detected to 195 ± 30% of 
control levels Catalase pre-treatment had no effect upon the level of polymerised F-
actin (Figure 4.20).  
Following the observation basal actin polymerisation was affected by 100μM H2O2 
exposure (Figure 4.20), the effect of H2O2 on actin polarisation to CXCL11 was 
determined. In the absence of H2O2 cells showed a polarised F-actin distribution upon 
CXCL11 stimulation, however cells treated with H2O2 did not have polarised actin 
(Figure 4.21). This suggests that high concentrations of H2O2 could impair T 
lymphocyte migration by dysregulation cellular actin and inhibiting the ability of the cell 
to polarise to chemokine 




Figure 4.20 H2O2, but not catalase, increases actin polymerisation of SEB-
activated T lymphocytes. 1 million SEB-activated T lymphocytes (8-12 days post 
isolation) were washed three times in serum free media and treated with H2O2 (100μM) 
or catalase (1mg/ml) for 30 minutes. Cells were fixed using BD fixation reagent for 20 
minutes, permeabilized and incubated with TRITC tagged phallodin for 30 minutes. 
Mean fluorescence intensity per 10,000 cell was measured using flow cytometry. Data 
are (left panel) representative FAC plots from one donor and (right panel) mean ± SEM 
minus IgG control, normalised to the untreated control from three independent donors. 
Statistical significance was determined by one way-ANOVA with Dunnett’s post-test 











































































Figure 4.21 Effect of H2O2 and CXCL11 upon polarisation of SEB-activated T 
lymphocytes. 1 million SEB-activated T lymphocytes (8-12 days post isolation) were 
pre-treated with 100μM H2O2 for 30 minutes then stimulated with 10nM CXCL11 for 5 
minutes. Then cells were fixed in BD fixation reagent, permeabilised with BD 
permeabilisation reagent and stained with TRITC tagged phallodin and DAPI. (A) 
Representative images showing actin and DAPI staining. The scale bar represents 
10μm. (B) Represents the mean ± SEM percentage of polarised cells observed from 
three independent donors, with 20 cells counted for each condition. Statistical 
significance was determined by two-way ANOVA with a Bonferroni post-test where 
**p<0.01 compared to control. 
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4.9 Chapter 4 - Results Summary 
(a) TCR responses:  
 Extracellular ROS is required for long term SEB-activated T lymphocyte survival 
 H2O2 pre-treatment had no effect upon TCR-induced Ca
2+ elevation  
 H2O2 significantly inhibited CD3/CD28-induced proliferation of naïve T 
lymphocytes 
 MnTBAP chloride had no effect upon CD3/CD28-induced proliferation of naïve 
T lymphocytes 
 DPI and catalase significantly impaired T lymphocyte proliferation 
 Basal and UCHT-1 stimulated adhesion to fibronectin was unaffected by H2O2 
pre-treatment 
 H2O2 had no effect upon expression of integrin receptor CD11a and CD49d 
(b) Migration and chemokine-induced responses:   
 H2O2 did not act as a chemoattractant for SEB-activated T lymphocytes 
 Exogenous H2O2 and SOD dismutase mimetic inhibits basal and CXCL11-
induced migration  
 Catalase enhances basal and CXCL11-induced SEB-activated T lymphocyte 
migration 
 DPI has no effect upon SEB-activated T lymphocyte migration 
 H2O2 had a less potent effect upon CXCL10 and CXCL12-induced migration of 
SEB-T lymphocytes 
 Naïve T lymphocyte migration was less potently effected by H2O2 pre-treatment 
whilst MnTBAP chloride and DPI had no effect; however catalase significantly 
enhanced basal and CXCL12-stimulated migration  
 High concentrations of H2O2 induce F-actin polymerisation and inhibits F-actin 
polarisation to CXCL11  
 H2O2 had no effect upon CXCL11-induced Ca
2+ elevation  
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4.10 Chapter 4 Discussion  
Validation of ROS manipulators - DCF fluorescence  
Oxidative sensitive dyes such as DCF are widely used to determine the levels of 
oxidants within cells. However, it is important to note the DCF can be oxidised by 
multiple species of oxidants (Zurgil et al., 2006), the actual species of oxidants 
produced in T lymphocytes have yet to be described. H2O2 was used as a positive 
control to verify DCF activity and confirm that treatment with exogenous H2O2 gives rise 
to a pro-oxidant intracellular environment. As the pharmacological antioxidants 
catalase and superoxide dismutase mimetic MnTBAP chloride are used to assess the 
roles of ROS in T lymphocytes, their activity was verified using DCF fluorescence. The 
superoxide dismutase mimetic enhanced the oxidation of DCF whilst catalase 
significantly reduced ROS production, confirming that these were suitable agents for 
manipulating ROS level in SEB-activated T lymphocytes. ROS producers and anti-
oxidant defence mechanisms are illustrated in Figure 1.4. The compounds used in this 
chapter are summarised in Figure 4.1. To further this work other compounds could 
have been investigated which also manipulate cellular and extracellular ROS. This 
approach induces 1) cell penetrating recombinant catalase, 2) extracellular SOD 
dismutase, 3) apocynin which inhibits NADPH oxidase, 4) antimycin A, which inhibits 
cytrochrome C-reductase and evokes the production of toxic quantities of free radical 
super oxide and 5) rotenone which inhibits the transfer of electrons from complex I to 
ubiquinone which creates a back-log of electrons in the mitochondrial matrix and 
enhanced superoxide production (Figure 4.22). In particular it would have been 
interesting to determine the effect of these reagents on SEB-activated T lymphocyte 
migration.    














Figure 4.22 Additional pharmacological manipulators of ROS. Schematic 
highlighting in red boxes some additional pharmacological compounds which could be 
used to manipulate ROS within cells. These reagents could further the observations 
reported in this chapter.   
 
The effect of ROS upon T lymphocyte viability 
ROS species are known to induce bifurcate responses, with high concentrations 
evoking cell death and low concentration required for cell survival. H2O2 can be 
converted to highly reactive ·OH radicals or reactive metal-oxygen intermediates which 
are cytotoxic (Halliwell et al., 1990). Most experimental models, including those used in 
this chapter, use a bolus addition of H2O2 to the culture media. However, the cytotoxic 
concentrations of H2O2 reported in the literature are variable across different cell types 
and appear to be affected by exposure time and intracellular concentration (Gulden et 
al., 2010). For example, naïve mouse T lymphocytes are reported to undergo oxidative 
stress at concentrations above 10μM (Klemke et al., 2008), whereas the T lymphoblast 
cell line Jurkat are significantly affected at concentrations above 50μM (Cox 2007). In 
mammalian cells, cytotoxic concentrations of H2O2 have been reported between 10-
1000μM (Nakamura et al., 2003). 
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Here, to determine the cytotoxic concentration of H2O2 in human peripheral activated T 
lymphocytes, cell viability was assessed using two distinct approaches; (1) MTT assay 
to determine the effect upon mitochondrial activity and (2) propidium iodide and 
annexin-V staining to investigate whether H2O2-induced cellular apoptosis or necrosis. 
The MTT assay verified that cells treated with 100μM H2O2 were still viable after 3 
hours. However 24 hour treatments suggests that long term exposure to 10μM H2O2 
will significantly decrease survival. This implies that both concentration and exposure 
time of H2O2 can affect the survival of T lymphocytes. Therefore, throughout Chapters 
4 and 5, the exposure time to H2O2 was strictly controlled and all pre-exposures of 
H2O2 were for 30 minutes. The literature also describes that T lymphocytes can also 
have distinct susceptibility to H2O2 depending upon their stage of development. 
Preferential cell death occurred in CD8+ effector memory T lymphocytes (CD45RA - 
CCR7 -) as compared to naïve (CD45RA+) (Takahashi et al., 2005). This could explain 
why naïve T lymphocytes appear to be more resistant to high concentrations of H2O2 in 
the migration assays. However, the effect of ROS manipulators on naïve T 
lymphocytes was not studied here. It would be interesting to determine how long H2O2 
lasts in cell culture before it diffuses or is degraded, thus whether cell death occurs due 
to a delayed cytotoxicity or due to prolonged exposure. This could be determined by 
washing away H2O2 after the initial exposure and then observing the effect on survival.  
As the MTT assay is redox based, results could be have been skewed if ROS 
treatment were still present. Therefore, cell viability was also assessed using annexin V 
and propidium iodide staining. ROS has been observed to enhance apoptosis of T 
lymphocytes (Buttke, 1995) however H2O2 did not induce apoptosis in peripheral T 
lymphocytes. Interestingly, thymoquinone, a compounds that induces ROS, has been 
observed to selectively evoke apoptosis of malignant T lymphocytes (Dergarabetian et 
al., 2013). PI staining confirmed enhanced necrosis of T lymphocytes but only at 10mM 
H2O2 concentrations. High level of H2O2 exposure has been previously shown to induce 
oxidative DNA lesions, lipid peroxidation and mitochondrial damage in mammal cells 
(Nakamura et al., 2003).  
To test whether low levels of ROS are required for long term survival of T lymphocytes, 
cell viability in the presence of anti-oxidants was examined by MTT and AV/PI staining. 
After a 3 hours exposure, all concentrations of catalase, MnTBAP chloride and DPI had 
no effect upon cell viability. Conversely, 24 hour treatment with catalase and DPI 
decreased activated T lymphocyte viability, indicating that ROS are required for long 
term survival. Interestingly, a new SOD mimetic isoform MnTBAP chloride has been 
shown to have specific cytotoxic properties against acute T lymphoblastic leukaemia 
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cells, and comparatively to our study, had no effect upon the healthy T lymphocyte 
viability (Pica et al., 2015). This suggests that pharmacological manipulation of ROS 
levels could represent a novel therapeutic strategy of selectively targeting malignant T 
lymphocytes.  
 
The role of ROS in TCR-induced proliferation and adhesion of human T 
lymphocytes  
Over the last decade, it has been extensively observed that ROS have putative roles in 
a vast number of physiological processes, including TCR activation and signalling. In 
addition, (Jackson et al., 2004)ligation of the TCR receptor leads to the generation of 
ROS in T lymphocytes (Devadas et al., 2002; Kwon et al., 2010; Hara-Chikuma et al., 
2012; Sena et al., 2013).  
 
(a) Proliferation  
Naïve T lymphocyte proliferation was induced with anti-CD3 and anti-CD28 antibodies, 
which were immobilized on microbeads. Immobilized antigen is thought to be more 
physiologically representative as they mimic antigen presenting cells and allow the 
formation of focal adhesions (Arndt et al., 2013). Moreover, a recent study has 
indicated that extracellular ROS produced on TCR stimulation is involved in cross talk 
between the T lymphocyte and antigen presenting dendritic cell to stabilise the 
activation (Angelini et al., 2002; Hivroz et al., 2012). The involvement of ROS in TCR-
induced proliferation was therefore examined. 
H2O2 caused a significant defect in the proliferation of CD3/CD28-stimulated naïve T 
lymphocytes but only at concentrations above 10μM. This was consistent with the 
concentrations of H2O2 that impaired T lymphocyte viability over 24 hours. MnTBAP 
chloride had no effect upon cell proliferation, which was consistent with it having no 
effect upon cellular viability, and with the effect of low concentrations of H2O2 on 
cellular proliferation. 10μM H2O2 had no effect upon TCR-induced Ca
2+ production in 
SEB-activated T lymphocytes, thus Ca2+ regulation does not appear to be the 
mechanism by which H2O2 alters TCR-induced proliferation or survival. 
 However, actin rearrangement is known to be important in cell division with 
dysregulation causing failure of centrosome separation and spindle assembly in the S 
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phase of the cell cycle (Bendris et al., 2015). High concentrations of H2O2 enhance F-
actin production and inhibit actin polarisation to chemokines. Dysregulation of actin 
could also underlie the inability of T lymphocytes to proliferate. Furthermore, during the 
cell cycle, a number of checkpoints ensure that proliferation is regulated, in particular 
the G1 checkpoint and G1 to S phase transition, which in general prevents unhealthy 
cells from proceeding further through the cell cycle (Foster et al., 2010). High levels of 
exogenous H2O2 induce Akt, c-Src and ERK phosphorylation in human T lymphocytes 
(Section 5.2). High levels of positive cellular signalling could indicate that the cell is 
unhealthy and in order to limit the chance of developing leukaemias these cells are 
prevented from proliferating. The possible reasons that high concentrations of H2O2 












Figure 4.23 Model for high exogenous H2O2 causing decreased T lymphocyte 
proliferation  
Extracellular scavenging of H2O2 with catalase significantly reduced naïve T 
lymphocyte proliferation, with the highest concentration of catalase completely 
attenuating cell division. Excitingly, ROS generated upon TCR ligation appears to be 
required for cellular proliferation. This is in direct contrast to a recent study which 
observed that catalase had no effect upon human naïve T lymphocyte proliferation 
(Belikov et al., 2014). In both experiments, cells were treated with catalase for 30 
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minutes prior to stimulation with CD3/CD8 antibody immobilised upon on microbeads. 
The only difference in the experimental design was that I used a naïve T lymphocyte 
isolation kit, whereas Belikov et al., 2014 used a pan T lymphocyte isolation kit. This 
could again suggest a differential requirement for ROS between T lymphocytes at 
different developmental stages. 
The NADPH enzyme inhibitor DPI also significantly inhibited T lymphocyte proliferation, 
corroborating the reduced proliferation observed following scavenging of ROS by 
catalase. Interestingly, DPI has been previously observed to inhibit cellular proliferation 
of RAT1 fibroblasts by blocking cell cycle progression to the G2 stage. DPI was 
observed to induce down-regulation of cyclin B and Thr288 phosphorylated Aurora-A 
levels and ultimately force mitotic exit (Scaife, 2004). 
 
(b) Adhesion 
It was important to address whether H2O2 treatment could alter the ability of T 
lymphocytes to adhere, as the adhesion of lymphocytes to components of the 
extracellular matrix and other cells is critical for successful cell migration, extravasation 
and the formation of immunological synapses (Hogg et al., 2011). It has been 
previously reported that H2O2 altered β2- integrin CD11b/CD18-activation and 
enhanced neutrophil adhesion (Blouin et al., 1999). Furthermore, H2O2 has been 
described to induce VCAM-1 expression in β-cells through extracellular Ca2+ influx (Lee 
et al., 2008) and enhance leukocyte adhesion to endothelial cells via NFKβ dependent 
gene regulation of VCAM-1 (Lee et al., 2007). Contrastingly, H2O2 decreased the 
adhesion of pluripotent stem cells and down-regulated their expression of adhesion 
receptors although it is conceivable that stem cells may not be resistant to exposure to 
ROS as they may not be exposed to high levels of ROS under normal physiological 
conditions, unlike T lymphocytes. Interestingly, although H2O2 has been shown to 
vastly affect the adhesion process in other immune cells types, it has not been 
extensively studied upon TCR stimulated T lymphocyte adhesion prior to the work 
reported here. Surprisingly, H2O2 had no effect upon both basal and TCR-stimulated 
adhesion to fibronectin or on expression the integrin receptors, LFA-1 (CD11a 
expression) and α4β1 (CD49d expression) in SEB-activated T lymphocytes. In 
addition, as H2O2 had no effect upon basal T lymphocyte adhesion, it is unlikely that a 
defect in adhesion underlies the suppression in migration observed with H2O2 
Chapter 4. Examining the functional consequences of ROS manipulation upon T cell biology 
166 
 
The roles of ROS in chemokine-induced signalling, migration and 
polarisation 
H2O2 does not act as an in vitro chemoattractant for human T lymphocytes, which was 
especially apparent when it was compared to other known chemoattractants CXCL11, 
CXCL10 and CXCL12. This is in contrast to the finding that H2O2-induced chemotaxis 
of mouse peritoneal neutrophils (Klyubin et al., 1996) and human neutrophils (Yoo et 
al., 2011) and that H2O2 is an early danger cue required for leukocyte recruitment to 
sites of tissue damage in in vivo models of inflammation (Niethammer et al., 2009; 
Moreira et al., 2010) [Figure 1.16]. This could have physiological importance, 
leukocytes are required early after wounding, however lymphocytes are not required 
until later in the wound repair process and therefore their migratory cues could be 
distinct (Figure 5.22). However, it is important to note that trans-well migration assays 
cannot fully model the role of H2O2 in vivo. In particular, they fail to model the tissue-
scale gradient of H2O2 that is generated at a wound site which extends between 100-
200μm into the tail fin (Niethammer et al., 2009). Indeed, as the concentration of H2O2 
was not monitored over the course of the experiment it is not known how rapidly it was 
degraded/ diffused. Therefore, a sustained gradient with continuous production of H2O2 
might have a distinct effect upon T lymphocyte migration.  
To expand on the interesting observation that H2O2 actually reduces basal T 
lymphocyte migration, the protocol was adapted to determine the effect of treating the 
cells with H2O2 then observing basal and chemokine-stimulated migration. Thus, 
instead of investigating H2O2 as a chemoattractant, this adapted protocol sought to 
determine the effect of H2O2 being present in the microenvironment of the T 
lymphocyte on its migratory response. ROS levels are enhanced in several pathologies 
that T lymphocytes play an important role, such as cancer and rheumatoid arthritis 
(Griffiths, 2005; Kesarwani et al., 2013). Cells were pre-treated with H2O2 before 
examining their migration towards either basal or chemokine containing media. 
Interestingly, H2O2 pre-treatment induced a selective and potent inhibition CXCL11-
mediated migration of SEB-activated T-lymphocytes. Inhibition of CXCL11-induced 
migration was more potent than the inhibition of basal migration. CXCL11-induced 
migration was also more potently inhibited than CXCL12- and CXCL10-induced SEB-
activated T lymphocyte migration and naïve T lymphocyte migration which was only 
affected by high concentrations of H2O2. H2O2 appears to discriminate between ligands 
and inhibits CXCL11 induced-migration more than basal migration. This implies that 
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H2O2 could have a precise signalling effect upon CXCR3 receptor which will be 
investigated further in Chapter 5.  
Consistently with H2O2, the SOD dismutase mimetic MnTBAP chloride also inhibited 
the migration of SEB-activated T lymphocytes, but had no effect upon naïve T 
lymphocytes. Interestingly, dampening the ROS levels using catalase significantly 
enhanced both basal, CXCL11-induced SEB-activated and CXCL12-induced naïve T 
lymphocyte migration. Although CXCL12 is known to stimulate ROS in naive T 
lymphocytes (Hara-Chikuma et al., 2012), the fact that basal migration was also 
enhanced suggests that basally migrating cells are producing and impeded by ROS. It 
would be very interesting to determine the levels of ROS in basally migrating cells. 
Cells that are metabolically active with increased energy demands are known to 
produce higher mitochondrial derived ROS (Leone et al.2011; Kluge et al., 2013), 
however the level of mitochondrial ROS production during T lymphocyte migration is 
unknown. Inhibition of NOX enzyme with DPI had no effect upon T lymphocyte 
migration, which implies the ROS suppressing T lymphocyte migration is not generated 
by NOX enzymes. Therefore, it was particularly interesting to determine the effect of 
hypoxia on T lymphocyte migration as there are a number of studies suggesting that 
under hypoxic conditions mitochondria increase their ROS release from Complex III 
(Guzy et al., 2005). 5% O2 reduced SEB-activated T lymphocyte migration, consistent 
with the theory that mitochondrial ROS suppresses migration, which could imply that 
mitochondria are a source of ROS that dampen T lymphocyte migration (Table 4.1).  
 
Table 4.1 Effect of ROS manipulation upon basal and CXCL11 stimulated 
migration in SEB-activated T lymphocytes. ↓ indicates inhibition of migration, 
↑indicates enhanced migration and – no effect upon cell migration.  
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H2O2 appears to have an important role in actin regulation, as it has been previously 
shown that preventing H2O2 uptake impairs actin polymerisation in murine T 
lymphocytes (Hara-Chikuma et al., 2012) whilst oxidative stress enhances actin 
polymerisation and impairs actin polarisation to chemokine stimulation in human naïve 
T lymphocytes (Klemke et al., 2008). H2O2 significantly increased the level of F-actin 
detected and inhibited actin polarisation to CXCL11 in activated T lymphocytes. The 
ability of H2O2 ability to alter the polarisation and dysregulate the production of F-actin 
is likely to be one mechanism underlying the ability of high concentrations of H2O2 to 
inhibit actin mediated processes such as migration and proliferation (Figure 5.22).   
 
Perspectives 
ROS potently inhibiting T lymphocyte migration was unexpected and has unearthed 
several interesting questions. What are the physiological consequences of low levels of 
ROS suppressing migration? There are several hypothetical scenarios (1) H2O2 could 
dampen the recruitment of adaptive immune cells which are required later in the wound 
repair process (2) in contrast, low level ROS could be responsible for capturing T 
lymphocytes at a site of high ROS by restricting their migration and (3) in a pathological 
setting, high ROS levels cause wide-spread suppression T lymphocyte migration and 
aid cancer cell survival or prolong chronic infection (Figure 5.22). In addition, the study 
by Hara-Chikuma et al 2012 indicated that H2O2 uptake through aquaporin 3 is required 
for CXCL12-induced mouse T lymphocyte migration; why the disparity? This could be 
due to interspecies variation between mouse and human cells, and indicates that 
further investigation into the role of aquaporin 3 and H2O2 should be undertaken in 
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5.1 Rationale  
As demonstrated in the previous chapter, exogenous H2O2 potently inhibits T 
lymphocyte migration. Unravelling the mechanism through which H2O2 modulates 
signalling pathways is vital for understanding its role in T lymphocyte biology. It is 
widely accepted in the literature that H2O2 and ROS can act as second messengers 
through their ability to reversibly oxidize specific cysteine residues in proteins 
(D'Autreaux et al., 2007). Indeed, ROS can oxidise phosphatases (Denu et al., 1998), 
kinases (Yoo et al., 2011) transcription factors (Haddad, 2002) and ion channels 
(Bogeski et al., 2010) to alter intracellular signalling. This chapter focuses on the ability 
of H2O2 to alter intracellular kinases and phosphatases.   
Lyn has been indicated to act as a redox sensor, which is required for neutrophil 
recruitment to wounds in zebrafish larvae (Yoo et al., 2011). Lyn is a SFK, known for 
their widespread cellular functions including cell migration. The critical residue which is 
oxidised in Lyn is cysteine 466 and importantly, this is conserved between species and 
SFK members. SFK isoforms which are highly expressed in T lymphocytes are Fyn 
and Lyn (Cooke et al., 1989; Olszowy et al., 1995). SFK oxidation has also been shown 
to be important in cell adhesion and cytoskeletal rearrangements in fibroblasts 
(Giannoni et al., 2005).  
In addition, Spleen tyrosine kinase family members (SYK) are also key signalling 
mediators downstream of SFK involved in a wide array of cellular processes including 
survival, proliferation and migration. SYK are required for H2O2 release in neutrophils 
(Fernandez et al., 1998) and are essential for oxidative stress mediated Ca2+ release in 
B cells (Takano et al., 2002).  
Finally, H2O2 has been observed to enhance PI3K signalling through the inactivation of 
phosphatase PTEN (Lee et al., 2002; Kwon et al., 2004). PTEN is a negative regulator 
of PI3K signalling which converts PI(3,4,5)P3 to PI(4,5)P2, thus augmenting PI3K/Akt 
signalling. PI3K signalling is known to contribute to several cellular processes including 
migration. SHIP-1 is also of particular interest as although H2O2 inactivates PTEN, its 
effects upon SHIP-1 have not been determined. SHIP-1 converts PI(3,4,5)P3 to 
PI(3,4)P2 and has been shown to be vital in T lymphocyte migration in Chapter 3.  
. 




This chapter aims to examine the contributions of SFKs, SYKs, PI3K and SHIP-1 in 
ligand and H2O2-mediated signalling in human T lymphocytes 
In particular I will: 
 examine the contribution of SFKs, SYK and PI3K signalling pathways in basal 
and CXCL11 stimulated migration. 
 determine whether H2O2 signals through PI3K, SYK or SFK signalling pathways 
to manipulate T lymphocyte functions. 
 examine both oxidative signalling and oxidative stress responses by using a 
wide range of H2O2 concentrations.  
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5.2 The importance of PI3K, SFK and SYK signalling in activated T 
lymphocyte migration 
 
5.2.1 SFK and SYK signalling is required for SEB-activated T lymphocyte 
migration  
The Neuroprobe migration assay was used to identify the contributions of SFK and 
SYK in SEB-activated T lymphocyte migration. SEB-activated T lymphocytes were pre-
treated with increasing concentration of the pan-SFK inhibitor PP2 for 30 minutes prior 
to being plated in the cell migration assay and exposed to either basal media or 
CXCL11. PP2 displays considerable selectivity for SFK family members, although it 
does not discriminate between different members. An in vitro assay with human 
peripheral blood the IC50 values of PP2 against Lck (4nM), Hck (5nM), Fyn (5nM), 
JAK2 (>50μM) and EGF-R (480nM) (Hanke et al., 1996). In a later, more thorough 
study PP2 inhibited Src and Lck with IC50 values of 50nM with a 3-10 fold lower 
potency at Csk, p38a MAPK and CK1d (Bain et al., 2007). In my experiments 1nM PP2 
caused a significant suppression of SEB-activated T lymphocyte migration in response 
to CXCL11, whereas basal migration was significantly suppressed at 100μM (Figure 
5.1 A). Thus, SFK signalling is required for directional migration of SEB-activated T 
lymphocytes and SFKs signalling is important following CXCL11 induced signalling.  
Secondly, SEB-activated T lymphocytes were pre-treated with increasing 
concentrations of the pan SYK-inhibitor piceatannol for 30 minutes. Picetannol (4-[(1E)-
2-(3,5-Dihydroxyphenyl)ethenyl]-1,2-benzenediol) is a resverate analogue that exhibits 
anti-proliferative and anti-inflammatory effects (Geahlen et al., 1989). It inhibits protein 
tyrosine kinases by competing for the tyrosine-containing substrate binding site. 
Picetannol inhibits Syk with an IC50 of 10μM and offers 10 fold selectively over 
inhibition of SFK kinase Lyn (Geahlen et al., 1989). However, picetannol also inhibits 
other protein tyrosine kinases, with IC50s against Lck of 15μM (Ashikawa et al., 2002) 
In my experiments, CXCL11 driven migration of SEB-activated lymphocytes was 
significantly inhibited following incubation with 1μM piceatannol, however basal 
migration was not affected (Figure 5.1 B). This implies that SYK signalling is required 
for CXCL11-induced directional but not basal migration of SEB-activated T 
lymphocytes.  



















Figure 5.1 Effect of SFK inhibitor PP2 and SYK kinase inhibitor piceatannol upon 
basal and CXCL11-induced SEB-activated T lymphocyte migration. SEB-activated 
T lymphocytes were washed in serum free media and resuspended at 3.2 x million 
cells per ml. Cells were pre-treated with either vehicle or stated concentrations of (A) 
PP2 or (B) piceatannol for 30 minutes. The in vitro basal migration of cells and 
migration towards the chemokine CXCL11 (10nM) was then assessed by Neuroprobe 
assay. Data are expressed as chemotactic index (Left panel) or as percentage of 
control migration (Right panel) of at least three independent donors with samples run in 
duplicate. Data are the mean ± SEM whilst statistical significance was determined 
using a one-way ANOVA with Dunnett’s post-test where *p<0.05, **p<0.01 and 
***p<0.001 compared to control.    
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5.2.2 Simultaneous treatment of SFK inhibitors with exogenous H2O2 could not 
rescue the migratory defect observed with H2O2 
SFK have also been linked with H2O2-induced chemotaxis in zebrafish wounding 
models (Niethammer et al., 2009). Therefore, a simplistic in vitro model was utilised to 
determine whether SFK and H2O2 could signal via the same pathway in human T 
lymphocytes. The effect of inhibiting SFK alone, exogenous H2O2 alone or treating cells 
with both in combination was compared.  
SEB-activated cells were treated with 1μM PP2 alone, 10nM H2O2 alone or both 1μM 
PP2 and 10nM H2O2 in combination before being exposed to a chemoattractant in the 
migration assay. All treatment combinations exhibited a similar inhibition of CXCL11-
induced migration, with no significant differences between when a cell was treated with 
H2O2 or PP2 alone compared to treatments given in combination (Figure 5.2 A).  
 
5.2.3 Simultaneous treatment of SYK or PI3K inhibitors with exogenous H2O2 
could not rescue the migratory defect observed with exogenous H2O2 treatment 
The same protocol was utilised to establish whether either SYK or PI3K and H2O2 
could signal through the same pathway in human T lymphocytes. Firstly, SEB-activated 
cells were treated with 1μM piceatannol alone, 10nM H2O2 alone or both 1μM 
picetannol and 10nM H2O2 in combination before being exposed to a chemoattractant 
in the migration assay. All treatment combinations exhibited a similar inhibition of 
CXCL11-induced migration, with no significant differences when a cell was treated with 
H2O2 or piceatannol alone compared to treatments given in combination (Figure 5.2 B). 
Secondly, SEB-activated cells were treated with 10μM ZSTK474 alone, 10nM H2O2 
alone or both 10μM ZSTK474 and 10nM H2O2 in combination before being exposed to 
a chemoattractant in the migration assay. 10μM ZSTK474 alone caused a very 
pronounced inhibition of basal and chemokine-induced SEB-activated T cell migration 
(Figure 5.2 C). This was an interesting observation as it has been previously observed 
that pan PI3K inhibition with LY294002 has no effect upon directional migration of SEB-
activated T lymphocytes (Smit et al., 2003; Cronshaw et al., 2006). Here, 10μM 
ZSTK474 significantly impaired basal migration to 37.1 ± 10.2 % and CXCL11-driven 
migration to 4.7 ± 1.5 % of control. However there was no significant different between 
ZSTK474 treatment alone and ZSTK474 plus H2O2 upon migration (Figure 5.2 C). 

























Figure 5.2 SFK, SYK or PI3K inhibition does not rescue or exacerbate the 
migratory defect observed with H2O2. SEB-activated T lymphocytes were washed in 
serum free media and resuspended at 3.2 million cells per ml and pre-treated with (A) 
1μM PP2 alone, 10nM H2O2 alone or PP2 and H2O2 in combination (B) 1μM picetannol 
(PIC) alone, 10nM H2O2 alone or PIC and H2O2 in combination and (C) 10μM ZSTK474 
alone, 10nM H2O2 alone or ZSTK474 and H2O2 in combination. The in vitro basal 
migration of cells and migration towards the chemokine CXCL11 (10nM) was then 
assessed by Neuroprobe assay. Data are expressed as chemotactic index (Left panel) 
or as percentage of control migration (Right panel) of at least three independent donors 
with samples run in duplicate. Data are the mean ± SEM and statistical testing using a 
two-way ANOVA with a Bonferroni post-test whereby significance is represented by 
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5.2.4 PI3K signalling is required for basal and CXCL11-induced migration of SEB-
activated T lymphocyte 
It has previously been shown that chemokine-induced migration of activated T 
lymphocytes is resistant to pan PI3K inhibitors LY294002 and wortmannin (Smit et al., 
2003; Cronshaw et al., 2006; Smith et al., 2007). However the pan PI3K inhibitor, 
ZSTK474 inhibited both basal and CXCL11 stimulated migration in Figure 5.2 C. 
Therefore, it was interesting to compare the effect of different PI3K inhibitors on the 
directed migration of SEB-activated T lymphocytes. The IC50 of each inhibitor at each 
PI3K Class IA isoform are described in Table 1.3.  
First, SEB-activated T lymphocytes were pre-treated with increasing concentration of 
LY294002 for 30 minutes prior to being plated in the cell migration assay and exposed 
to either basal media or CXCL11. LY294002 inhibited basal migration but had no effect 
upon directional migration (Figure 5.3 A) consistent with previous findings (Smith et al., 
2007). Next, cells were treated with ZSTK474, which significantly impaired basal to 
16.16 ± 6.67 % and CXCL11-induced migration to 41.28 ± 12.80 % of control (Figure 
5.3 B) 
As migration was inhibited by a pan PI3K inhibitor (ZSTK474) the effect of isoform 
specific PI3K inhibitors was examined. Neither PI3Kγ inhibitor AS-605240 (Figure 5.4 
A) nor PI3Kδ inhibitor IC871114 (Figure 5.4 B) had any effect upon basal or CXCL11 
migration. However, as different isoforms of PI3K have redundant roles, the effect 
combining AS-605240 and IC871114 was examined. The combination of both inhibitors 
significantly impaired both basal to 28.48 ± 18.97 % and CXCL11-induced migration to 
53.84 ± 15.93 % of control, in a similar fashion to ZSTK474 (Figure 5.4 C). Therefore it 
appears like PI3Kgamma and delta isoform signalling is required for CXCL11-induced 
migration of SEB-activated T lymphocytes though there is a residual migratory 
response resistant to inhibitors of these isoforms  
 


















Figure 5.3 Pan PI3K inhibition by ZSTK474 and LY249002 inhibit basal and 
CXCL11-induced migration of SEB-activated T lymphocyte. SEB-activated T 
lymphocytes were washed in serum free media and resuspended at 3.2 million cells 
per ml. Cells were pre-treated with increasing concentrations of (A) LY249002 or (B) 
ZSTK474 for 30 minutes. The basal migration and migration towards the chemokine 
CXCL11 (10nM) was then assessed by the Neuroprobe assay. Data are expressed as 
chemotactic index (Left panel) or as percentage of control migration (Right panel). Data 
are the mean ± SEM of three independent donors. Statistical significance was 
determined using a one-way ANOVA with Dunnett’s post-test where *p<0.05, **p<0.01 
and ***p<0.001 compared to control.    
























































































































Figure 5.4 Basal and CXCL11-induced SEB-activated T lymphocyte migration is 
not abrogated by specific inhibition of PI3Kδ and PI3Kγ. SEB-activated T 
lymphocytes were washed in serum free media and resuspended at 3.2 million cells 
per ml. Cells were pre-treated with either vehicle or stated concentrations of (A) 
IC871114, (B) AS-605240 or (C) IC87114 & AS-605240 for 30 minutes. The basal 
migration of cells and migration towards the chemokine CXCL11 (10nM) was then 
assessed by the Neuroprobe assay. Data are expressed as chemotactic index (Left 
panel) or as percentage of control migration (Right panel). Data are the mean ± SEM of 
three independent donors. Statistical significance was determined using a one-way 
ANOVA with Dunnett’s post-test where *p<0.05 compared to control.    
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5.2.5 PLC is required for SEB-activated T lymphocyte migration to CXCL11 
Although PI3K appears to be non-dispensable for SEB-activated T lymphocyte 
migration, inhibition did not completely abrogate migration, which could suggest that 
SEB-activated T lymphocyte migration may also require signalling through PI3K-
independent pathways. PLC is required for PI[4,5]P2 hydrolysis into two second 
messengers diacyloglycerol (DAG) and inositol triphosphate (IP[1,4,5]P3) and IP3 
binds to the IP3 receptor (IP3R), and evokes the release of Ca2+ from intracellular 
endoplasmic reticulum (ER) Ca2+ stores in a PI3K independent manner. CXCL11 has 
been shown to elicit robust elevation of Ca2+ (Figure 3.10). DAG binds to PKC to initiate 
signalling, and has also been found to be involved in migration of T cells (Cronshaw et 
al., 2006). 
Therefore the roles of PLC and PKC in the directional migration of human SEB-
activated T were investigated. SEB activated T lymphocytes were pre-treated with 1μM 
PLC inhibitor U73122 (1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-
1H-pyrrole-2,5-dione), an inactive anolog of U73122 (U73343) or the PKC inhibitor RO-
32-0432 for 30 minutes prior to being plated in the Neuroprobe migration assay and 
exposed to either basal media or 10nM CXCL11. PLC inhibitor U73122 inhibits IP3-
mediated Ca2+ release at concentrations of 1–2 μM, however it does not reduce the 
production of IP3, used as an indicator of PLC activity, until higher concentration of 
10μM and above (Smallridge et al., 1992; Alter et al., 1994; Hellberg et al., 1996). Ro-
32-0432 is a cell-permeable selective inhibitor of PKC which according to Santa Crutz 
Biotechnology displays a 10-fold greater selectivity for PKCα (IC50 = 9.3 nM); and a 4-
fold greater selectivity for PKC-β over PKCε (IC50 = 108 nM).  
U73122 significantly inhibited both basal and CXCL11-induced migration consistent 
with previous findings (Cronshaw et al., 2006). The inactive anolog, U73343 did exhibit 
a smaller but significant decrease in basal migration but had no effect upon CXCL11-
induced migration. Finally, PKC inhibition significantly decreased basal but had no 
effect upon CXCL11-induced migration (Figure 5.5). This implies that PLC induced 
signalling is vital for SEB-activated lymphocyte basal and directional migration, 
however PKC signalling through DAG is only important in basal migration. 












Figure 5.5 PLC, but not PKC, is required for SEB-activated T lymphocyte 
migration towards CXCL11. SEB-activated T lymphocytes were washed in serum 
free media and resuspended at 3.2 million cells per ml. Cells were pre-treated with 
either DMSO vehicle or 1μM U73343, U73122 or RO-32-0432 for 30 minutes. The 
basal migration of cells and migration towards the chemokine CXCL11 (10nM) was 
then assessed by the Neuroprobe assay. Data are expressed as percentage of control 
migration. Data are the mean ± SEM of three independent donors. Statistical 
significance was determined using a one-way ANOVA with Dunnett’s post-test *p<0.05, 
**p<0.01 and ***p<0.001 compared to basal and ##p<0.01 compared with CXCL11 
control. 
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5.3 H2O2 induces the phosphorylation of Akt, Src and ERK in SEB-
activated T lymphocytes 
To explore the ability of H2O2 to initiate cellular signalling, its ability to activate PI3K, 
SFK or MAPK kinases in SEB-activated T lymphocytes was examined. Both PI3K and 
MAPK signalling have been previously implicated as being activated by H2O2 
(Kefaloyianni et al., 2006; Sadidi et al., 2009; Ha et al., 2012) whilst the SFK member 
Lyn was determined to have a critical cysteine, cys-466, which is required for it to 
exhibit redox sensitivity in zebrafish (Yoo et al., 2011). 
Akt (Ser473) phosphorylation, c-Src phosphorylation (Tyr416) and ERK1 (Tyr202) and 
ERK2 (Tyr204) were determined as an indirect measure of PI3K, SFK and MAPK 
activity, respectively. SEB-activated T lymphocytes were pre-treated with increasing 
concentrations of H2O2 for 30 minutes and then levels of phosphorylated Akt, ERK and 
Src were determined by Western Blot. H2O2 induced a significant increase in Akt 
phosphorylation at concentrations above 100μM (Figure 5.6 A). Src phosphorylation 
was significantly increased at 10mM H2O2 (Figure 5.6 B). Consistently, ERK 
phosphorylation was only significantly increased at 10mM H2O2 (Figure 5.6 C). H2O2 
can thus induce PI3K, Src kinase and MAPK signalling but only at high concentrations, 
which are likely to place cells under oxidative stress and were previously shown to 
effect cell viability following 3 hour exposure (Figure 4.2). 






















Figure 5.6 High concentrations of H2O2 induce the phosphorylation of Akt, ERK 
and Src kinase in SEB-activated T lymphocytes. SEB-activated T lymphocytes were 
treated with increasing concentration of H2O2 for 30 minutes. Cells were lysed as 
described, loaded onto poly-acrylamide gels and proteins separated under reducing 
conditions using SDS-PAGE. Proteins were transferred to nitro-cellulose membrane, 
blocked and Immunoblotted for (A) p-Akt, (B) p-Src and (C) p-ERK and then stripped 
and re-probed for ERK1/2. Anti-CD3 antibody (UCHT-1) was used as a positive control 
Representative Immunoblots with the units representing kDa (left panel) and the mean 
± SEM of image J quantified blots from three independent donors (right panel) are 
shown. Statistical significance was determined by one-way ANOVA with Dunnett’s 
post-test whereby significance is represented by *p<0.01, **p<0.05 or ***p<0.001 
compared to control.    
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5.3.1 PI3K signalling is required for H2O2 to induce phosphorylation of Akt 
To further verify that H2O2 actives PI3K signalling, the effect of pan PI3K inhibitor 
ZSTK474 on H2O2-induced Akt phosphorylation was determined. SEB-activated T 
lymphocytes were pre-treated with ZSTK474 (1μM) for 30 minutes and then stimulated 
with CXCL11 (10nM) for 5 minutes to initiate down-stream signalling including PI3K. 
ZSTK474 completely abolished CXCL11-induced Akt phosphorylation (Figure 5.7 A) 
verifying that ZSTK474 was indeed functional and able to inhibit PI3K dependent 
signalling.  Cells were stimulated with H2O2 (100μM) for 30 minutes and levels of Akt 
phosphorylation determined by Western Blotting. ZSTK474 pre-treatment significantly 
reduced the ability of H2O2 to induce the phosphorylation of Akt (Figure 5.7 B). Thus, 
H2O2- -induced Akt phosphorylation appears to be dependent on PI3K activation.  
 
5.3.2 Catalase pre-treatment completely attenuates H2O2-induced 
phosphorylation of Akt. 
The effect of catalase upon Akt phosphorylation was examined and its ability to 
dampen H2O2 signalling verified. SEB-activated T lymphocytes were pre-treated with 
increasing concentrations of catalase for 30 minutes prior to exposing them to H2O2 
(100μM) and Akt phosphorylation measured using Western Blotting. Catalase had no 
effect upon basal Akt phosphorylation and significantly decreased H2O2-induced Akt 
phosphorylation (Figure 5.8 A). Heat-inactivated catalase had no effect upon H2O2-
induced Akt phosphorylation (Figure 5.8 B).  


















Figure 5.7 PI3K signalling is required for H2O2 to induce phosphorylation of Akt 
in SEB-activated T lymphocytes. SEB-activated T lymphocytes were pre-treated with 
increasing concentrations of ZSTK474 for 30 minutes. Cells were then treated with (A) 
10nM CXCL11 or (B) 100μM H2O2 for 30 minutes, lysed, loaded onto poly-acrylamide 
gels and proteins separated under reducing conditions using SDS-PAGE. Proteins 
were transferred to nitro-cellulose membrane, blocked and Immunoblotted for p-Akt 
and then stripped and re-probed for ERK1/2. Representative Immunoblots (left panel) 
and the mean ± SEM of image J quantified blots of three independent donors (right 
panel) are shown. Statistical significance was determined using a (A) two-way ANOVA 
with Bonferri’s post-test and (B) one-way ANOVA with Dunnett’s post-test where 
*p<0.05 compared to control.    















































































Figure 5.8 Catalase pre-treatment attenuates H2O2 induced Akt phosphorylation 
in SEB-activated T lymphocytes. SEB-activated T lymphocytes were pre-treated with 
either vehicle control or increasing concentrations of catalase for 30 minutes. Cells 
were then treated with 100μM H2O2 for 30 minutes. Cells were lysed as described, 
loaded onto poly-acrylamide gels and proteins separated under reducing conditions 
using SDS-PAGE. Proteins were transferred to nitro-cellulose membrane, blocked and 
Immunoblotted for p-Akt and then stripped and re-probed for ERK1/2. (A) Data shown 
are representative Immunoblots, units represent kDa (left panel) and the mean ± SEM 
of three independent donors of image J quantified blots (right panel). (B) is a 
representative blot of 2 donors. Statistical significance was determined by a one-way 
ANOVA with Dunnett’s post-test where *p<0.05, **p<0.01 or ***p<0.001 compared to 
control.    
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5.4 H2O2 enhances the phosphorylation of SHIP-1  
SHIP-1 has been shown to enhance cell survival in response to oxidative stress (Gloire 
et al., 2006). In Chapter 3, SHIP-1 activation negatively impaired T lymphocyte 
polymerisation, migration and polarisation. Likewise, H2O2 was also shown in Chapter 
4 to negatively regulate these processes. The effect of exogenous H2O2 on SHIP-1 
activity was therefore determined. Upon cell stimulation, SHIP-1 is recruited to the 
membrane where it is tyrosine phosphorylated upon Y1020, which lies in the second 
NPXY motif towards its C-terminal. Phosphorylation is used as a marker of activated 
SHIP-1, when SHIP-1 is located at the cell membrane (Phee et al., 2000) and is able to 
bind the phosphotyrosine binding (PTB) domains of Shc (Lioubin et al., 1996) plus 
Dok1 and Dok2 (Dong et al., 2006). SEB-activated T lymphocytes were treated 
increasing concentrations of H2O2 for 30 minutes. Cells were then fixed, permeabilised 
and level of phosphorylated SHIP-1 assessed using flow cytometry. Increasing 
concentrations of H2O2 increased SHIP-1 phosphorylation in a bell-shaped fashion; 
with maximal phosphorylation at 1μM (Figure 5.9) SHIP-1 phosphorylation occurs at 
concentrations of H2O2 which do not affect cellular viability but do significantly alter the 
migration of T lymphocytes. This is an interesting finding that indicates regulation of 
SHIP-1 phosphorylation could be a mechanism by which H2O2 influences T lymphocyte 
migration. 





Figure 5.9 H2O2-induced SHIP-1 phosphorylation in SEB-activated T 
lymphocytes. SEB-activated T lymphocytes were washed three times in serum free 
media and treated with increasing concentrations of H2O2 for 30 minutes. Cells were 
fixed using BD fixation reagent, permeabilized, incubated with SHIP-1 antibody for 30 
minutes followed by FITC conjugated secondary antibody. Mean fluorescence intensity 
per 10,000 cell was measured using flow cytometry. The left panel is a representative 
FAC plot and the right panel is the MFI mean ± SEM of three independent donors 
expressed as percentage change from control. Statistical significance was determined 
by one way ANOVA with Dunnett’s post-test where **p<0.01 as compared to control. 
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5.4.1 H2O2 requires SFK signalling to induce phosphorylation of SHIP-1  
In B lymphocytes, the phosphorylation of SHIP-1 in response to FcγRIIb stimulation 
has been observed to be dependent upon Lyn, a SFK member (O'Neill et al., 2011). 
Although Lyn kinase is not expressed in T lymphocytes (Korade-Mirnics et al., 2000; 
Scapini et al., 2009), other members of the SFK might be involved in SHIP-1 
phosphorylation and therefore the effect of inhibiting SFK upon H2O2-induced SHIP-1 
phosphorylation was examined. 
Firstly, SEB-activated T lymphocytes were pre-treated with 1μM PP2, a non-selective 
SFK inhibitor, for 30 minutes. Cells were then exposed to increasing concentrations of 
H2O2 and SHIP-1 phosphorylation observed by flow cytometry. Pre-treatment with PP2 
significantly impaired H2O2-induced SHIP-1 phosphorylation (Figure 5.10 A), indicating 
that H2O2-induced SHIP-1 phosphorylation requires SFK activation.  
Lck is a SFK member known to be expressed in T lymphocytes. The role of Lck in 
SHIP-1 phosphorylation was therefore examined. 1188890-30-3 is an ATP competitive 
inhibitor of Lck, which according to Calbiochem has an IC50 of 867nM. SEB-activated T 
lymphocytes were pre-treated with 1μM 1188890-30-3 for 30 minutes, exposed to 
increasing concentrations H2O2 and the level of SHIP-1 phosphorylation determined by 
flow cytometry. Although 1188890-30-3 completely attenuated SHIP-1 phosphorylation, 
the basal levels of SHIP-1 phosphorylation was variable between donors. This resulted 
in the Lck pre-treated SHIP-1 phosphorylation not being significantly different to control 
(Figure 5.10 B).  
 















Figure 5.10 Effect of SFK inhibitor (PP2) and Lck inhibitor (1188890-30-3) upon 
H2O2-induced SHIP-1 phosphorylation in SEB-activated T lymphocytes. SEB-
activated T lymphocytes were washed three times in serum free media and pre-treated 
with (A) SFK inhibitor (PP2) and (B) Lck inhibitor (1188890-30-3) for 30 minutes. Cells 
were fixed using BD fixation reagent, permeabilized, incubated with SHIP-1 antibody 
for 30 minutes followed by FITC conjugated secondary antibody.  Left panel is a 
representative FAC plot from a single donor and the right panel is the MFI mean ± SEM 
of three independent donors expressed as percentage change from control. Statistical 
significance was determined by one way-ANOVA with Dunnett’s post-test where 
**p<0.01 as compared to control. 
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5.4.2 H2O2 signalling enhanced the catalytic activity of SHIP-1 
Although phosphorylation of SHIP increases recruitment to the plasma membrane and 
allows for increased SHIP-1 proximity to it substrate, it must be noted that tyrosine 
phosphorylation has been reported to not directly affect catalytic activity (Phee et al., 
2000). The effect of H2O2 on the catalytic activity of SHIP-1 was examined. The 
malachite green assay, which is previously described in section 3.2, was utilised. 
Briefly, the phosphate product generated by SHIP-1 can be measured using malachite 
green molybdate; a chemical that reacts with free organic phosphate to form 
molybdophosphoric acid, which absorbs light at 650nm.   
Firstly, the effect of directly treating recombinant SHIP-1 with H2O2 was examined. 1μM 
recombinant SHIP-1 was incubated with increasing concentrations of H2O2 for 30 
minutes before incubation with in vitro substrate inositol 1,3,4,5-tetrakisphosphate (IP4) 
for a further 30 minutes. Malachite green molybdate was added to determine the level 
of free phosphate. H2O2 had no effect upon the ability of recombinant SHIP-1 ability to 
de-phosphorylate IP4 (Figure 5.11 A). This suggests the H2O2 has no direct effect upon 
recombinant SHIP-1s catalytic activity. 
A common problem with recombinant proteins is that they can be misfolded. To combat 
the possibility of misfolding altering the oxidative sensitivity of the SHIP-1, it was 
instead immunoprecipitated from SEB-activated T lymphocytes. Immunoprecipitated 
SHIP-1 was pipetted from one stock aliquot to ensure the level of SHIP-1 protein is 
equal in each treatment condition. Immunoprecipitated SHIP-1 was treated with 1μM 
H2O2 for 30 minutes before incubation with substrate IP4. Free phosphate production 
was determined by addition of malachite green molybate and absorbance read on a 
plate reader. Control absorbance from immunoprecipitated SHIP-1 alone was 
significantly enhanced after incubation with the IP4 substrate indicating 
immunoprecipitated SHIP-1 acted as a phosphatase. However H2O2 treatment had no 
direct effect upon immunoprecipitated SHIP-1 catalytic activity (Figure 5.11 B).  
The observation that H2O2 requires an SFK to phosphorylate SHIP-1 (Figure 5.10 A) 
suggests that H2O2 does not directly oxidise SHIP-1 but instead requires intracellular 
signalling. As such, it could be hypothesised that the catalytic activity of SHIP-1 could 
be higher in whole cells treated with H2O than un-treated cells. Thus, SEB–activated T 
lymphocytes were treated with media control, 1 or 10μM H2O2 for 30 minutes and then 
SHIP-1 was immunoprecipitated. Half the immunoprecipitated SHIP-1 was plated in a 
96 well plate for the malachite green assay and the other half used to verify that the 
amount of immunoprecipitated SHIP-1 was equal in each group by Western Blot. The 
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immunoprecipitated SHIP-1 was then incubated with substrate IP4 and the level of 
phosphate production determined by the addition of malachite green molybate. 
Treatment of the whole cells with 1μM H2O2 evoked a significant increase in the 
catalytic activity of SHIP-1 (Figure 5.11 C). This implies that H2O2 induces intracellular 
signalling to enhance the catalytic activity of SHIP-1. Enhanced SHIP-1 activity within 
















Figure 5.11 Cellular treatment with H2O2 enhanced the catalytic ability of SHIP-1, 
but had no effect upon recombinant or immunoprecipitated SHIP-1. (A) 1μM full 
length recombinant SHIP-1 or (B) the absorbance of immunoprecipitated SHIP-1 alone 
(no subs) or treated with 1μM of H2O2 for 30 minutes at 37
oC. (C) SEB-activated T 
lymphocytes were treated with 1 or 10μM H2O2 for 30 minute and then SHIP-1 was 
immunoprecipitated. 100μM inositol(1,3,4,5)tetrakisphosphate (IP4) was added to the 
SHIP-1 for 30 minutes at 37oC and then 100μl malachite green solution was added. 
The level of free phosphate was quantified by reading the absorbance at 650nm. Level 
of SHIP-1 protein was quantified using Western Blotting, using fluorescently tagged 
secondary antibody and fluorescence detected using LiCor Image analyser. Statistical 
significance was determined by one way-ANOVA with Dunnett’s post-test where 
*p<0.05, **p<0.01 as compared to control or ##p<0.01 as compared to no substrate 
control 
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5.5 ROS manipulation on the surface expression of CXCR3 
ROS manipulation was previously shown to alter T lymphocyte migration and actin 
polarisation to CXCL11 (Chapter 4), processes which require signalling through the 
chemokine receptor CXCR3. Therefore, the effect of ROS manipulation upon the 
surface expression of CXCR3 was investigated. A 30 minute treatment of ROS 
manipulators was used in an attempt to limit any transcriptional changes which would 
be unlikely to occur within this short timeframe, and instead focused upon determining 
the effect of ROS upon receptor trafficking. 
 
5.5.1 Exogenous application of hydrogen peroxide (H2O2) causes down-
regulation of cell surface CXCR3 expression but MnTBAP chloride had no effect  
Firstly, SEB-activated T lymphocytes were treated with increasing concentrations of 
H2O2 for 30 minutes and CXCR3 surface expression was determined by flow 
cytometry. H2O2 treatment caused a concentration dependent reduction in CXCR3 
expression (Figure 5.12 A) with an IC50 2μM. Thus, H2O2 significantly decreases the 
expression of CXCR3 at concentrations which affect migration but are not cytotoxic.  
The effect of superoxide dismutase mimetic, MnTBAP chloride was also examined 
upon CXCR3 expression in order to determine whether increasing intracellular H2O2 
would have the same effect as exogenous application of H2O2. However, inconsistently 
with its ability to decrease migration (Figure 4.12), MnTBAP chloride had no effect 
upon SEB-activated T lymphocyte CXCR3 expression (Figure 5.12 B). 






















Figure 5.12 H2O2 reduced the surface receptor expression of CXCR3 in SEB-
activated T lymphocytes, but MnTBAP chloride had no effect. SEB-activated T 
lymphocytes were washed three times in serum free media and treated with increasing 
concentrations of (A) H2O2 or (B) MnTBAP chloride for 30 minutes. Cells were washed 
in ice cold PBS, then blocked in 1% BSA for 30 minutes. Cells were then incubated 
with Alexa-PE-conjugated CXCR3 antibody on ice for 30 minutes. Mean fluorescence 
intensity per 10,000 cell was measured using flow cytometry. The left panel is a 
representative FACS plot from a single donor and the right panel is the mean ± SEM of 
three independent donors, normalised to the un-treated control. Statistical significance 
was determined by one way-ANOVA with Dunnett’s post-test where *p<0.05, **p<0.01 
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5.5.2 Effect of dampening the redox environment upon the surface expression of 
CXCR3 
As application of exogenous H2O2 down-regulated the surface expression of CXCR3, 
the effect of dampening ROS upon CXCR3 expression was examined. Firstly, catalase 
pre-treatment of SEB-activated T lymphocytes caused a small but significant increase 
in CXCR3 expression (Figure 5.13 A). Catalase evoking a marginal increase in CXCR3 
expression is consistent with it increasing migration of CXCL11-induced migration 
(Figure 4.13). To control for possible impurities in the catalase, the solution was boiled 
for 10 minutes to deactivate the catalase. Deactivated catalase had no effect upon 
surface CXCR3 expression (Figure 5.13 B).  
 
Secondly, the redox environment was dampened using diphenyleneiodonium (DPI), a 
potent NOX inhibitor. Consistently with its inability to alter cell migration (Figure 14.13), 
DPI had no significant effect upon surface expression of CXCR3 (Figure 5.9 C). Finally, 
dithiothreitol (DTT) is a reducing agent which has been shown to restore protein activity 
lost by oxidation (Cleland, 1964). DTT significantly enhanced the surface expression of 
CXCR3 (Figure 5.13 D), suggesting that oxidation is involved in the internalisation of 
CXCR3. 
 
5.5.3 Hypoxia significantly enhanced surface receptor expression of CXCR3 
Exposure to low oxygen (hypoxia) elevates mitochondrial ROS generated within the 
cells and appeared to impair SEB-activated T lymphocyte directional migration (Figure 
4.14 A). Therefore the effect of a 3 hour exposure to hypoxia was examined to 
determine whether it had any affect upon the surface expression of CXCR3. Hypoxia 
un-expectantly enhanced the level of CXCR3 surface expression (Figure 5.14). 
Although, it was unlikely that 30 minute treatment with H2O2 would induce any 
transcriptional changes in CXCR3 expression, a 3 hour exposure to hypoxia could 
increase the transcription of CXCR3 resulting in higher surface CXCR3 expression.  



















Figure 5.13 Effect of catalase and DPI upon surface receptor expression of 
CXCR3 in SEB-activated T lymphocytes. SEB-activated T lymphocytes were washed 
three times in serum free media and treated with increasing concentrations of (A) 
catalase, (B) deactivated catalase, (C) DPI or (D) DTT for 30 minutes. Cells were 
washed in ice cold PBS, then blocked in 1% BSA for 30 minutes. Cells were then 
incubated with Alexa-PE-conjugated CXCR3 antibody on ice for 30 minutes. Mean 
fluorescence intensity per 10,000 cells was measured using flow cytometry. The left 
panel is a representative FAC plot for a single donor and the right panel is the mean ± 
SEM of three independent donors, normalised to the un-treated control. Statistical 
significance was determined by one way-ANOVA with Dunnett’s post-test where 
*p<0.05, **p<0.01 or *** p<0.001 as compared to control. 






























































































































Figure 5.14 Hypoxia significantly enhanced surface receptor expression of 
CXCR3 in SEB-activated T lymphocytes. SEB-activated T lymphocytes were washed 
three times in serum free media and placed in either standard cell culture conditions 
(air: 5% CO2: 37
oC) or a hypoxic chamber (5% O2: 5% CO2: 90% N2 37
oC) for 3 hours. 
Cells were washed in ice cold PBS, then blocked in 1% BSA for 30 minutes. Cells were 
then incubated with Alexa-PE-conjugated CXCR3 antibody on ice for 30 minutes. Mean 
fluorescence intensity per 10,000 cells was measured using flow cytometry. The left 
panel is a representative FACs plot from a single donor and the right panel is them 
mean ± SEM of three independent donors, normalised to the un-treated control. 
Statistical significance was determined by one way-ANOVA with Dunnett’s post-test 
where *p<0.05, as compared to control. 
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5.5.4 H2O2-induced down-regulation of CXCR3 surface expression requires SFK 
signalling 
As SFK signalling is required for H2O2-induced SHIP-1 phosphorylation, the effect of 
SFK inhibition upon H2O2-induced CXCR3 down-regulation was examined. Firstly, 
SEB-activated T lymphocytes were pre-treated with 1μM PP2, a non-selective SFK 
inhibitor, for 30 minutes. Cells were then exposed to increasing concentrations of H2O2 
and levels of surface CXCR3 expression observed by flow cytometry. Pre-treatment 
with PP2 significantly impaired the ability of H2O2 to down-regulate CXCR3 expression 
(Figure 5.15 A), suggesting that CXCR3 down-regulation in activated T lymphocytes 










Figure 5.15 SFK inhibitor (PP2) inhibited H2O2-induced down-regulation of 
CXCR3 surface receptor expression in SEB-activated T lymphocytes. SEB-
activated T lymphocytes were washed three times in serum free media and treated with 
(A) PP2 (1μM) for 30 minutes then cells were treated with increasing concentration of 
H2O2. Cells were washed in ice cold PBS, then blocked in 1% BSA for 30 minutes. 
Cells were then incubated with Alexa-PE-conjugated CXCR3 antibody on ice for 30 
minutes. Mean fluorescence intensity per 10,000 cells was measured using flow 
cytometry. The left panel is a representative FACS plot from a single donor and the 
right panel is the mean ± SEM of three independent donors, normalised to the un-
treated control. Statistical significance was determined by two-way ANOVA with 
Bonferroni’s post-test where *p<0.05 or **p<0.01 as compared to control and #p<0.05, 
#p<0.01 comparison with H2O2. 
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5.5.5 H2O2-induced down-regulation of CXCR3 surface expression does not 
require PI3K signalling 
H2O2 has been shown to activate both PI3K and SHIP-1 signalling. Thus, PI3K 
signalling could also play a part in H2O2 decreasing CXCR3 expression. To examine 
whether the PI3K signalling was required for H2O2-induced decrease in CXCR3 surface 
expression, SEB-activated T lymphocytes were pre-treated with 1μM ZSTK474 a pan 
PI3K kinase inhibitor for 30 minutes before exposure to increasing concentrations of 
H2O2. Pre-treatment with PI3K inhibitor had no effect upon H2O2 to down-regulate 
CXCR3 expression (Figure 5.16 A). This implies CXCR3 down-regulation does not 
require PI3K signalling, and is consistent with the observation that SHIP-1 activation 
and inhibition did not affect CXCR3 expression (Figure 3.13). 
 
5.5.6 CXCL11-induced down-regulation of CXCR3 expression does not require 
SFK   
Ligand-induced desensitization and internalization of chemokine receptors is a critical 
mechanism by which GPCR signalling is regulated. CXCL11 is known to down-regulate 
the surface expression of CXCR3 at the surface membrane by enhancing receptor 
recycling and degradation (Meiser et al., 2008). Interestingly H2O2-induced down-
regulation of CXCR3 surface expression required SFK signalling; therefore the next 
step was to establish whether CXCL11 also required SFK signalling to reduce 
expression of CXCR3.  
SEB-activated T lymphocytes were pre-treated with 1μM PP2, a non-selective SFK 
inhibitor, or 1μM Lck inhibitor 1188890-30-3 for 30 minutes. Cells were then exposed to 
increasing concentrations of CXCL11 and levels of surface CXCR3 expression 
observed by flow cytometry. CXCL11 evoked a concentration dependent reduction in 
the expression of CXCR3, however neither SFK nor Lck inhibition had any effect upon 
CXCL11-induced down-regulation of CXCR3 (Figure 5.16 B). This suggests that H2O2 
and CXCL11 induce distinct intracellular signalling to internalise the CXCR3 receptor.   






















Figure 5.16 PI3K inhibition does not affect H2O2-induced down-regulation of 
CXCR3 and CXCL11-induce downregulation of CXCR3 does not require SFK (A) 
SEB-activated T lymphocytes were washed three times in serum free media and 
treated with ZSTK474 (1μM) for 30 minutes, followed by treatment with increasing 
concentration of H2O2. Cells were washed in ice cold PBS, then blocked in 1% BSA for 
30 minutes. Data are (left panel) a representative FAC plot and (right panel) the mean 
± SEM normalised to untreated control from two independent donors. SEB-activated T 
lymphocytes were washed three times in serum free media and treated with (A) PP2 
(1μM) or (B) 1188890-30-3 (1μM) for 30 minutes then cells were treated with 
increasing concentration of CXCL11. Cells were then incubated in either IgG control 
antibody or Alexa-PE-conjugated CXCR3 antibody on ice for 30 minutes and washed 
twice in ice cold PBS. Mean fluorescence intensity per 10,000 cells was measured 
using flow cytometry. Data are (left panel) a representative FACS plot and (right panel) 
the mean ± SEM minus IgG control, normalised to untreated control from three 
independent donors.  
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5.6 H2O2 induces Ca
2+ elevation in SEB-activated T lymphocytes  
An important signal cellular signal involved in T cell activation and migration is 
elevation of intracellular Ca2+ (Negulescu et al., 1994). There have been many reports 
across mammalian cells that H2O2 can cause mobilisation of intracellular Ca
2+ (Korzets 
et al., 1999). To determine whether H2O2 induces intracellular Ca
2+ release in human T 
lymphocytes, cells were loaded with a Ca2+ sensitive reporter Fluo-4, and fluorescence 




2+ elevation is unaffected by removal of extracellular Ca2+ 
SEB-activated T lymphocyte were treated with increasing concentration of H2O2 and 
level of Ca2+ measured over time. 1mM and 10mM H2O2 evoked a significant increase 
in intracellular Ca2+ with an initial steep rise in Ca2+ until a stable plateau was reached 
(Figure 5.17 A). High concentrations of H2O2 immediately induce Ca
2+ mobilisation 
within T lymphocytes. 
To verify that the H2O2-induced Ca
2+ response is due to oxidation and to test whether it 
is a reversible response, the ability of dithiothreitol (DTT) to reverse the Ca2+ rise was 
examined. DTT is a reducing agent which has been shown to restore protein activity 
lost by oxidation (Cleland, 1964). Cells were treated with 10mM H2O2 until a stable 
plateau was established, then DTT was added and the reversal measured. 1mM DTT 
significantly reduced that Ca2+ elevation and 10mM DTT completely attenuated the 
response to resting levels (Figure 5.17 B). This indicates that the H2O2 response is 
reversible and occurs due to oxidation. 
Next, the ability of H2O2 to induce Ca
2+ elevation in low Ca2+ media was investigated. 
By using low Ca2+ media, extracellular Ca2+ was reduced which allowed the proportion 
of Ca2+ from intracellular stores to be established. The removal of extracellular Ca2+ did 
cause a marginal reduction of H2O2-induced Ca
2+ elevation, although not significant 
(Figure 5.17 C). This suggests that the major Ca2+ source is intracellular stores.  
























Figure 5.17 H2O2-induced intracellular calcium mobilisation is dependent upon 
oxidation and Ca2+ release from intracellular stores in SEB-activated T 
lymphocytes. SEB-activated T lymphocytes were washed into PBS and loaded for 45 
minutes with 1μM Fluo-4. Cells were washed 3 times and re-suspended at 1 million 
cells per ml in Ca2+ free-HBSS and (A & B) extracellular Ca2+ adjusted to 1mM. Cells 
were plated in a black 96 well plate and either allowed to rest or treated with (A & C) 
increasing concentrations of H2O2 for 30 minutes or (B) 10mM H2O2 (until a stable 
plateau in Ca2+ response was reached) followed by increasing concentrations of DTT. 
1µM ionomycin was used as a loading control. the left panel is a kinetic trace indicating 
change in fluorescence from basal (∆F/F0) from one representative donor. The right 
panel is the (A & C) peak change in fluorescence generated by H2O2 as a percentage 
of the peak change generated by ionomycin and (B) % reversal of H2O2 response. Data 
are the mean ± SEM from averaged duplicates of three independent donors. Statistical 
significance was tested using a one-way ANOVA with Dunnett’s post-test relative to 
control where * p<0.05 or ***p<0.001. 






































































































































2+ elevation requires PLC but not PI3K, SFK, SYK, MAPK or 
PKC signalling 
H2O2-induced Ca
2+ elevation has been shown to be sensitive to the tyrosine kinase 
blocker genistein in PBMCs (Korzets et al., 1999). Therefore the effect of inhibiting 
several cellular kinases was established to determine whether H2O2 requires them to 
initiate Ca2+ signalling. 
SEB-activated T lymphocytes were treated with the stated concentration each inhibitor 
for 30 minutes followed by increasing concentrations of H2O2 and the level of 
intracellular Ca2+ measured using fluo-4 fluorescence. As shown above, H2O2 induces 
Ca2+ elevation at concentrations which were shown to activate Akt, ERK and Src 
kinase phosphorylation (Figure 5.6). In addition, as SFKs are required for H2O2-induced 
SHIP-1 phosphorylation and CXCR3 down-regulation, the effects of PI3K, SFK and 
SYK inhibition were investigated. 1μM PI3K (LY294002 and ZSTK474), SFK (PP2) and 
SYK (picetannol) inhibition had no effect upon H2O2-induced Ca
2+ mobilization (Figure 
5.18) and therefore are not required for H2O2-induced Ca
2+ release. 
IKK inactivates NFκB and participates in several protein cascades including MAPK. 
Alongside IKK (TPCA-1α), mitogen-activated protein kinases (p38; SCIO-469α) and 
mitogen-activated protein kinase kinase (MEK; PD0325901α) inhibition was 
investigated to determine whether Ca2+ release was dependent upon MAPK signalling. 
IKK, p38 and MEK inhibition had no effect upon H2O2-induced Ca
2+ mobilization (Figure 
5.19). This implies MAPK signalling is not involved in H2O2-induced Ca
2+ elevation. 
The most common pathway involved in Ca2+ mobilisation is phospholipase C (PLC), 
which hydrolyses the membrane lipid PI(4,5)P2 into IP3 and diacylglycerol (DAG). IP3 
binds to the IP3 receptor, a Ca2+ channel which releases Ca2+ from the endoplasmic 
reticulum. PLC inhibitor U73122 significantly reduced the effect of 10mM H2O2 to evoke 
Ca2+ mobilization (Figure 5.20 B). Importantly, U73343, an inactive chemical analog of 
U73122, was used as a negative control and had no effect upon H2O2-induced Ca
2+ 
mobilization (Figure 5.20 A), hence H2O2 requires PLC signalling to maximally elevate 
intracellular Ca2+. DAG activates protein kinase C (PKC) and therefore the effect of 
PKC inhibition was also determined on H2O2-induced Ca
2+. The PKC inhibitor RO-32-
0432 had no effect upon H2O2-induced Ca
2+ mobilization (Figure 5.20 C).  
 
Chapter 5. Investigating H2O2-induced signalling in T lymphocytes  
203 
 
Figure 5.18 PI3K, SFK and SYK inhibition had no effect upon H2O2-induced 
intracellular calcium mobilisation in SEB-activated T lymphocytes. SEB-activated 
T lymphocytes were washed into PBS and loaded for 45 minutes with 1μM Fluo-4. 
Cells were washed 3 times and re-suspended at 1 million cells per ml in HBSS and 
extracellular Ca2+ adjusted to 1mM. Cells were plated in a black 96 well plate and 
treated with 1μM (A) LY294002, (B) ZSTK474, (C) PP2 or (D) piceatannol, and then 
treated with increasing concentrations of H2O2 for 30 minutes. 1µM ionomycin was 
used as a loading control. Left panel is a kinetic trace indicating change in fluorescence 
from basal (∆F/F0) from one representative donor. The right panel is the percentage of 
the ionomycin response and is the mean ± SEM from averaged duplicates of three 
independent donors. Statistical significance was determined using a two-way ANOVA 






















































































































































































Figure 5.19 p38, MEK and IKK inhibition had no effect upon H2O2-induced 
intracellular calcium mobilisation in SEB-activated T lymphocytes. SEB-activated 
T lymphocytes were washed into PBS and loaded for 45 minutes with 1μM Fluo-4. 
Cells were washed 3 times and re-suspended at 1 million cells per ml in Ca2+ free-
HBSS and extracellular was Ca2+ adjusted to 1mM. Cells were plated in a black 96 well 
plate and treated with 10μM (A) SCIO-469α (B) PD0325901α and (C) TPCA1α and 
then treated with increasing concentrations of H2O2 for 30 minutes. 1µM ionomycin was 
used as a loading control. Left panel is a kinetic trace indicating change in fluorescence 
from basal (∆F/F0) from one representative donor. The right panel is the percentage of 
the ionomycin response and is the mean ± SEM from averaged duplicates of three 
















































































































































Figure 5.20 PLC but not PKC inhibition significantly inhibited H2O2-induced 
intracellular calcium mobilisation in SEB-activated T lymphocytes. SEB-activated 
T lymphocytes were washed into PBS and loaded for 45 minutes with 1μM Fluo-4. 
Cells were washed 3 times and re-suspended at 1 million cells per ml in Ca2+ free-
HBSS and extracellular Ca2+ adjusted to 1mM. Cells were plated in a black 96 well 
plate and treated with 1μM (A) U73343 (B) U73122 and 5μM (C) RO-32-0432 and then 
treated with increasing concentrations of H2O2 for 30 minutes. 1µM ionomycin was 
used as a loading control. Left panel is a kinetic trace indicating change in fluorescence 
from basal (∆F/F0) from one representative donor. The right panel is the percentage of 
the ionomycin response and is the mean ± SEM from averaged duplicates of three 
independent donors. Statistical significance was tested using a two-way ANOVA with 
Bonferroni post-test where *p<0.05 relative to untreated control. 
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5.7 Chapter 5 Results Summary 
(a) Small molecule inhibitors upon SEB-activated T lymphocyte migration 
 Basal migration requires PI3K, PLC, PKC and SFK signalling 
 CXCL11-induced migration requires PI3K, PLC, SFK and SYK signalling 
 Inhibition of SFK, SYK or PI3K cannot rescue the migratory defect observed 
with H2O2 
(b) Hypoxia 
 Exposure to hypoxia significantly inhibits SEB-activated migration to CXCL11 
 Exposure to hypoxia for 3 hours significantly enhanced the surface expression 
of CXCR3  
 
(c) ROS signalling 
 High concentrations of H2O2 require PLC signalling to induce Ca
2+ mobilisation 
 Oxidative stress induces phosphorylation of Src kinase, Akt and ERK 
 Catalase treatment can suppress H2O2-induced Akt phosphorylation 
 Low concentrations of H2O2 require SFK signalling to enhance the 
phosphorylation and catalytic activity of SHIP-1 
 Low concentrations of H2O2 down regulated the surface expression of CXCR3, 
however MnTBAP chloride had no effect 
 Catalase marginally increased surface expression of CXCR3, whereas DPI had 
no effect 
 SFK signalling was required to down-regulate the surface expression of CXCR3 
 PI3K signalling was not required to down-regulate the surface expression of 
CXCR3 
 CXCL11 does not require SFK signalling to down-regulate the surface 
expression of CXCR3 
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5.8 Chapter 5 Discussion  
 
Importance of SFK and SYK in CXCL11-induced migration 
SFK members, Lck and Fyn, and SYK, ZAP-70, are known to have a critical role in T 
lymphocyte development and activation and are recruited and phosphorylate 
immunoreceptor tyrosine based activation motifs (ITAMs) within CD3 and the zeta 
chain of the TCR receptor (Salmond et al., 2009). Phosphorylated ITAMs serve as 
docking sites for SYK to become activated and initiate signalling. However, the 
signalling roles of SFKs and SYK in T lymphocyte migration are less well understood. 
The G protein, Gαi, has been shown to directly stimulate Src kinase activity (Ma et al., 
2000) and Lyn kinase is activated downstream of both CXCR4 in B cells (Ptasznik et 
al., 2002) and CCR5 in macrophages (Tomkowicz et al., 2006).  
Here, the specific contribution of SFK and SYK signalling in SEB-activated T 
lymphocyte migration towards CXCL11 was examined. It has previously been observed 
that either genetic silencing of the Lck (Zaman et al., 2008) or ZAP-70 (Ottoson et al., 
2001) in Jurkat cells inhibits their migration towards CXCL12. CXCR3 stimulation with 
CXCL10 has been shown to require both SFK and SYK signalling to induce adhesion 
to VCAM-1 in Jurkat cells stably expressing CXCR3 (Sun et al., 2014). Interestingly, 
both SFK and SYK signalling is required for CXCL11-induced directional migration of 
primary human SEB-activated T lymphocytes (Table 5.1), indicating that CXCL11-
induced ligation of the CXCR3 receptor initiates SFK and SYK signalling.  
 
PI3K signalling is required for activated T lymphocyte migration  
Activation of PI3K is a robust signalling event, which occurs upon ligation of chemokine 
receptors and has been reported to be required for directional migration across several 
cell types (Welf et al., 2012; Gambardella et al., 2013; Wu et al., 2015). Specifically in T 
lymphocytes, PI3K signalling has been shown to regulate the chemotactic migration of 
freshly isolated CD4/CD8 T lymphocytes and leukemic T cell lines to CCL19, CCL21 
and CXCL12 (Sasaki et al., 2000; Reif et al., 2004). However, it has previously been 
observed that chemokine-induced migration of activated T lymphocytes is resistant to 
the pan PI3K inhibitors LY294002 and wortmannin (Smit et al., 2003; Cronshaw et al., 
2006). This led to the hypothesis that ex-vivo maintenance and activation/differentiation 
of the T lymphocytes leads to the acquiring a resistance to PI3K inhibition and 
undertaking migration using PI3K independent signalling.  
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Surprisingly, the pan PI3K inhibitor ZSTK474 evoked a concentration dependent 
reduction in CXCL11-driven migration of activated T lymphocytes which was significant 
at 10μM. Consistently with the previous studies, the directional migration of activated T 
lymphocytes was resistant to pan PI3K inhibitor LY294002. In an attempt to understand 
the distinct outcomes of ZSTK474 and LY294002 upon SEB-activated migration, their 
molecular pharmacological profile was researched in the literature. LY294002 is a 
member of the first generation of PI3K inhibitors and is 30 fold less potent than 
ZSTK474 at inhibiting PI3K isoforms. ZSTK474 is most effective at inhibiting PI3Kδ, 
whereas LY294002 is most effective at inhibiting PI3Kα (Kong et al., 2007). The IC50 of 
each drug at inhibiting PI3K isoforms are summarised in Table 1.3. In addition to 
LY29004 being a less potent inhibitor of PI3K, it has also been shown to have more 
non-selective effects, with concentrations above 10μM LY29004 inhibiting other 
signalling enzymes including class II PI3K and Ptdlns 4-kinases (Fruman et al., 1998). 
LY29004 also has activity against mTOR signalling above 5μM (Brunn et al., 1996). 
Thus, ZSTK474 is more selective and potent than LY294002. Even at 100μM, 
ZSTK474 only weakly inhibits mTOR (Kong et al., 2007).  
As the pan PI3K inhibitor ZSTK474 inhibited migration, the effect of isoform specific 
inhibitors of PI3K were investigated upon the migration of activated T lymphocytes. 
Neither the PI3Kγ inhibitor AS-252424 nor PI3Kδ inhibitor IC871114 had any effect 
upon basal or CXCL11 migration. However, as redundancy often exists between the 
different isoforms of PI3K (Chaussade et al., 2007; Foukas et al., 2010; Juss et al., 
2012), the effect combining AS-252424 and IC871114 was examined. The collective 
inhibition of both isoforms significantly impaired both basal and CXCL11-induced 
migration in a similar fashion to ZSTK474, confirming that PI3K signalling is required 
for directional migration towards CXCL11 and implying that PI3Kγ and PI3Kδ provide 
compensatory roles. In addition, ZSTK474 was observed to completely attenuate 
CXCL11-induced Akt phosphorylation, indicating the importance of PI3K in initiating 
signalling in SEB-activated T lymphocytes. 
It is important to note that migration was not completely abrogated with PI3K inhibition, 
suggesting that although PI3K signalling is not dispensable, activated T lymphocytes 
may also require PI3K independent signalling pathways to undertake migration. 
Indeed, it was also shown that CXCL11-induced migration required signalling through 
phospholipase C (PLC), a PI3K independent pathway involved in T lymphocyte 
migration (Table 5.1). Phospholipase C (PLC) hydrolyses the membrane lipid PI(4,5)P2 
into IP3 and diacylglycerol (DAG). IP3 binds to the IP3 receptor, a Ca2+ channel which 
releases Ca2+ from the endoplasmic reticulum. The PLC inhibitor U73122 significantly 
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reduced basal and CXCL11-induced migration. Importantly, the negative control 
U73343, an inactive chemical analog of U73122, had no effect upon CXCL11-induced 
migration, but surprisingly appeared to have a marginal effect upon basal migration. 
This suggests that the inhibition of basal migration by U73122 may at least partially 
occur through a non-selective effect. Interestingly, inhibition of PKC had no effect upon 
CXCL11 migration, which implies DAG induced signalling is not required for CXCL11-
induced migration of activated T lymphocytes. 
 
Compound Inhibits Basal migration 
CXCL11-induced 
migration 
LY29004 Pan PI3K ↓ - 
ZSTK474 Pan PI3K ↓ ↓ 
AS-252424 PI3Kγ - - 
IC871114 PI3Kδ - - 
AS-252424 & 
IC871114 
PI3Kγ & PI3Kδ ↓ ↓ 
PP2 SFK ↓ ↓ 
Piceatanol SYK - ↓ 
U73343 Inactive PLC ↓ - 
U73122 Active PLC ↓ ↓ 
RO-32-0432 PKC ↓ ↓ 
 
Table 5.1 Signalling involved in basal and CXCL11-stimulated migration of 
activated T lymphocytes↓ migration decreased, - migration un-affected  
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Effect of hypoxia upon T lymphocyte migration and CXCR3 expression   
In contrast to standard cell culture conditions which provide 20% oxygen, the human 
body provides much lower oxygen concentrations, ranging from 16% in the pulmonary 
alveoli, to 6% in most organs (Semenza, 2001). Oxygen concentrations can be 
extremely low in pathological sites with low vasculature, such as tumours and sites of 
infection (Vaupel, 1977; Via et al., 2008). Indeed, dysregulation of O2 homeostasis is 
observed in inflammatory and cardiovascular diseases, cancer, cerebrovascular 
disease, and chronic obstructive pulmonary disease. 
Under hypoxic (5% O2) conditions, mitochondria produce higher levels of ROS from the 
respiratory complex III (Guzy et al., 2005). This diffuses into the cytosol where it 
stabilises hypoxia-inducible factor 1, leading to gene transcription and cellular adaption 
to the hypoxic conditions (Eltzschig et al., 2011). Therefore, in addition to being a 
relevant environment setting for an activated T lymphocyte, acute exposure to hypoxia 
presents a method of manipulating the redox environment of the cell.  
Emerging evidence suggests that the expression and functions of GPCRs can be 
controlled by microenvironment triggers. Hypoxia regulates leukocyte migration, 
suppressing the migration of macrophages and monocytes (Turner et al., 1999; 
Grimshaw et al., 2001). Indeed, decreased expression of CCR2 has been observed in 
macrophages associated with the hypoxic environment of human carcinoma (Sica et 
al., 2000) whilst HIF-1α expression induced CXCR4 up-regulation in human 
monocytes, macrophages, endothelial cells and cancer cells (Schioppa et al., 2003). 
Similarly to macrophages, hypoxia reduced the migration of SEB activated T 
lymphocytes. Interestingly 3 hours exposure to hypoxia caused a 400% enhancement 
in CXCR3 expression which could imply that hypoxia is prohibiting the internalisation of 
the receptor or that HIF-1α is able to up-regulate total CXCR3 expression in 3 hours. It 
would be interesting to further this work and investigate the effects of hypoxia on other 
aspects of human T lymphocytes biology. It is important to note that although 5% O2 is 
hypoxic compared to standard cell culture conditions this is likely to be a physiological 
level or “tissue normoxia” rather than pathological hypoxia. It would be interesting to 
further reduce the O2 level to reflect inflammatory hypoxia.  
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H2O2-induced signalling in T lymphocytes  
The mechanisms that immune cells use to detect ROS are not well established. It has 
been proposed the leukocytes could express H2O2 sensitive receptors (Niethammer et 
al., 2009). Alternatively H2O2 has been shown to manipulate cell function through 
entering the cytoplasm and directly modifying intracellular mediators. Unravelling the 
mechanism through which H2O2 signals is vital for understanding its role in T 
lymphocyte biology. Firstly, high concentrations of H2O2 impair T lymphocyte 
proliferation, viability and actin regulation. This section focuses on discussing the effect 
of high concentrations of H2O2 on cellular signalling. 
(a) H2O2 induces Thiol modifications to increase cytosolic Ca
2+  
High concentrations of H2O2-induced an immediate and sustained mobilisation of Ca
2+ 
in SEB-activated T lymphocyte, consistent with reports that oxidative stress causes an 
increase in intracellular Ca2+ mobilisation in various mammalian cells (Krippeit-Drews et 
al., 1995; Herson et al., 1999; Wang et al., 1999; Colston et al., 2002; Zimmerman et 
al., 2005; Sato et al., 2009). Several different mechanisms and types of Ca2+ signalling 
have been indicated in these cells. Therefore, it was important to determine the 
mechanism behind ROS-induced Ca2+ elevation in human T lymphocytes. Extremely 
high concentrations of H2O2, which are known to affect T cell viability over a longer 
period, were assumed to cause toxic, irreversible modification of Ca2+ homeostasis. 
However, basal morphological changes were unremarkable after the T lymphocytes 
were exposed to high (100μM) of H2O2 for 30 minutes (Figure 4.20) and ligand-induced 
Ca2+ elevation was unaffected by 30 minute pre-treatment of 100μM H2O2 (Figure 4.5 & 
4.18). Moreover, the elevation of cytosolic Ca
2+ was eliminated by the addition of 
dithiothreitol (DTT). DTT reduces the disulphide bond within the target protein or 
between protein cysteine thiol and low-molecular-mass thiols such as glutathione. 
Therefore, H2O2 may exert its action by the formation of disulphide bonds. 
Although redox homeostasis is tightly maintained by antioxidants, H2O2 is known to 
oxidise lipids and proteins in response to ligand stimulation. In T lymphocytes, ROS is 
produced from a variety of stimuli, including mitogens (Williams et al., 1996), viral and 
bacterial superantigens (Weber et al., 1995; Hildeman et al., 1999), TCR peptide 
agonists (Devadas et al., 2002; Kwon et al., 2003) and CXCL12 (Hara-Chikuma et al., 
2012) I have shown that low concentrations of ROS are required for human T 
lymphocyte survival and proliferation. Thus, H2O2 could cause a reversible modification 
of proteins to trigger positive Ca2+ signalling required for cellular survival.  
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(b) Origin of Ca2+ rise induced by H2O2 
Previous studies have reported that oxidative stress-induced cytosolic Ca2+ elevation is 
distinct in different cell types, with multiple mechanisms reported including release from 
the endoplasmic reticulum (ER), mitochondria and/or Ca2+ influx (Colston et al., 2002; 
Zimmerman et al., 2005; Nakamura et al., 2009). Extracellular Ca2+ influx is not 
required in H2O2-induced Ca
2+ elevation in human SEB activated T lymphocytes, since 
the omission of extracellular Ca2+ did not abolish the Ca2+ increase. Cytosolic Ca2+ 
elevation in human T lymphocytes occurs from intracellular sources. Possible sources 
include the ER and mitochondria. Ca2+ may also be liberated from non-ER and non-
mitochondrial Ca2+ pool, such as the endosomes and golgi apparatus (Rizzuto et al., 
2006) or if due to necrosis from calcium bound to annexin V (Cuschieri et al., 2005) 
Further experiments using thapsigarin, a sarco/endoplasmic reticulum Ca2+ ATPase to 
deplete the ER or FCCP, a mitochondria un-coupler could help determine the 
intracellular location of the elevated Ca2+ 
It is interesting to note that our results are in disagreement with Bogeski et al 2010. 
Here, primary TH cells from human donors respond to acute H2O2 by immediate 
increases in intracellular Ca2+, however was caused by the opening non-selective 
cation channels (such as redox sensitive TRPM). Interestingly, T lymphocyte 
differentiation shifted the activating EC50 values from 130 to 740μM, indicating that 
naïve T lymphocytes appear to be more sensitive to ROS (Bogeski et al., 2010). This 
disparity could be due to the use of different T lymphocyte sub-types; specifically they 
used T helper cells, whereas I used a mixed population. 
 
(c) PLC inhibition reduced H2O2 induced Ca
2+ increase  
H2O2 -induced Ca
2+  elevation in peripheral blood mononuclear cells (PBMC) is 
sensitive to the tyrosine kinase inhibitor, genistein (Korzets et al., 1999), indicating that 
intracellular tyrosine kinase co-ordinates Ca2+ elevation in PBMCs. In addition, H2O2 
has been observed to act directly upon inositol 1,4,5-trisphosphate receptors to 
activate Ca2+ release in endothelial cells (Zheng et al., 2005). Here, inhibition of 
kinases PI3K, SFK, SYK, PKC and MAPK had no effect upon this H2O2 driven 
response, suggesting their signalling was not required to stimulate cytosolic Ca2+ 
elevation. However, PLC signalling was shown to be required for maximal Ca2+ 
elevation (Figure 5.20). PLC has previously been shown to be redox sensitive in 
macrophages (Liu et al., 2007).  
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Perspective – Effect of high concentrations of H2O2 on T lymphocytes   
ROS species are known to induce bifurcate responses within cells, with high 
concentrations evoking cell death and low concentration required for cell survival, 
signalling and proliferation. Here, high concentrations of H2O2 activate cellular 
signalling including PI3K, MAPK, Src (discussed below) and PLC. However, although 
these are positive signalling pathways that are known to be required for T cell survival 
and proliferation, it is likely that oxidative stress overwhelms the cellular antioxidants 
causing oxidative damage (Steinberg, 2013) resulting in the dysregulation of actin, 
decreased proliferation and survival of T lymphocytes (Figure 5.21).  
Consistently with the bifurcate roles, dampening the redox environment also decreases 
human T lymphocyte survival and proliferation. Interestingly, quantification of thiol 
oxidation in cells has indicated that oxidation events are not equal across different 
cellular organelles (Balaban et al., 2005; Go et al., 2008) Instead oxidation events 
occur in cellular compartments to co-ordinate precise cellular signalling. I hypothesize 
that under physiological conditions localised ROS in cellular compartments may 
accumulate to high concentrations to signals through similar positive signalling 
pathways required for cell proliferation and survival without overwhelming cellular 
antioxidants and evoking cell death (Figure 5.21).  
New methods for studying redox compartmentalization have recently become 
available, with probes which now permit the observation of rapid redox changes in real 
time and within single organelles (Belousov et al., 2006; Woolley et al., 2013; Ezerina 
et al., 2014). Development of these novel tools to measure compartmentalized ROS 
formation and redox status, will allows for better characterization of ROS signals in 
compartments and microdomains (Kaludercic et al., 2014). 




Figure 5.21 Model of oxidative stress-induced signalling in human SEB activated 
T lymphocytes. This model is based on the results of this chapter and chapter 4 and 
the findings of (Kwon et al., 2003; Kashiwada et al., 2006) 1) Several pathologies result 
in accumulation of high levels of ROS including wounds, chronic infection and cancer 
exposing T lymphocytes to oxidative stress. 2) TCR stimulation also produces H2O2 
through NOX2/DUOX enzymes, which are known to be expressed on the cell 
membrane and membranes of cellular organelles. Thus, ROS accumulates in micro-
domains to regulate precise cell signalling. Mitochondria also produce high levels of 
ROS, especially under hypoxic conditions. 3) Exposure to >100μM exogenous H2O2 
places cell under oxidative stress. H2O2 enters the cell through aquaporin channels 4) 
>100μM H2O2-induces the phosphorylation of Src, Akt and ERK, however oxidation 
might occur at lower concentrations. 5) >100μM alters actin polarisation and 
polymerisation, although basal cell morphology is unaltered 6) >100μM H2O2 requires 
PLC to stimulate intracellular Ca2+ from an unknown intracellular source (possibly ER, 
golgi or mitochondria) 7) >100μM H2O2 evokes oxidative stress which culminates in 
reduced T lymphocyte proliferation and survival. 8) Proposed outcomes of exposure to 
high ROS.  
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Unravelling the mechanism of H2O2-induced migratory defect 
Secondly, in order to unravel the mechanisms of H2O2-induced migratory defect, the 
effect of H2O2 upon was examined in signalling pathways that are (1) important in 
cellular migration and (2) have previously been indicated as being redox sensitive, 
including PI3K, SHIP-1, MAPK and SFK signalling (Truong et al., 2013). In addition, it  
was thought prudent to investigate the effect of ROS manipulation upon the chemokine 
receptor CXCR3.  
PI3K signalling 
Firstly, the asymmetric distribution of PI3Ks product, PI(3,4,5)P3 at the front of the cell 
is a hallmark of cell polarisation (Wang et al., 2002a; Wang, 2009). Earlier I described 
the importance of PI3K in the directional migration of SEB-activated T lymphocytes. 
Redox inactivation of PTEN, a negative regulator of the PI3K pathway signalling 
pathway has been previously described and occurs by the formation of a disulphide 
bond between Cys 124 residue of the active site and Cys71 (Lee et al., 2002; Kwon et 
al., 2004). High concentrations of H2O2 increased Akt phosphorylation in SEB activated 
T lymphocytes, indicating that H2O2 can manipulate PI3K-dependent signalling. 
However, PI3K inhibition was able to completely attenuate the accumulation of Akt 
phosphorylation, which implies that H2O2 activates PI3K to enhance Akt 
phosphorylation, rather than inhibiting PTEN (Figure 5.21).  
H2O2 signalling through PI3K to phosphorylate Akt has been previously described in 
several other cells types including vascular smooth muscle cells (Ushio-Fukai et al., 
1999) and Jurkat cells (Lahair et al., 2006). Interestingly, direct oxidation of Akt has 
also been described at several specific cysteine residues (Wani et al., 2011), in 
particular a disulphide bond formed between Cys297 and Cys311, resulting in 
increased association of Akt with the negative regulatory phosphatase PP2A and 
dampened Akt signalling (Murata et al., 2003; Durgadoss et al., 2012). 
MAPK signalling   
Mitogen-activated protein kinases (MAPKs) play crucial roles in cell migration, with 
ERK important in phosphorylating myosin light chain kinase (MLCK), calpain and FAK 
(Huang et al., 2004). The MAPK/ERK pathway has also been previously suggested to 
be redox responsive through inactivation of its regulatory phosphatases (Lee et al., 
2003). In addition, there is some evidence of H2O2 directly activating MAPKs (Galli et 
al., 2008), with low levels of H2O2 oxidising cysteine residues in ERK2 leading to 
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conformational changes and increased binding to MEK1/2 whilst oxidative stress 
inhibits MEKK1 by site specific glutathionylation within the ATP binding domain (Cross 
et al., 2004). Here, H2O2 enhanced the phosphorylation of ERK1/2, although this was 
only observed a very high concentration of H2O2 (Figure 5.21).  
The concentrations of H2O2 that evoked phosphorylation of Akt and ERK were likely to 
place cells under oxidative stress as these concentrations are cytotoxic to SEB-
activated T lymphocytes after 24 hour exposure (Figure 4.2). PI3K and MAPK/ERK 
signalling cascades are also important cellular survival mechanisms. Thus, PI3K and 
MAPK activation could be a survival signal following oxidative stress. Hypothetically, it 
is also possible that lower concentrations of H2O2 oxidise cysteine residues within 
signalling proteins which alters their conformation structure and activity without 
resulting in the phosphorylation of the proteins. Determining whether protein activation 
through oxidation always results in phosphorylation (a more understood mechanism of 
protein regulation) would be really interesting to study further. Oxidation has been 
shown to trigger dimerization or oligomerisation through disulphide bond formation or 
tag the protein for trafficking or sequestrations, thus indirectly removing it from the 
vicinity of its target, perhaps exposing it to novel binding partners (Corcoran et al., 
2013).  
SHIP-1 signalling 
H2O2 inactivates the phosphatase PTEN (Lee et al., 2002; Kwon et al., 2004) and 
therefore it has been presumed that it also inactivates SHIP-1, another negative 
regulator of PI3K signalling. However, the direct effect of H2O2 on SHIP-1 catalytic has 
not been investigated. Therefore, our finding that low concentrations of H2O2-induced 
the phosphorylation and enhanced the catalytic activity SHIP-1 was unexpected. 
However, SHIP-1 has previously been shown to have a role in protecting cells against 
H2O2 mediated cell death (Gloire et al., 2006), which could possibly be due to it 
activating signalling down-stream of SHIP-1. SHIP-1 activation could also be a possible 
mechanism by which H2O2 inhibits migration (Figure 5.22), as SHIP-1 activation 
severely impedes the migration of SEB-activated T lymphocyte migration in Chapter 3. 
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CXCR3 receptor internalisation 
Another mechanism by which H2O2 could decrease the migration of T lymphocytes is 
by regulating the level of chemokine receptor internalisation. Receptor internalisation 
decreases the amount of available receptor on the cell surface, thus attenuating 
receptor mediated signalling (Lefkowitz, 1998; Morris et al., 1999) and migration. 
Chemokines such as CXCL11 cause receptor internalisation to regulate their signalling. 
Interestingly, H2O2 significantly decreases the cell surface expression of CXCR3 in 
human activated T lymphocytes and dampening the redox environment using catalase 
resulted in a marginally enhanced surface expression. Thus, H2O2 could inhibit T 
lymphocyte migration by decreasing the surface expression of CXCR3, preventing the 
cell from detecting and signalling to CXCL11. Both the H2O2-induced decrease and 
catalase-induced increase in CXCR3 surface expression were observed after a 30 
minute treatment with H2O2, therefore they are unlikely to be changes in the overall 
expression of the receptor and are likely due to internalisation of the receptor.  
Meiser et al. observed that even 3 hours after treatment with CXCL11, only 70-80% 
expression of CXCR3 was re-established. They determined that CXCR3 is degraded 
following receptor internalisation and has to be replenished on the membrane by de 
novo synthesis (Meiser et al., 2008).This requirement for de novo receptor synthesis 
for expression of CXCR3 may allow for a larger window to observe the effect upon 
CXCR3 internalisation, however CXCL11 and H2O2 might internalise the receptor 
through completely independent mechanisms.  
The regulation of CXCR3 surface expression by H2O2 is an important observation as 
CXCR3 has been indicated in playing a central role in the induction and perpetuation of 
several human inflammatory disorders including atherosclerosis (Mach et al., 1999), 
autoimmune diseases (Sorensen et al., 1999), transplant rejection (Hancock et al., 
2000) and viral infection (Liu et al., 2000). Thus, the finding that oxidation has a role in 
regulating surface expression may be an important consideration in the treatment of 
these diseases. 




To further understand the mechanism by which H2O2 is detected by immune cells, I 
was particularly interested in determining whether SFKs act in the same signalling 
pathway as H2O2 in human SEB activated T lymphocytes. SFK member Lyn has been 
indicated as a redox sensor involved in early neutrophil recruitment to H2O2 at wounds. 
Mutation of a single conserved cysteine residue to alanine at position Cys466 
abolished the ability of Lyn to be oxidised by H2O2. This mutation resulted in an inability 
of the cell to detect and migration towards the H2O2 gradient (Yoo et al., 2011).  
Cys466 is highly conserved across species (zebrafish Lyn, Drosophila Src-42A and 
human Lyn) thus oxidation-dependent activation may be a general method of activation 
for all SFK members, however this has not been fully established. Early evidence 
suggested that nitric oxide (NO)-releasing agents enhanced the catalytic activity of Src 
tyrosine kinase through direct oxidation of the kinase (Akhand et al., 1999; Minetti et 
al., 2002). Subsequently, a number of redox sensitive cysteine residues were identified 
in Src which are important for the enzymes activity (Senga et al., 2000). Lck and Fyn 
are expressed in T lymphocytes, were confirmed to contain the critical cysteine 466 
residue and Lck has been reported to have redox sensitivity (Nakamura et al., 1993). 
The phosphorylation of c-Src at Tyr 416 was assessed as a marker of H2O2 ability to 
activate SKFs in T lymphocytes. The c-Src antibody is likely to cross react with T 
lymphocyte SFKs, Fyn and Lck. c-Src phosphorylation was not observed until high 
concentration of H2O2. However, as described above it is still possible that oxidation 
could alter the kinase activity without enhancing phosphorylation. For instance, 
Giannoni et al. observed that ROS exposure caused a disulphide bond formation 
between Cys245 and Cys487 which enhanced the enzymes activity (Senga et al., 
2000; Giannoni et al., 2005).  
Excitingly, SFK signalling was required for H2O2-induced SHIP-1 phosphorylation in 
SEB-activated T lymphocytes. This is consistent with how SHIP-1 is phosphorylated 
down-stream of receptor signalling. SFK kinase Lyn has previously been shown to be 
required for FcγRIIb-induced phosphorylation of SHIP-1 in B lymphocytes (O'Neill et al., 
2011). However, Lyn kinase is not expressed in T lymphocytes (Korade-Mirnics et al., 
2000; Scapini et al., 2009), which implies redundancy between different SFK members 
to phosphorylate SHIP-1. This provides evidence to connect oxidative signalling and 
SFKs in common pathway in human T lymphocytes and also implies that SFKs are 
activated by much lower concentration of H2O2 than observed to phosphorylate c-Src.  
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Genestein, a tyrosine kinase inhibitor, has no effect upon CXCL11-induced CXCR3 
internalization (Sauty et al., 2001) suggesting that tyrosine kinases are not required in 
internalisation of CXCR3 upon activation with their ligand. Consistently, SFK inhibition 
had no effect upon CXCL11-induced internalisation of CXCR3 in SEB activated T 
lymphocytes. However, SFK inhibition completely attenuated the ability of H2O2 to 
decrease the surface expression of CXCR3. It appears that agonist ligation and 
oxidative signalling induce distinct pathways to down-regulate CXCR3 surface 
expression. Consistently to SHIP-1 phosphorylation, H2O2 requires SFKs to regulate 
CXCR3 internalisation.  
Finally, inhibition of SFK, SYK and PI3K could not rescue the migratory defect 
observed with H2O2. Instead, all three signalling pathway were required for CXCL11-
driven migration. Hypothetically, if H2O2 was acting independently of SFK, SYK and 
PI3K signalling, their inhibition should have produced an additive suppression of 
migration. SFK signalling appears to play a central role in regulating H2O2-induced 
repression of activated T lymphocyte migration, with activation of SHIP-1 (and 
subsequent inhibition of PI3K) and decreased expression of CXCR3 two mechanisms 
through which this may occur (Figure 5.22).  
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Figure 5.22 Model of mechanisms underlying ROS-induced migratory defect in T 
lymphocytes. This model is based on the results of this thesis and some of the 
findings of (Kwon et al., 2010; Hara-Chikuma et al., 2012). 1) Several pathologies 
result in accumulation of high levels of ROS including wounds, chronic infection and 
cancer. 2) Chemokine stimulation also produces exogenous H2O2 through 
NOX2/DUOX enzymes, which are known to be expressed on T lymphocytes. 3) 
Signalling concentrations of exogenous H2O2 enters the cell through aquaporin 
channels and can manipulate proteins in the cytosol. 4) H2O2 signals through SFKs to 
internalise chemokine receptor CXCR3, internalisation could occur through arrestin 
recruitment/ clathrin coated pits, caveolae or an independent mechanism. Once 
internalised, CXCR3 is degraded in the endosome. 5) H2O2 also signals through SFKs 
to phosphorylate and activate SHIP-1. SHIP-1 activation inhibits the ability of CXCL11 
to de-phosphorylate cytoskeletal proteins ezrin, radixin and ERM and 6) inhibits actin 
polarisation. H2O2 also increases total F-actin. 7) Collectively, chemokine 
internalisation, SHIP-1 activation and actin dysregulation reduce cytoskeletal re-
organisation and cell chemotaxis. 8) Proposed outcomes of migration deficiency in T 
lymphocytes.
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6.1 SHIP-1 in T lymphocyte biology 
Overview  
This thesis began by examining how SHIP-1, a negative regulator of PI3K, operates in 
human T lymphocyte biology. The role of PI3Ks in cell function has been extensively 
investigated in recent years, particularly as they have shown much promise as drug 
targets in cancer (Fruman et al., 2009; Foster et al., 2012; So et al., 2012b; 
Okkenhaug, 2013). However, as yet inhibitors have failed to have significant impact in 
the treatment of autoimmune and inflammatory diseases. SHIP-1 now stands at a 
crossroads, with the first activator of SHIP-1 entering Phase III clinical trials for the 
treatment of asthma. However, its functions remain less well understood in human T 
lymphocytes.  
I used a SHIP-1 activator and SHIP-1 inhibitor in combination with in vitro assays to 
allow side by side evaluation of SHIP-1 roles in T lymphocyte biology.  A considerable 
amount of data was generated with key findings indicating that SHIP-1 is crucial in the 
regulation of ligand-mediated signalling, proliferation, adhesion, cytoskeletal protein re-
arrangement and migration of primary human T lymphocytes. The product of SHIP-1 
((PI3,4)P2) is distinct from the phospholipid which is elevated by the direct antagonism 
of PI3K signalling (i.e. PI(4,5)P2). In our hands, both activation and inhibition of SHIP-1 
lead to the same functional outcomes in T lymphocytes, which suggests that both 
PI(3,4,5)P3 and PI(3,4)P2 are vital in T lymphocyte signalling (Figure 3.15). This is 
consistent with the “two PIP signalling hypothesis” described by Kerr which suggests 
PI(3,4,5)P3 and PI(3,4)P2 have independent signalling roles, with the requirement for 
each depending on the cell type and surrounding environment (Kerr, 2011). .  
Whilst some of our findings were in line with data from murine models others, such as 
the decreased proliferation, ran contrary to the findings in mice, and serve to highlight 
the fact that there are often substantial differences between the immune systems of 
mice and humans. This indicates the importance of studying the role of proteins in 
human cells, even if the assays available are somewhat limited compared to animal 
models.  
SHIP-1 now stands at a crossroads, with the first activator of SHIP-1 entering Phase III 
clinical trials. Importantly, although pre-clinical experiments have indicated that SHIP-1 
modulation can alter TCR-induced response, no inappropriate T cell mediated 
autoimmunity or T cell neoplasm have thus far been demonstrated in either the 
pharmacological or genetic strategies implemented to manipulate SHIP-1. Work 
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identified in this thesis suggests SHIP-1 is a key role as a modulator of PI3K signalling 
in T lymphocytes and provides evidence to support using SHIP-1 modulators as 
treatments of inflammatory and autoimmune diseases. 
In addition, there are potential benefits to targeting SHIP-1 over isoform specific PI3K 
inhibitors. Firstly, there is a large amount of functional redundancy and plasticity 
between PI3K isoforms, thus isoform targeted therapies might not warrant successful 
treatments in disease setting. Moreover, PI3K dysregulation is often caused by over-
active mutations in PI3K (Pazarentzos et al., 2015; Young et al., 2015), these could 
alter the efficacy and affinity of PI3K inhibitors. Furthermore, the ubiquitous nature of 
PI3K signalling implies that any successful PI3K inhibitors could be complicated by 
non-selective effects and worryingly, it has recently been reported that resistance 
mechanisms can be developed to combat PI3K-targeted therapy (Ilic et al., 2011); 
although selective pressure driving resistance could vary between cancer and 
inflammatory setting. SHIP-1 exhibits a restricted expression prolife limiting non-
selective effects and modulation of SHIP-1 appears to have prolific effects on the 
immune system. SHIP-1 could be a superior target, and at the very least it will be 
beneficial to have multiple mechanisms to pharmacologically target PI3K signalling. 
Future work  
In light of investigations described in this thesis, future experiments should seek to 
address the following unanswered questions and hypotheses.  
 Examine mechanisms underlying SHIP-1 manipulators effect on proliferation. At 
what stage of the cell cycle is the proliferation inhibited? 
 To identify the roles of SHIP-1 compounds upon the differentiation of T 
lymphocytes to different sub-sets. 
 In a migrating cell, PI3K localises to the front of the cell and PTEN to the back to 
generate a polarised production of PI(3,4,5)P3. Is SHIP-1 expression polarised 
during chemotaxis? As SHIP-1s product PI(3,4)P2 has roles in lamellipodia 
formation and actin regulation through its downstream effector TAPP1 and Lpd, I 
hypothesise that SHIP-1s product PI(3,4)P2 is not solely localised at the back of the 
cell. This could be determined using by expressing a fluorescent PI(3,4)P2 reporter 
into T lymphocytes, such as fluorescently labelled PH domain of TAPP1. SHIP-1 
localisation would then be observed under basal and ligand stimulated conditions.  
 Our pharmacological approach could be applied to determine the functional effects 
of SHIP-1 activation or inhibition on T lymphocytes isolated from patients with T 
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lymphocyte component to their pathologies, such as asthma or COPD. Further 
supporting the use of these compounds as specific disease treatment.   
 
6.2 ROS in human T lymphocyte biology 
Overview 
The second facet of this thesis sought to determine the functional and signalling roles 
of ROS in T lymphocyte biology. There is a rapidly growing consensus the oxidative 
signalling is important in diverse cell functions. At present, the roles of ROS in human T 
cell biology are under-investigated, particularly whether ROS affect the cells ability to 
migrate. Two models of inflammation have indicated the importance of H2O2 as a cue 
for innate immune cell migration to a wound (Niethammer et al., 2009; Moreira et al., 
2010). Results which were duplicated in human neutrophils (Yoo et al., 2012) and 
consistent with an observation that H2O2 uptake is required for mouse T lymphocyte 
migration to chemokine (Hara-Chikuma et al., 2012). Therefore I hypothesised that 
H2O2 could act as a chemoattractant for human T lymphocytes. Specific results have 
already been discussed in the previous sections; a more detailed discussion of the 
possible implications and limitations of these studies will now follow. 
ROS species are known to induce bifurcate responses within cells, with high 
concentrations evoking oxidative stress-induced cell death and low concentration 
required cell signalling and function. Therefore, the effects of pharmacological 
manipulation of ROS was examined with anti-oxidants used to lower the redox 
environment and a wide range of concentrations of H2O2 (1nM-10mM) to examine both 
the signalling roles and effect of oxidative stress on T lymphocyte biology. In addition to 
using a wide range of concentrations of H2O2 I could have also have examined a time 
course for H2O2 signalling, as although consistent, 30 minutes is a long exposure time 
to H2O2 in terms of its half-life. Dampening the redox environment with anti-oxidants 
decreased long term human T lymphocyte survival and proliferation, indicating that low 
levels of oxidants are required for T lymphocytes to function. Interestingly, instead of 
acting like a chemoattractant, low concentrations of H2O2 (1nM) appear to signal 
through SFK to selectively phosphorylate and increase the catalytic activity of SHIP-1 
and down-regulate the expression of CXCR3, resulting in inhibition of T lymphocyte 
chemotaxis (Figure 5.22).  
High concentrations of H2O2 activated cellular signalling including PI3K, MAPK, Src and 
PLC and intracellular Ca2+ elevation. However, although these are positive signalling 
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pathways that are known to be required for T cell survival and proliferation, it is likely 
that oxidative stress overwhelms the cellular antioxidants causing oxidative damage 
(Steinberg, 2013) resulting in our observations of dysregulated F-actin, decreased 
proliferation and survival of T lymphocytes (Figure 5.21). 
Interestingly, quantification of protein thiol oxidation in cells has indicated that oxidation 
events are not equal across the cells, particularly at distinct cellular organelles 
(Balaban et al., 2005; Go et al., 2008). Instead of global signalling roles, oxidants 
appear to accumulate in cellular compartments to co-ordinate precise, local signalling 
events. It has been very difficult to determine the concentrations of ROS found in cells 
however, work has been done to determine the location of ROS production in different 
cell compartments using sub-cell-compartment targeted ROS sensitive GFP reporter 
expression. Distinct responses have been observed in different cell types (Go et al., 
2008; Waypa et al., 2010) and this approach could be used to look at the accumulation 
of ROS in T lymphocytes. 
I speculate that under physiological conditions ROS localised to small cellular 
compartments may accumulate to high concentrations, thus could signals through 
similar positive signalling pathways that were observed with global H2O2 exposure, 
without overwhelming cellular antioxidants and evoking cell death. An elegant 
approach would be to use these organelle specific H2O2 reporters to witness ROS 
accumulation in T lymphocytes downstream of ligand stimulation. 
H2O2 is a very small, highly diffusible molecule with a short half-life due to its rapid 
reactivity and degradation. Therefore, as described above, the approach to add bolus 
application of H2O2 is unlikely to represent the intricacies of ROS signalling in vivo. The 
concentration of H2O2 was not monitored over the course of these experiments and 
therefore it is not known how rapidly it was degraded/ diffused. In particular, the bolus 
pre-treatment of H2O2 is unlikely to model the tissue-scale gradient of H2O2 that is 
generated at a wound site which extends between 100-200μm into the tail fin 
(Niethammer et al., 2009). Therefore, a sustained gradient with continuous production 
of H2O2 might have a distinct effect upon T lymphocyte migration. It is however 
possible that bolus treatments of H2O2 might be more reflective of disease states, such 
as cancer where persistent oxidative stress in observed (Coussens et al., 2002; 
Griffiths, 2005; Bartsch et al., 2006; Murata et al., 2014).  
In addition, it has also been shown that bolus and continuous low level H2O2 exposure 
can lead to substantially different signal transduction and cellular responses (Sobotta et 
al., 2013), with high bolus H2O2 reported to lead to artificial results. However, at present 
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it is still very difficult to reliably predict that physiological and pathological levels of 
ROS. Chemiluminescence methods have determined that H2O2 concentration in 
stimulated human neutrophils rarely exceed 10μM (Mueller et al., 1995). In the 
zebrafish tailfin wounding model a maximal concentration of 50μM H2O2 was observed 
at the wound edge. Thus, these two differing concentrations indicate how difficult it 
would be to extrapolate the precise concentrations of ROS within the human body in 
each given scenario. Until these concentrations are known it is difficult to predict a 
bolus treatment concentration which can be described as “artificial”. However, both 
studies suggest that it is unlikely cells will be exposed to prolonged concentrations of 
H2O2 in the millimolar range.   
Based on the information provided in this thesis it is clear that reactive oxygen species 
are not merely an unwanted by product of aerobic respiration which cause unwanted 
damage, instead are biological entities that are required for co-ordinating crucial 
physiological processes. The physiological environment of a T lymphocyte should be 
considered when planning in vitro studies investigating the biology of T lymphocytes. 
Importantly, the timing and subcellular localization of ROS generation are likely of 
greater influence in T cell responses than overall redox balance. Interestingly, 
controlled clinical trials have failed to show a consistent benefit of antioxidants in 
diseases setting (Rapola et al., 1997; Yusuf et al., 2000; Tang et al., 2005). This 
supports our observation that oxidants are not solely toxic to the human body, that 
ROS are both protective and deleterious depending on concentration. 
ROS potently inhibiting T lymphocyte migration was unexpected and has unearthed 
several interesting questions. What are the physiological consequences of low levels of 
ROS suppressing migration? There are several hypothetical scenarios (1) H2O2 could 
dampen the recruitment of adaptive immune cells which are required later in the wound 
repair process (2) in contrast, low level ROS could be responsible for capturing T 
lymphocytes at a site of high ROS by restricting their migration and (3) in a pathological 
setting, high ROS levels cause wide-spread suppression T lymphocyte migration and 
aid cancer cell survival or prolong chronic infection. In addition, a study by Hara-
Chikuma et al. 2012 indicated that H2O2 uptake through aquaporin 3 is required for 
CXCL12-induced mouse T lymphocyte migration; why the disparity? This could be due 
to interspecies variation between mouse and human cells, and indicates that further 
investigation into the role of aquaporin 3 and H2O2 should be undertaken in human T 
lymphocytes. 
 





In light of investigations described in this thesis, future experiments should seek to 
address several un-answered questions and objectives: 
 Determine whether ROS have a role in the differentiation of T lymphocyte 
subsets (i.e. Th1/Th2 or Th17 generation) 
 Examine mechanisms underlying ROS manipulators effect on proliferation. At 
what stage of the cell cycle is the proliferation inhibited? 
 Clarify whether protein phosphorylation is a good marker of oxidative activation. 
 Design an in vitro migration assay which maintains a gradient of H2O2 and 
allows H2O2 to be detected over the time course of the experiment 
 Determine the source of basal ROS that reduces T lymphocyte migration? (i.e. 
why is migration enhanced when cells are pre-treated with catalase), and are 
there any other functions of T lymphocytes which are enhanced by catalase 
treatment? 
 Investigate the mechanism behind H2O2-induced internalisation of the CXCR3 
receptor 
 Use organelle specific, redox sensitive probes to determine the changes in 
ROS accumulation in real time within single organelles following ligand 
stimulation in T lymphocytes 
 Examine the roles of hypoxic environment upon T lymphocyte functions 
(activation, differentiation, survival, migration to more chemokines). 
Furthermore, investigate the effect of manipulating ROS in a hypoxic 
environment   
 Peroxynitrites also appear to have signalling roles within cells (Pacher et al., 
2007; Liaudet et al., 2009). Characterise the roles of peroxynitrites in human T 
lymphocyte biology 
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6.3 Concluding remarks 
T lymphocytes rely upon co-ordinated cellular signalling to undertake their physiological 
functions and resolve infections. However, these pathways often become dysregulated 
in states of pathology. Too much or too little signalling greatly perturbs the ability of T 
lymphocyte to function which can lead to hypo-responsiveness or hyper-activation. This 
thesis provides insight into how signalling pathways function in T lymphocytes. 
Understanding T lymphocyte signalling will lead to novel therapeutic strategies for T 
lymphocyte driven pathologies, including autoimmune/inflammatory disease and 
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